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Abstract	Osteocyte	regulation	of	bone	quality	in	homeostasis	and	in	skeletal	disease	by	Courtney	Mazur		 Osteocytes	are	the	most	numerous	cells	in	bone,	working	from	within	the	mineralized	matrix	to	exert	control	over	their	local	environment	and	cells	on	the	bone	surface.	Healthy	osteocytes	 are	 key	 to	 bone	 homeostasis,	 but	 the	 full	 functional	 importance	 of	 their	 local	remodeling	activity,	called	perilacunar/canalicular	remodeling	(PLR),	is	only	recently	being	discovered.	This	work	uses	multiple	mouse	models	to	investigate	the	molecular	mechanisms	controlling	osteocyte	PLR	and	demonstrates	 that	 repression	of	PLR	causes	severe	 loss	of	bone	 material	 quality.	 Additionally,	 osteocyte	 dysfunction	 is	 shown	 to	 disrupt	 bone	homeostasis	during	skeletal	disease	and	to	promote	degradation	of	overlying	cartilage	in	the	joint.	Finally,	we	begin	to	determine	the	extent	to	which	PLR	is	mechanosensitive,	revealing	distinct	 site-	and	magnitude-specific	modulation	of	osteocyte	behavior	with	applied	 load.	Together	these	findings	reveal	new	essential	roles	for	osteocytes	and	PLR	within	bone	and	joints	during	homeostasis	and	disease.		
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		Chapter	1	Introduction	
To	provide	its	critical	functions	supporting	locomotion	and	protecting	internal	organs,	bone	must	 be	 strong	 enough	 to	 resist	 fractures	 during	 normal	 activity.	 Bone	 mass,	 typically	measured	 with	 2D	 areal	 projections	 in	 the	 clinic,	 has	 largely	 been	 the	 focus	 of	 fracture	prevention	treatment.	To	this	end,	anti-resorptive	drugs	like	bisphosphonates	and	anabolic	therapies	like	intermittent	PTH	injections	are	used	by	several	million	Americans	per	year	(1).	While	these	therapies	are	successful	at	increasing	bone	mass,	having	higher	bone	mass	does	not	necessarily	reduce	fractures,	with	one	8000-person	study	finding	that	half	of	 its	patients	with	fractures	were	not	clinically	osteoporotic	(2).	Therefore	there	is	a	critical	need	to	understand	and	target	other	contributions	to	bone	strength.		 Bone	 quality	 encompasses	 characteristics	 of	 bone	 that	 contribute	 to	 its	 strength	independent	of	quantity.	Metrics	of	bone	quality	 include	bone	geometry,	 the	organization	and	 composition	 of	 the	 extracellular	 matrix,	 flexural	 properties	 before	 and	 after	deformation,	and	material	properties	like	elastic	modulus	and	toughness	(3–8).	In	materials	science	and	engineering,	a	long	history	of	research	connects	metallurgic	and	manufacturing	techniques	 to	 the	 quality	 and	 subsequent	 fracture	 resistance	 of	metals	 and	 ceramics.	 In	
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biology,	however,	the	molecular	and	cellular	control	of	bone	quality	is	not	well	understood,	a	situation	exacerbated	by	the	lack	of	non-invasive	clinical	bone	quality	diagnostics	(9).			 Much	 of	what	 is	 known	 about	 bone	 quality	 stems	 from	 analyses	 of	 animal	 bones	performed	ex	vivo.	 In	particular,	 the	 foundational	work	of	 John	Currey	has	described	 the	uniquely	 adapted	material	 properties	 that	 accompany	mineralized	 tissues	with	 different	functions.	Adult	polar	bear	bones,	for	example,	have	a	higher	elastic	modulus	than	juvenile	bones,	which	helps	 the	 longer	 adult	 bones	 to	withstand	deformation	under	much	higher	body	 weight	 (10).	 Deer	 antlers	 have	 relatively	 low	 mineralization	 but	 high	 toughness,	decreasing	the	likelihood	of	fracture	in	an	impact	with	an	opponent	(11).	Even	within	a	single	animal,	 tissue-specific	 calibration	 of	 material	 properties	 correlates	 with	 specialized	functions	like	weight-bearing	and	hearing	(4).	Given	the	remarkable	specificity	of	material	properties	achieved	in	nature,	cellular	mechanisms	to	maintain	them	must	exist.		 In	 bone,	 there	 are	 three	main	 types	 of	 cells.	 Bone-forming	 osteoblasts	 and	 bone-resorbing	 osteoclasts	 reside	 on	 bone	 surfaces,	 and	 osteocytes	 are	 located	 within	 the	mineralized	matrix	in	cavities	called	lacunae.	Osteocytes	derive	from	the	osteoblast	lineage,	undergoing	 a	 series	 of	 transcriptional	 and	 morphological	 changes	 as	 they	 become	surrounded	by	bone	matrix	(12).	Mature	osteocytes	are	characterized	by	expression	of	E11,	Dmp1,	and	sclerostin,	and	have	an	extensive	network	of	dendrites	which	connect	to	other	osteocytes,	 vasculature,	 and	 surface	 cells	 through	 channels	 in	 bone	 called	 canaliculi.	Originally	thought	to	be	quiescent	cells,	a	rapidly-growing	body	of	research	over	the	past	century	has	revealed	osteocytes	as	active,	essential	participants	in	bone	homeostasis.					 Despite	 differentiating	 from	 the	 osteoblast	 lineage,	 osteocytes	 have	 the	 ability	 to	resorb	 surrounding	 bone	 and	 enlarge	 their	 lacunae,	 a	 process	 initially	 called	 osteocytic	
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osteolysis	(13).	In	humans	with	rickets	and	osteomalacia	(14),	and	in	hibernating	squirrels	and	 bats	 (15,	 16),	 enlarged	 osteocyte	 lacunae	 were	 associated	 with	 metabolic	 stress	 or	pathological	conditions.	It	was	later	studies	in	rats,	egg-laying	hens,	and	lactating	mice	that	demonstrated	that	osteocytes	could	also	deposit	bone,	making	the	maintenance	of	the	matrix	surrounding	their	 lacunae	a	reversible	process	(17–19).	 Improvements	 in	techniques	and	technologies	available	for	studying	these	bone-embedded	cells	has	shown	that	the	canaliculi	are	 also	 subject	 to	 remodeling	 (20,	 21),	 giving	 rise	 to	 the	 current	 term	 for	 osteocytic	maintenance	of	their	surroundings:	perilacunar/canalicular	remodeling,	or	PLR.			 Increases	or	decreases	in	perilacunar/canalicular	remodeling	(PLR)	activity	can	be	characterized	 by	 analyzing	 molecular,	 cellular,	 and	 tissue-level	 hallmarks	 (22).	 Genes	involved	 in	 matrix	 degradation	 and	 acidification,	 such	 as	 matrix	 metalloproteinase	 13	(Mmp13),	 Cathepsin	 K	 (Ctsk),	 carbonic	 anhydrase	 1	 and	 2,	 tartrate	 resistant	 acid	phosphatase	 5	 (Acp5),	 and	 ATPase	 subunits,	 are	 strongly	 induced	 with	 the	 increase	 in	lacunar	size	that	occurs	during	 lactation,	and	they	return	to	baseline	expression	 levels	as	lacunar	 size	 returns	 to	 normal	 (19,	 23).	 The	 involvement	 of	 these	 molecules	 in	 PLR	 is	supported	by	studies	showing	that	their	systemic	ablation	causes	abnormal	organization	of	bone	 extracellular	matrix,	 another	 hallmark	 of	 PLR.	 Specifically,	 changes	 to	 the	 size	 and	organization	of	the	lacunocanalicular	network	and	disruption	of	normal	collagen	linearity	are	associated	with	systemic	repression	of	PLR	genes	(24–28).	At	the	tissue	level,	systemic	repression	 of	 PLR	 genes	 can	 both	 increase	 and	 decrease	 bone	 mineralization	 (24,	 27).	Therefore,	osteocytes	use	protease	secretion	and	acidification	to	maintain	the	collagen	and	mineral	in	the	bone	extracellular	matrix.		
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As	of	2014,	osteocytes	were	recognized	as	important	participants	in	bone’s	response	to	 metabolic	 stress	 and	 in	 bone	 homeostasis,	 but	 many	 important	 gaps	 in	 knowledge	remained.	First,	since	previous	studies	investigating	PLR	had	used	systemic	stimuli	or	gene	ablation,	 the	 extent	 to	 which	 PLR	 is	 regulated	 specifically	 by	 osteocytes	 was	 unknown.	Similarly,	factors	that	act	in	an	osteocyte-intrinsic	manner	to	control	PLR	in	vivo	had	not	yet	been	identified.	Second,	while	repression	of	PLR	hallmarks	was	often	accompanied	by	bone	fragility,	 the	 ability	 of	 osteocytes	 and	 PLR	 to	 causally	 control	 bone	 quality	 had	 not	 been	determined.	Third,	effects	on	or	by	osteocytes	and	PLR	during	musculoskeletal	disease	were	largely	unexplored,	as	were	the	interactions	of	osteocytes	with	nearby	tissues	like	muscle,	articular	 cartilage,	 nerves,	 and	 vasculature.	 And	 fourth,	 while	 osteocytes	 are	mechanosensitive	and	able	to	coordinate	the	response	of	osteoblasts	and	osteoclasts	to	load,	it	was	not	known	whether	PLR	itself	is	regulated	by	load.	Answers	to	these	questions	would	provide	critical	advances	towards	the	identification	of	cellular	and	molecular	targets	for	the	treatment	of	bone	quality	as	a	contributor	to	bone	strength.	This	 work	 used	 novel	mouse	models	 and	 rigorous	material	 testing	 techniques	 to	identify	osteocyte	PLR	as	a	novel	mechanism	regulating	bone	material	quality	under	control	of	cell-intrinsic	TGFb	signaling	and	MMP13.	With	human	surgical	and	cadaveric	tissues	and	mouse	 models	 of	 joint	 injury,	 we	 showed	 that	 osteocyte	 PLR	 is	 repressed	 in	 multiple	musculoskeletal	 diseases	 and	 that	 repression	 of	 PLR	 through	 MMP13	 can	 promote	osteoarthritis.	Finally,	 I	addressed	the	hypothesis	that	osteocyte	PLR	is	mechanosensitive	and	 identified	 a	 possible	 role	 for	 the	 sympathetic	 nervous	 system	 in	 osteocyte	 TGFb	signaling.	Together	this	work	highlights	osteocytes	as	critical	regulators	of	bone	and	joint	health	in	homeostasis	and	disease.		
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		Chapter	2	Methods	
Many	methods	were	in	development	over	the	course	of	my	dissertation	work,	so	protocols	for	 similar	 experiments	 sometimes	 vary	 across	 chapters.	 Common	methods	 are	 detailed	here,	with	further	details	provided	within	each	chapter	as	applicable.		
 
Mice	 Mice	were	bred	and	housed	in	a	specific	pathogen-free	environment	at	UCSF.	Animals	were	 housed	 in	 groups	 with	 temperature	 maintained	 between	 68-74	 °F,	 humidity	maintained	 between	 30-70%,	 12-hour	 light/dark	 cycles,	 and	 access	 to	water	 and	 rodent	chow	ad	libitum.	To	control	for	the	sexually	dimorphic	effects	of	bone	material	properties	(1),	osteoarthritis	(2),	and	PLR	itself	(3),	only	male	mice	were	used	for	these	studies.	The	procedures	for	animal	experiments	were	approved	by	the	Institutional	Animal	Care	and	Use	Committee	at	the	University	of	California,	San	Francisco.		 Mouse	lines	bred	for	these	studies	are	described	in	Table	2.1.	Homozygous	MMP13fl/fl	mice	 and	 homozygous	 TbRIIfl/fl	 mice	 were	 bred	 with	 hemizygous	 DMP1-Cre+\-	 mice	 to	
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generate	litters	with	wildtype	(Cre-/-)	and	knockout	(Cre+/-)	mice	compared	in	Chapters	3	and	5.	All	experiments	were	initiated	when	mice	reached	8	weeks	of	age.		At	 the	 end	 of	 experiments,	 mice	 were	 euthanized	 by	 CO2	 inhalation	 followed	 by	cervical	dislocation.	Tissues	designated	for	RNA	or	protein	analysis	were	collected	first	and	quickly	processed	through	to	liquid	nitrogen.	Tissues	designated	for	histology,	microCT,	and	mechanical	testing	were	then	collected	as	needed.		Animals	were	monitored	 during	multi-day	 experiments	 and	 humanely	 euthanized	before	the	experimental	endpoint	as	needed	to	relieve	distress,	for	example,	due	to	weight	loss,	severe	fight	wounds,	or	other	morbidity.	
						Table	2.1:	Mouse	lines	bred	at	UCSF	
Name	 Background	 Jackson	Labs	#	 Chapters	 Reference	DMP1-Cre+\-	 C57BL/6	 023047	 3,	5	 (4)	TbRIIfl/fl	 C57BL/6J	 012603	 3	 (5)	MMP13fl/fl	 FVB	 005710	 5	 (6)	SBE	 C57BL/6	x	SJL	 005999	 6,	8	 (7)		
Tissue	processing	for	histology	Mouse	 tibias,	 femurs,	 mandibles,	 or	 intact	 knee	 joints	 were	 fixed	 in	 10%	 neutral	buffered	formalin	for	48	hours	and	decalcified	for	two	weeks	in	0.5	M	di-	and	tetra-sodium	EDTA,	 changed	 three	 times	 per	 week.	 Tissues	 were	 dehydrated	 in	 graded	 ethanol	 and	infiltrated	with	paraffin.	Knees	were	embedded	in	paraffin	blocks	at	90	degrees	of	flexion	and	sectioned	in	the	frontal	plane.	Hemimandibles	were	embedded	and	sectioned	sagittally.	Femurs	and	 tibias	were	embedded	and	sectioned	axially	 to	generate	6-7	μm	sections.	All	brightfield	imaging	was	conducted	on	a	Nikon	Eclipse	E800	microscope,	and	all	fluorescence	imaging	was	conducted	on	a	Leica	DMi8	confocal	microscope.	
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Analysis	of	collagen	fiber	orientation	by	picrosirius	red	stain	Polarized	 light	microscopy	was	performed	on	deparaffinized	 sections	 stained	 in	 a	saturated	aqueous	solution	of	picric	acid	with	0.1%	Direct	Red-80	for	one	hour,	as	described	(8,	 9)	 to	 visualize	 collagen	 fiber	 orientation.	 During	 microscopy,	 polarized	 filters	 were	rotated	 to	achieve	 the	maximum	birefringence	before	capturing	each	 image.	Red	channel	images	were	processed	using	the	OrientationJ	plugin	for	ImageJ	to	generate	histograms	of	collagen	fiber	orientation	for	comparison	(10).		
Analysis	of	the	lacunocanalicular	network	by	Ploton	silver	stain	To	visualize	the	osteocyte	lacunocanalicular	network,	sections	were	deparaffinized	and	incubated	in	two-parts	50%	silver	nitrate	and	one-part	1%	formic	acid	in	2%	gelatin	solution	for	55	minutes,	as	described	(8,	11).	Stained	slides	were	then	washed	in	5%	sodium	thiosulfate	for	10	minutes	and	subsequently	dehydrated,	cleared,	and	mounted.	Brightfield	images	 were	 acquired	 at	 100x	 for	 analysis,	 and	 comparable	 regions	 of	 interest	 were	compared	(i.e.	medial,	lateral,	anterior	or	posterior	for	axial	sections,	and	medial	or	lateral	for	frontal	sections).	Analysis	methods	are	detailed	within	each	chapter.	
	
Immunohistochemistry	(IHC)	IHC	was	used	to	examine	protein	 localization	qualitatively	and	semi-quantitatively	(i.e.	%	positively	stained	cells).	For	IHC,	slides	were	deparaffinized	and	hydrated	prior	to	incubation	 in	 Innovex	Uni-Trieve	 low	 temperature	 retrieval	 solution	 (NB325)	 in	 a	 65	 °C	water	bath	for	30	minutes.	Endogenous	peroxidase	activity	was	quenched	using	3%	H2O2	for	10	 minutes	 at	 room	 temperature.	 For	 the	 subsequent	 steps,	 Innovex	 Universal	 Animal	
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Immunohistochemistry	Kit	(329ANK)	was	utilized.	Samples	were	blocked	with	Fc-Block	and	Background	 Buster	 for	 45	minutes	 each	 at	 room	 temperature.	 Primary	 antibodies	 were	diluted	in	PBS	(Table	2.2)	and	incubated	in	a	humid	chamber	at	4°C	overnight.	Secondary	linking	antibody	and	HRP-enzyme	were	both	used	at	room	temperature	for	10	minutes	each.	Fresh	DAB	solution	was	applied	and	incubated	at	room	temperature	for	5	minutes	prior	to	washing	with	tap	water	and	mounting	with	Innovex	Advantage	aqueous	mounting	medium.	Negative	controls	were	performed	by	substituting	rabbit	IgG	at	the	same	concentration	as	primary	antibody.			
Immunofluorescence	(IF)	IF	was	used	to	examine	protein	localization	qualitatively	and	semi-quantitatively	(i.e.	%	positively	stained	cells).	Sections	were	deparaffinized	and	antigens	were	retrieved	with	0.25%	trypsin-EDTA	at	37	°C	for	25	minutes,	or	with	Uni-Trieve	solution	as	above.	Sections	were	blocked	with	Background	Buster	(Innovex)	for	10	minutes	or	10%	normal	goat	serum	for	one	hour,	incubated	with	PBS/0.1%	Tween	for	5	minutes,	and	then	incubated	overnight	with	primary	 antibodies	diluted	 in	PBS	with	0.1%	Tween	and	5%	BSA	 (Table	2.2).	After	washes	in	PBS,	secondary	antibody	conjugated	to	Alexa	Fluor	594	(Table	2.2)	was	applied	for	60	minutes.	Background	was	reduced	with	copper	sulfate	for	10	minutes,	and	slides	were	mounted	with	Prolong	Gold	antifade	reagent	with	DAPI.		
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Table	2.2:	Antibodies	used	for	immunostaining	and	Western	blotting	
Target	 Product	number	 Concentration	 Chapter	MMP13	 Abcam	39012	 1:50	–	1:100	 4,	5,	8	Cathepsin	K	 Abcam	19027	 1:50	 5	Aggrecan	 Abcam	216965	 1:200	 5	Collagen	II	 Abcam	34712	 1:200	 5	CGGFVDIPEN	 Gift	from	Dr.	John	Mort	 1:200	 5	CGGNITEGE	 Gift	from	Dr.	John	Mort	 1:200	 5	Goat	anti-rabbit	 Invitrogen	A-11012	 1:1000	 5	Sclerostin	 R&D	AF1589	 1:100	–	1:200	 8	Donkey	anti-goat	 Invitrogen	A-11058	 1:1000	 8	Beta-actin	 Abcam	8226	 1:2000	 6,	7,	8	pSmad3	 Gift	from	Dr.	Ed	Leof	 1:1000	 6	pSmad3	 Abcam	52903	 1:2000	 7	pCreb	 Cell	signaling	#9198	 1:1000	 7	pAkt	 Cell	signaling	#4060	 1:1000	 7,	8	p-p38	 Cell	signaling	#9211	 1:1000	 7	
 
	
Micro-computed	tomography	(µCT)		 For	 skeletal	 phenotyping,	 tibias,	 femurs,	 or	 intact	 knee	 joints	were	 dissected	 and	stored	in	70%	ethanol.	Cortical	analysis	was	conducted	in	a	1-mm	region	equidistant	from	the	proximal	and	distal	ends	of	the	bone.	Femoral	trabecular	analysis	was	conducted	in	a	2-mm	region	immediately	proximal	to	the	distal	growth	plate.	Samples	were	scanned	using	a	Scanco	μCT50	specimen	scanner	with	an	X-ray	potential	of	55	kVp,	current	of	109	μA,	and	voxel	size	of	10	μm.	Thresholding	and	quantification	was	performed	as	previously	described	(12,	13).	
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Cells	
	 Osteocyte	cell	lines	were	cultured	on	plates	coated	with	rat	tail	collagen	type	I	in	20%	O2	and	5%	CO2.	MLO-Y4	osteocyte-like	cells	were	cultured	in	a-MEM	with	nucleosides	with	2.5%	FBS,	2.5%	FCS	and	1%	P/S	at	37	°C	(14).	OCY454	cells	were	cultured	in	a-MEM	with	nucleosides	with	10%	FBS	and	1%	antibiotic/antimycotic	at	34	°C	until	confluent	(Day	0),	then	differentiated	at	37	°C	for	14	days	before	use	(15).		
	
Quantitative	RT-PCR	analysis		Humeri	or	tibias	designated	for	mRNA	analysis	were	quickly	cleaned	of	muscle	and	periosteum,	epiphyses	were	trimmed,	and	marrow	was	removed	by	centrifugation	(16).	If	applicable,	tibias	were	then	cut	into	proximal	and	distal	portions.	All	bones	were	snap-frozen	in	liquid	nitrogen.	Two	humeri	per	animal	were	combined	into	one	tube	with	1.5	mL	TRIzol,	and	tibia	portions	were	each	placed	into	a	tube	with	1	mL	QIAzol.	Tubes	were	stored	on	ice	and	each	bone	sample	homogenized	with	a	rotor-stator	homogenizer	(GLH,	Omni).	Lysate	was	then	stored	at	-80	°C	until	RNA	extraction.					 For	RNA	extraction,	QIAzol	or	TRIzol	lysate	was	thawed,	and	200	µL	chloroform	per	mL	 of	 lysate	was	 added	 and	mixed	well.	 The	mixture	was	 centrifuged	 for	 15	minutes	 at	12,000	g	 at	4	 °C,	 and	 the	 aqueous	 supernatant	was	 carefully	 transferred	 to	 a	 clean	 tube.	mRNA	collected	in	TRIzol	was	purified	using	the	RNeasy	Mini	Kit,	and	mRNA	and	miRNA	collected	 in	 QIAzol	 was	 purified	 using	 the	 miRNeasy	 Mini	 Kit	 (Qiagen),	 following	manufacturer’s	 instructions	 for	 each	 kit.	 On-column	 DNase	 (Qiagen)	 was	 applied	 for	 15	minutes,	 and	 the	 RNA	 was	 eluted	 in	 35	 µL	 RNase-free	 water.	 RNA	 concentration	 was	quantified	with	a	NanoDrop	spectrophotometer	and	the	product	stored	at	-80	°C	until	use.	
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To	make	 cDNA,	1	µg	or	15	µL	RNA	per	 sample	was	 reverse-transcribed	using	 the	iScript	cDNA	synthesis	kit,	and	the	concentration	was	brought	to	10	ng/µL	with	clean	water.	cDNA	was	stored	at	-20	°C	until	use.	qPCR	 was	 performed	 with	 both	 Taqman	 and	 SYBR-based	 technologies.	 Primer	product	numbers	and	sequences	are	given	in	Table	2.3.	10-80	ng	equivalent	of	cDNA	was	used	per	reaction,	with	input	quantity	chosen	for	each	gene	in	order	to	achieve	threshold	values	of	amplification	between	20	and	30	cycles.	All	reactions	were	performed	in	technical	duplicates.	Expression	was	then	quantified	by	the	DDCt	method	(17).			
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Table	2.3:	SYBR	primer	sequences	and	TaqMan	Assay	IDs	used	for	gene	expression	analysis	of	murine	cDNA	
Target	 Sequence	 ng	input	 Chapter	L19	(sense)	L19	(antisense)	 5’-ACGGCTTGCTGCCTTCGCAT	-3’	5’-AGGAACCTTCTCTCGTCTTCCGGG-3’		 20	 4,	6	β-actin	(sense)	β-actin	(antisense)	 5’-CTCTGGCTCCTAGCACCATGAAGA-3’	5’-GTAAAACGCAGCTCAGTAACAGTCCG-3’	 10-20	 5,	6,	7	β-actin	 Mm02619580_g1	 10-20	 5,	8	18s	(sense)	18s	(antisense)	 5’-CGAACGTCTGCCCTATCAAC-3’		5’-GGCCTCGAAAGAGTCCTGTA-3’		 1-10	 6,	7	18s	 Mm03928990_g1	 1-10	 7	Gilz	(sense)	Gilz	(antisense)	 5’-TGACTGCAACGCCAAAGC-3’	5’-CTGATACATTTCGGTGTTCATGGTT-3’		 20-50	 4	Mmp13	(sense)	Mmp13	(antisense)	 5’-CGGGAATCCTGAAGAAGTCTACA-3’	5’-CTAAGCCAAAGAAAGATTGCATTTC-3’	 20-50	 4,	5,	6	Mmp14	(sense)	Mmp14	(antisense)	 5’-AGGAGACGGAGGTGATCATCATTG-3’	5’-GTCCCATGGCGTCTGAAGA-3’	 20-50	 4,	5	Mmp2	(sense)	Mmp2	(antisense)	 5’-AACGGTCGGGAATACAGCAG-3’	5’-GTAAACAAGGCTTCATGGGG-3’	 20-50	 4,	5	Ctsk	(sense)	Ctsk	(antisense)	 5’-	GAGGGCCAACTCAAGAAGAA-3’	5’-	GCCGTGGCGTTATACATACA-3’	 20-50	 4,	5	Acp5	(sense)	Acp5	(antisense)	 5’-CGTCTCTGCACAGATTGCAT-3’	5’-AAGCGCAAACGGTAGTAAGG-3’	 20-50	 4,	5	Car2	(sense)	Car2	(antisense)	 5’-GAGCTTCACTTGGTTCACTGG-3’	5’-TGTGAGGCAGGTCCAATCTTC-3’	 20-50	 4,	5	Mmp13	 Mm00439491_m1	 20-50	 5	Rankl	(sense)	Rankl	(antisense)	 5’-CCAAGATCTCTAACATGACG-3’	5’-CACCATCAGCTGAAGATAGT-3’	 20-50	 5	Opg	(sense)	Opg	(antisense)	 5’-AGAGCAAACCTTCCAGCTGC-3’	5’-CTGCTCTGTGGTGAGGTTCG-3’	 20-50	 5	Timp1	(sense)	Timp1	(antisense)	 5’-CTCAAGACCTATAGTGCTGGC-3’	5’-CAAAGTGACGGCTCTGGTAG-3’	 20-50	 5,	6	Timp2	(sense)	Timp2	(antisense)	 5’-AGTGCAAGATCACTCGCTGT-3’	5’-CGCGCAAGAACCATCACTTC-3’	 20-50	 5	Atp6v0d2	(sense)	Atp6v0d2	(antisense)	 5’-TCTTGAGTTTGAGGCCGACAG-3’	5’-GCAACCCCTCTGGATAGAGC-3’	 20-50	 5	Atp6v1g1	(sense)	Atp6v1g1	(antisense)	 5’-TGAGCAGTTGACTTAGGCCG-3’	5’-CCTCCGGTTCTTTCGCTTGC-3’	 20-50	 5	
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Target Sequence ng	input Chapter Sost	(sense)	Sost	(antisense) 5’-TCCTCCTGAGAACAACCAGAC-3’	5’-TGTCAGGAAGCGGGTGTAGTG-3’ 40-80 6,	7 AP	(sense)	AP	(antisense) 5’-TAGTACTGGCCATCGGCACC-3’	5’-AGGTCTCTTGGGCTTGCTGT-3’ 20-50 6 OC	(sense)	OC	(antisense) 5’-GCTGCGCTCTGTCTCTCTGA-3’	5’-GCCCTCCTGCTTGGACATGA-3’ 20-50 6 OP	(sense)	OP	(antisense) 5’-TCTGGCAGCTCAGAGGAGAA-3’	5’-CTGAGATGGGTCAGGCACCA-3’ 20-50 6 Col1a1	(sense)	Col1a1	(antisense) 5’-GACGCATGGCCAAGAAGACA-3’	5’-ACCTCGGGTTTCCACGTCTC-3’ 20-50 6 Ptgs2	(sense)	Ptgs2	(antisense) 5’-CTCACGAAGGAACTCAGCAC-3’	5’-GGATTGGAACAGCAAGGATTTG-3’ >75 6,	7 Serpine1	(sense)	Serpine1	(antisense) 5’-CAGATGACCACAGCGGGGAA-3’	5’-GGCATGAGCTGTGCCCTTCT-3’	 20-50 6,	7 Sost Mm00470479_m1 40-80 7 Phex Mm00448119_m1 50 7 Dmp1 Mm01208363_m1 50 7 Adra2a	(sense)	Adra2a	(antisense) 5’-CGCAGGCCATCGAGTACAA-3’	5’-GATGACCCACACGGTGACAA-3’	 20-50 7 Adra2b	(sense)	Adra2b	(antisense) 5’-TCCCTCTGGGAGGCAAGTG-3’	5’-GGCCAGGATTCCAGACCATT-3’	 20-50 7 Adra2c	(sense)	Adra2c	(antisense) 5’-CATGGGCGTGTTCGTACTGT-3’	5’-CAGGCCTCACGGCAGATG-3’	 20-50 7 Adrb2	(sense)	Adrb2	(antisense) 5’-GCCACGACATCACTCAGGAAC-3’	5’-CGATAACCGCACTGAGGATGG-3’ 20-50 7 c-fos	(sense)	c-fos	(antisense) 5’-AAGGGGCAAAGTAGAGCAGC-3’	5’-TTGATCTGTCTCCGCTTGGA-3’ 50 7 Serpine1 Mm00435858_m1 20-50 8 Ptgs2 Mm00478374_m1 >75 8 Gja1 Mm01179639_s1 40 8 
	
Flexural	strength	tests	Bones	 designated	 for	 mechanical	 testing	 were	 gently	 cleaned	 of	 muscle	 to	 avoid	scratching	the	bone	surface,	then	stored	in	HBSS	at	4	°C	for	up	to	two	weeks,	or	wrapped	in	HBSS-soaked	gauze	and	stored	at	-20	°C.	All	bones	were	brought	to	room	temperature	before	
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testing.	Whole	 hydrated	 femurs	 were	 loaded	 to	 failure	 in	 3-point	 bending	 using	 a	 Bose	Electroforce	3200	test	frame.	Tests	were	performed	in	air	at	a	fixed	displacement	rate	of	10	μm/s,	and	load-displacement	data	was	recorded.	Data	processing	is	described	within	each	Chapter.		
In	vivo	axial	tibial	loading	
	 After	 troubleshooting	 and	 optimization	 (Chapter	 6),	 the	 final	murine	 in	 vivo	 axial	tibial	loading	protocol	applies	5-7	N	compressive	load	to	the	right	leg,	or	approximately	800-1200	microstrain.	Before	loading,	mice	are	anesthetized	with	injectable	ketamine/xylazine	anesthesia	(100	mg/kg	ketamine	and	10	mg/kg	xylazine)	and	lack	of	response	to	a	toe	pinch	is	confirmed	before	the	right	leg	is	placed	into	the	load	frame.	A	BOSE	Electroforce	ELF3200	desktop	load	frame	is	fitted	with	custom	fixtures	to	cup	the	mouse	heel	and	knee	and	provide	axial	compressive	load	to	the	tibia	(Figure	6.1).	The	actuator	is	manually	displaced	until	the	load	feedback	reads	the	desired	maximum	load	and	then	a	preload	of	-0.5	N.	The	actuator	is	then	set	to	cycle	between	these	two	positions	for	600	cycles	at	1	Hz	in	displacement	control	mode,	with	 load	data	 recorded	on	a	50	 lb	 load	cell.	One	10-minunte	 loading	 session	was	performed	 per	 day	 for	 up	 to	 five	 consecutive	 days.	 After	 each	 loading	 session,	mice	 are	returned	 to	 a	 warm	 cage	 to	 recover	 and	 then	 ambulate	 normally	 until	 the	 next	 loading	session	or	predetermined	harvest	time.	After	harvest,	the	non-loaded	left	tibia	serves	as	an	internal	control	for	each	animal.				
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Protein	extraction	from	bone	Tibias	 designated	 for	 protein	 analysis	 were	 quickly	 cleaned	 of	 muscle	 and	periosteum,	 epiphyses	 were	 trimmed,	 and	 marrow	 was	 removed	 by	 centrifugation.	 If	applicable,	tibias	were	then	cut	into	proximal	and	distal	portions.	Foil-wrapped	bones	were	stored	in	liquid	nitrogen	until	protein	extraction.	RIPA	buffer	(10	mM	Tris	pH	8,	1	mM	EDTA,	1	 mM	 EGTA,	 140	 mM	 NaCl,	 1%	 Triton	 X,	 0.1	 %	 sodium	 deoxycholate,	 0.1%	 SDS)	supplemented	with	protease	and	phosphatase	inhibitors	(5	mM	sodium	orthovanadate,	10	mM	 sodium	 pyrophosphate,	 100	mM	NaF,	 500	µM	 PMSF,	 1x	 cOmplete	Mini	 tablet)	 was	prepared	fresh	on	the	day	of	protein	harvest	(18,	19).	In	the	final,	optimized	protocol,	2-mL	tubes	containing	2.8-mm	ceramic	beads	are	pre-chilled	at	-20	°C.	Whole	tibias	or	proximal	and	distal	portions	are	placed	in	individual	tubes	with	90	µL	ice	cold	RIPA.	Without	allowing	bones	to	thaw,	tubes	are	then	placed	in	a	Bead	Mill	24	Homogenizer	(Omni)	and	shaken	at	5	m/s	for	four	bouts	of	10	seconds	with	rest	on	ice	 half-way	 through.	 After	 bone	 lysate	 is	 in	 RIPA,	 samples	 are	 incubated	 on	 ice	 for	 30	minutes,	sonicated	8x15	seconds	with	a	cup-horn	sonicator	in	a	circulating	ice	water	bath,	and	centrifuged	for	6	minutes	at	12,000	g	at	4	°C.	Liquid	protein	lysate	is	then	transferred	to	a	clean	tube	for	storage	at	-20	°C	for	one	week	or	-80	°C.		
Protein	quantification		 To	normalize	protein	loading	into	Western	blots,	protein	lysate	from	loaded	and	non-loaded	tibias	was	quantified	using	the	Bradford	assay.	Technical	duplicates	of	1	µL	of	each	protein	sample	are	loaded	into	UV-transparent	96-well	plates	(Corning	#3635).	A	standard	curve	 of	 BSA	 from	1.26	µg/µL	 to	 10.08	µg/µL	 plus	 1	µL	RIPA	 per	well	 is	 also	 plated	 in	
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technical	duplicates.	Protein	assay	dye	concentrate	(BioRad	#500-0006)	is	diluted	in	water,	and	 200	 µL	 are	 mixed	 into	 each	 well.	 A	 single	 read	 at	 595	 nm	 is	 then	 performed	 on	 a	spectrophotometer	 and	 sample	 protein	 concentrations	 interpolated	 from	 the	 standard	curve.			
Western	blotting		 8.5%	or	10%	polyacrylamide	gels	with	5%	stacking	gels	were	prepared	in	the	lab	and	stored	at	4	°C	for	up	to	one	week.	Protein	lysate	was	thawed	on	ice	and	preparations	of	equal	protein	content	with	Laemmli	buffer	were	made	for	each	sample.	Protein	preparations	were	heated	 in	 a	 95	 °C	 bath	 for	 10	 minutes,	 then	 cooled	 on	 ice	 and	 briefly	 spun	 to	 collect	condensation.	Equal	volumes	of	prepared	protein	were	loaded	in	each	lane	along	with	ladder	and	TGFb-treated	 cell	 lysate	 as	 a	 positive	 control.	 60-70	V	was	 applied	 until	 the	 protein	passed	through	the	stacking	gel,	then	100-150	V	was	applied	until	the	37	kDa	band	of	the	ladder	 was	 near	 the	 bottom	 of	 the	 gel.	 The	 protein	 was	 transferred	 to	 a	 nitrocellulose	membrane	at	100	V	for	50-70	minutes,	blocked	with	5%	milk	in	TBS	for	50-90	minutes,	and	washed	 in	TBST	before	application	of	primary	antibodies	(Table	2.2).	Primary	antibodies	were	 applied	 for	 1	 hour	 at	 room	 temperature	 or	 overnight	 at	 4	 °C	with	 gentle	 shaking.	Secondary	antibodies	with	 IR	 tags	were	applied	 for	1	hour	at	 room	 temperature.	β-actin	antibody	was	prepared	in	1%	milk,	and	phospho-protein	antibodies	were	prepared	in	5%	BSA.	Protein	was	detected	on	an	Odyssey	Infrared	Imager	(Licor)	and	images	quantified	in	ImageStudio	Lite	software.	Signal	 from	test	protein	bands	was	normalized	 to	signal	 from	corresponding	β-actin	control	bands	for	each	sample	and	then	compared	across	conditions.		
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		Chapter	3	TGFb	regulates	fracture	toughness	via	osteocytes	
This	 chapter	 is	 based	 on	 work	 published	 in	 the	 peer-reviewed	 article	 titled	 “Osteocyte	intrinsic	TGFβ	signaling	regulates	bone	quality	through	perilacunar/canalicular	remodeling“	by	 Neha	 S.	 Dole,	 Courtney	M.	 Mazur,	 Claire	 Acevedo,	 Justin	 P.	 Lopez,	 David	 A.	 Monteiro,	Tristan	W.	Fowler,	Bernd	Gludovatz,	Flynn	Walsh,	 Jenna	N.	Regan,	 Sara	Messina,	Daniel	 S.	Evans,	 Thomas	 F.	 Lang,	 Bin	 Zhang,	 Robert	 O.	 Ritchie,	 Khalid	 S.	 Mohammad,	 and	 Tamara	Alliston	in	Cell	Reports.			
Introduction	Differences	in	bone	mass	do	not	fully	explain	bone	fragility,	leaving	bone	quality	as	an	 important	 and	 underutilized	 therapeutic	 target	 for	 reducing	 fracture.	 Bone	 quality	includes	mass-independent	properties	across	multiple	length	scales,	such	as	bone	geometry,	organization	and	composition	of	the	extracellular	matrix,	flexural	properties	before	and	after	deformation,	 and	 material	 properties	 like	 elastic	 modulus	 and	 toughness	 (1–4).	 The	
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properties	 of	 mineralized	 tissues	 vary	 widely	 in	 nature,	 allowing	 for	 function-driven	adaptations	like	the	stiff	whale	bulla	and	flexible,	tough	antlers	(5).	Despite	the	remarkable	specialization	of	bone	quality	parameters,	the	biological	mechanisms	controlling	them	are	incompletely	understood.		Transforming	growth	factor	beta	(TGFb)	is	an	essential	regulator	of	both	bone	mass	and	bone	quality.	Previous	work	from	the	Alliston	Lab	and	others	has	implicated	osteoblasts	and	 osteoclasts	 as	 TGFb-responsive	 regulators	 of	 bone	mass	 and	density	 (4,	 6–8).	 These	systemic	 or	 osteoblast-targeted	 interventions	 for	 TGFb	 signaling	 have	 also	 caused	differences	in	bone	flexural	strength,	mineralization,	and	toughness	(6,	7,	9,	10).	However,	the	cellular	mechanisms	by	which	TGFb	regulates	bone	quality	remain	unknown.		Osteocytes	are	a	prime	candidate	to	be	the	cellular	target	of	TGFb	 in	 its	control	of	bone	 quality.	 In	 addition	 to	 their	 coordination	 of	 osteoblast	 and	 osteoclast	 function,	osteocytes	 play	 a	 direct	 role	 in	 the	 maintenance	 of	 the	 surrounding	 ECM	 through	perilacunar-canalicular	 remodeling	 (PLR)	 (11).	While	PLR	has	previously	been	described	primarily	as	a	stress-response	mechanism	for	liberating	minerals	in	times	of	high	metabolic	demand	(12),	 recent	work	has	highlighted	 this	process	as	essential	 for	homeostatic	bone	ECM	organization	and	material	properties	(11).	Further,	systemic	ablation	of	proteases	that	act	downstream	of	TGFb,	 including	MMP2,	MMP13,	MMP14,	and	Cathepsin	K,	has	caused	suppression	of	PLR	hallmarks	(11,	13–16).	It	was	not	yet	known	whether	this	process	was	regulated	in	an	osteocyte-intrinsic	manner.	Using	mice	with	a	DMP1-Cre-mediated	ablation	of	the	TGFb	receptor	type	II	(TbRII),	Dole	et	al.	 tested	the	hypothesis	 that	TGFb	controls	PLR	in	an	osteocyte-intrinsic	manner	(17).	 Male	mice	 with	 an	 osteocyte-specific	 loss	 of	 function	 in	 TGFb	 signaling	 had	 lower	
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expression	of	key	PLR	genes	Mmp2,	Mmp13,	Mmp14,	Cathepsin	K	and	Acp5.	While	collagen	linearity	 was	 not	 affected,	 the	 ability	 of	 osteocytes	 to	 maintain	 their	 lacunocanalicular	network	was	visibly	reduced,	with	disorganized	canaliculi	that	were	50%	shorter	than	in	WT	bones.	These	findings	are	consistent	with	osteocyte-intrinsic	control	of	PLR	and	now	allow	for	testing	of	the	hypothesis	that	osteocyte	PLR	is	the	cellular	mechanism	by	which	TGFb	regulates	bone	quality.		
Methods	
Mice	 DMP1-Cre	 (9.6-kb	 promoter)	 and	 TbRIIfl/fl	 mice	 were	 bred	 at	 UCSF	 to	 generate	wildtype	(DMP1-Cre-;	TbRIIfl/fl)	and	TbRIIocy-/-	(DMP1-Cre+;	TbRIIfl/fl)	mice	with	osteocyte-targeted	inhibition	of	TGFb	signaling	(Table	2.1).	At	two	months	old,	femurs	were	dissected	from	male	mice	of	each	genotype	and	gently	cleaned	of	soft	tissue	before	storage	in	Hank’s	Balanced	 Salt	 Solution	 (HBSS)	 at	 4	 °C.	 Tests	were	 conducted	within	 one	month	 of	 bone	harvest.			
Flexural	testing	HBSS-soaked	femurs	were	brought	to	room	temperature	and	positioned	on	a	6	mm	span	with	 the	 central	 loading	point	 at	 the	mid-diaphysis.	Tests	were	 conducted	with	 the	anterior	side	in	compression,	and	load-displacement	data	was	recorded.	After	fracture,	bone	cross-sections	were	imaged	in	a	variable	pressure	scanning	electron	microscope	(VP-SEM,	Hitachi	S-4300SE/N)	for	measurement	of	diameter	and	cortical	thickness,	and	moment	of	inertia	 was	 calculated	 modeled	 as	 an	 elliptical	 cross-section	 (18).	 Load-displacement	
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measurements	 were	 converted	 to	 stress-strain	 using	 standard	 beam	 theory	 equations.	Bending	modulus	was	calculated	from	the	linear	portion	of	the	stress-strain	curve	and	yield	stress	was	calculated	using	the	0.2%	offset	method	(19)	with	custom	Python	scripts	for	n=5	per	group.			
In	situ	fracture	toughness	testing	One	femur	per	animal	was	notched	at	the	mid-diaphysis	on	the	posterior	side	to	a	depth	of	approximately	one	third	the	anterior-posterior	diameter	using	an	oscillating	razor	blade	irrigated	with	0.05	μm	diamond	suspension.	Bones	were	briefly	sonicated	to	remove	diamond	 residue,	 then	 returned	 to	 storage	 in	 HBSS	 at	 4	 °C.	 Three-point	 bending	 was	performed	with	the	notched	posterior	side	in	tension	on	a	6mm	span	with	a	Gatan	Microtest	2-kN	stage	(Gatan,	Abingdon,	UK)	mounted	in	the	VP-SEM	at	35	Pa.	Loading	was	performed	at	a	displacement	rate	of	50	μm/min	while	samples	were	observed	in	real	time	in	the	SEM	in	back-scattered	electron	mode	at	an	excitation	voltage	of	20	kV.	Images	were	captured	and	peak	load	recorded	each	time	a	crack	advanced.	This	protocol	was	performed	on	n≥6	femurs	from	individual	animals,	but	bones	were	excluded	from	analysis	if	scratches	from	dissection	were	apparent	in	SEM	images	or	if	the	notch	was	found	to	be	too	shallow	or	deep.	Work	of	fracture	was	 calculated	 for	n=5	bones	per	 group,	 and	 crack	 resistance	 curves	 (R-curves)	were	generated	for	n=3	bones	per	group.		
	
Nanoindentation	Femurs	from	WT	and	TbRIIocy-/-	mice	were	embedded	in	EpoxiCure	2	resin.	Sections	were	 generated	 at	 the	 mid-diaphysis	 using	 a	 low-speed	 circular	 saw,	 polished	 with	
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increasing	grits	of	sandpaper,	and	finished	with	1	μm	diamond	polish,	then	stored	in	HBSS	at	4	°C.	Samples	were	blotted	dry	immediately	before	mounting	in	a	nanoindenter	with	a	Berkovitch	tip.	Indents	were	made	every	5	μm	between	the	endosteal	and	periosteal	surface	using	a	trapezoidal	loading	profile	with	1000	μN	peak	load	and	a	10-second	hold.	The	load-displacement	 curves	 were	 used	 to	 calculate	 local	 elastic	 modulus	 by	 the	 Olivier-Pharr	method	for	n=3	per	group	(6,	20).			
Results		 	 DMP1-Cre+;TbRIIfl/fl	mice	(TbRIIocy-/-)	have	an	osteocyte-specific	 loss	of	 function	 in	TGFb	signaling,	which	was	validated	using	immunohistochemistry.	Additionally,	changes	in	gene	expression	and	lacunocanalicular	network	organization	are	consistent	with	repression	of	PLR	(17).	While	trabecular	bone	mass	is	elevated	in	TbRIIocy-/-	femurs,	cortical	thickness	was	unchanged.	Therefore,	any	evidence	of	cortical	bone	fragility	would	be	attributable	to	defects	in	bone	quality.		 	 Flexural	 testing	was	 initially	performed	on	 three	genotypes:	wild-type	mice	 (WT),	mice	expressing	DMP1-Cre	with	one	floxed	TbRII	allele	(TbRIIocy	+/-),	and	mice	expressing	DMP1-Cre	 with	 two	 floxed	 TbRII	 alleles	 (TbRIIocy-/-).	 Average	 stress-strain	 curves	 from	flexural	tests	for	n=5	bones	per	group	demonstrate	an	allelic	dosage	effect	of	TbRII	deletion	(Figure	3.1	A),	but	only	WT	and	TbRIIocy-/-	specimens	were	analyzed	further.	TbRIIocy-/-	bone	showed	a	26%	reduction	in	bending	modulus	and	27%	reduction	in	yield	stress	compared	to	 WT	 bone,	 indicating	 reduced	 resistance	 to	 elastic	 deformation	 (Figure	 3.1	 B-C).	 The	Young’s	 modulus	 of	 cortical	 bone	 tissue	 as	 measured	 by	 nanoindentation	 was	 also	significantly	lower	in	TbRIIocy-/-	bone	(Figure	3.1	D).		
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Figure	 3.1:	 Flexural	 properties	 of	 TbRIIocy-/-	 bone.	 (A)	 Stress-strain	 curves	 from	 femurs	tested	 in	 3-point	 bending,	 where	 lines	 represent	 the	 average	 of	 five	 bones.	 (B)	 Bending	modulus	and	(C)	yield	stress	parameters	were	calculated	from	the	same	five	animals.	(D)	Tissue	elastic	modulus	was	measured	by	nanoindentation	for	n=3	bones.	Graphs	show	mean	+/-	SD.	*p<0.05.			 	 In	addition	to	flexural	properties,	the	ability	of	bones	to	resist	fracture	depends	on	their	 ability	 to	 absorb	 energy	 as	 they	 deform,	 called	 toughness.	 To	 evaluate	 the	 role	 of	osteocyte-intrinsic	TGFb	signaling	in	fracture	toughness,	we	used	in	situ	fracture	toughness	tests,	which	allow	simultaneous	observation	of	the	crack	growth	from	a	predefined	notch	and	quantitative	measurement	of	force	required	to	propagate	the	crack.	Overall,	these	tests	demonstrated	 that	 TβRIIocy−/−	cortical	 bone	 has	 a	 significant	 65%	 reduction	 in	 work	 of	fracture	compared	with	WT	bone	(Figure	3.2	A).			 	 Calculation	of	the	crack-resistance	curve	(R-curve)	allows	for	comparison	of	the	crack	initiation	toughness	and	crack	growth	toughness	between	genotypes	(Figure	3.2	B).	While	R-curves	are	often	shown	 in	 terms	of	 the	stress	 intensity	 factor	K,	 the	small	geometry	of	mouse	bones	used	here	makes	measurement	of	K	strictly	invalid.	Therefore,	R-curves	were	calculated	in	terms	of	work	of	fracture.	
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Figure	 3.2:	 Fracture	 toughness	 of	 TbRIIocy-/-	 bone.	 (A)	Work	 of	 fracture	 calculated	 from	notched	3-point	bending	tests.	Graph	shows	mean	+/-	SD,	n=5,	*p<0.05.	(B)	R-curves	from	in	situ	fracture	toughness	testing.	Graph	shows	95%	confidence	intervals	calculated	based	on	a	power	fit,	n=3.				 	 Crack	 initiation	 toughness	 is	 primarily	 determined	 by	 a	 material’s	 intrinsic	toughening	mechanisms,	 such	 as	 small-scale	 plastic	 deformation,	which	 act	 ahead	 of	 the	crack	tip	to	increase	resistance	to	microstructural	damage.	The	crack	initiation	toughness	can	be	determined	from	the	R-curve	as	the	crack	extension	approaches	0	but	could	not	be	conclusively	 differentiated	 between	WT	 and	 TbRIIocy-/-	 bone	 in	 this	 study.	 Crack	 growth	toughness	is	largely	determined	by	extrinsic	toughening	mechanisms,	such	as	crack	bridging,	which	act	behind	 the	 crack	 tip	 in	order	 to	 shield	 the	 crack	 from	 the	applied	 force.	Crack	growth	toughness	manifests	in	the	slope	of	the	R-curve,	which	was	significantly	lower	for	TbRIIocy-/-	bone	than	wildtype	(Figure	3.2	B).			 	 Differences	in	extrinsic	toughening	were	also	apparent	from	qualitative	changes	in	crack	growth.	Specifically,	in	100%	of	WT	bones,	crack	extension	was	accompanied	by	crack	
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deflection	and	uncracked	ligament	bridging.	In	TbRIIocy-/-	bone,	uncracked	ligament	bridging	occurred	less	often	and	in	some	mice	was	entirely	absent.	Both	genotypes	displayed	a	similar	number	of	crack	deflections	during	extension,	but	the	crack	angle	tended	to	be	smaller	and	deflections	more	parallel	to	the	crack	extension	in	TbRIIocy-/-	bone.	We	quantified	this	effect	with	the	ratio	of	the	crack	path	length	relative	to	maximum	crack	extension,	which	was	35%	lower	in	TbRIIocy-/-	bone	than	in	wildtype	bone	(Figure	3.3).	Collectively	these	analyses	show	defects	in	multiple	aspects	of	bone	quality	in	mice	with	an	osteocyte-intrinsic	defect	in	TGFb	signaling.				
	
Figure	3.3:	Loss	of	crack	deflection	 in	TbRIIocy-/-	bone.	(A)	Representative	SEM	images	of	crack	 paths	 extending	 from	 preformed	 notches	 in	mouse	 femurs	 during	 in	 situ	 fracture	toughness	 testing.	Scale	bar	=	100	µm.	 (B)	Quantification	of	 crack	path	 length	relative	 to	extension.	Graph	shows	mean	+/-	SD,	n=5,	*p<0.01.		
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Discussion	This	study	advances	our	understanding	of	bone	fragility	by	identifying	osteocytes	as	major	cellular	mediators	of	bone	quality.	In	mice	with	an	osteocyte-specific	ablation	of	TbRII,	the	bone	quality	contributors	flexural	strength,	elastic	modulus,	and	fracture	toughness	were	reduced.	These	results	confirm	the	importance	of	homeostatic	TGFb	signaling	and	the	role	of	 osteocytes	 in	 maintaining	 bone	 quality.	 Therefore	 targeting	 osteocytes	 with	 future	therapeutics	may	improve	bone	resistance	to	fracture	in	cases	where	fragility	accompanies	normal	bone	mass.			 	 These	results	using	an	osteocyte-specific	defect	in	TGFb	signaling	complement	prior	studies	 that	 demonstrate	 the	 importance	 of	 homeostatic	 TGFb	 for	 maintenance	 of	 bone	quality.	 Together	 these	 studies	 show	dose-dependent	 and	 cell	 type-specific	 responses	 to	changes	 in	 TGFb	 signaling	 (6,	 7,	 9).	 While	 these	 prior	 studies	 suggested	 that	 systemic	suppression	of	TGFb	signaling	increases	tissue	elastic	modulus	and	toughness,	this	work	was	the	 first	 to	 isolate	 the	 role	 of	 osteocytes.	 Therefore,	 this	 approach	 may	 have	 disrupted	intricate	 TGFb	 -mediated	 cellular	 coordination	 that	 was	 maintained	 during	 systemic	interventions.		 	 In	addition	to	material	bone	quality	defects,	TbRIIocy-/-	bone	demonstrated	reductions	in	hallmarks	of	PLR	including	organization	of	the	lacunocanalicular	network	and	expression	of	 PLR	 genes	 such	 as	Mmp13	 (17).	 These	 results	were	 similar	 to	 bones	 from	mice	with	systemic	ablation	of	Mmp13,	which	have	disorganized	collagen	and	canaliculi	and	reduced	fracture	toughness	(11).	Therefore,	TGFb	likely	regulates	bone	quality	through	its	control	of	osteocyte	PLR.	The	mechanisms	by	which	PLR	contributes	to	extrinsic	toughening,	as	well	as	the	specific	contributions	of	each	protease	downstream	of	TGFb,	remain	to	be	determined.		
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		Chapter	4	Osteocytes	in	skeletal	disease		
This	chapter	is	based	on	work	in	two	peer-reviewed	publications:	Fowler	et	al.	Glucocorticoid	suppression	of	osteocyte	perilacunar	remodeling	is	associated	with	subchondral	bone	degeneration	in	osteonecrosis.	Sci	Rep.	7,	44618	(2017).		Alemi	 et	 al.	 Glucocorticoids	 cause	 mandibular	 bone	 fragility	 and	 suppress	 osteocyte	perilacunar-canalicular	remodeling.	Bone	Rep.	9:	145–153	(2018).		
Introduction	A	growing	body	of	evidence	establishes	that	functional	osteocytes	are	essential	for	skeletal	 homeostasis.	 As	 discussed	 in	 Chapter	 3,	 suppression	 of	 TGFb	 signaling	 severely	impairs	osteocyte	perilacunar/canalicular	remodeling	(PLR)	and	bone	material	properties	(1).	 Systemic	 ablation	 of	 just	 one	 PLR	 enzyme,	 Mmp13,	 reduces	 organization	 of	 the	lacunocanalicular	network	and	collagen	in	the	bone	extracellular	matrix	and	causes	fragility	(2).	Expression	of	MMP13	by	osteocytes	in	at	least	some	bones	is	necessary	for	resorption	of	the	lacunar	walls	to	meet	the	high	metabolic	demand	of	lactation	(2).	In	skeletal	diseases,	however,	 effects	 on	 or	 by	 osteocytes	 are	 largely	 unknown.	 Since	 osteocytes	 are	 such	
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important	 regulators	 of	 bone,	we	hypothesized	 that	 they	 could	 also	play	 a	 causal	 role	 in	disease.	We	set	out	 to	address	this	gap	 in	understanding	by	examining	the	role	of	PLR	in	glucocorticoid-induced	skeletal	disease.			 Glucocorticoid	(GC)	treatment	is	a	major	risk	factor	for	osteonecrosis	(ON),	in	which	bone	 tissue	 dies,	 mechanically	 fails,	 and	 eventually	 causes	 painful	 collapse	 of	 overlying	articular	 cartilage.	 Degeneration	 of	 osteonecrotic	 bone	 is	 not	 currently	 reversible,	 and	 it	often	necessitates	 joint	 replacement	 surgery	or	other	 reconstruction	 for	 relatively	 young	patients.	 Also	 called	 avascular	 necrosis,	 the	 traditional	 understanding	 of	 ON	 is	 that	interrupted	bloodflow	in	the	bone	begins	a	cascade	of	cell	death	(3).	In	end-stage	disease,	apoptosis	of	osteoblasts	and	osteocytes	has	been	observed	adjacent	to	the	collapsed	bone	(4),	leading	to	the	hypothesis	that	osteocyte	death	is	one	of	the	main	mechanisms	driving	GC-induced	 ON.	 However,	 osteocyte	 death	 and	 other	 observed	 changes	 to	 osteoblasts,	osteoclasts,	and	vasculature	do	not	fully	explain	the	intricacies	of	the	ON	phenotype,	which	includes	sclerotic	zones	and	reduction	in	tissue	elastic	modulus.	Since	mice	with	ablation	of	Mmp13	and	with	osteocyte-specific	inhibition	of	TGFb	signaling	also	show	changes	to	bone	mineralization	and	material	properties,	our	group	hypothesized	 that	GCs	affect	osteocyte	PLR	before	the	appearance	of	other	ON	symptoms.		 One	 of	 the	major	 sites	 of	 GC-induced	ON	 is	 the	 hip,	 but	 ON	 can	 also	 occur	 in	 the	mandible	as	a	severe	complication	of	radiation	therapy.	The	mesodermally-derived	femur	and	 the	 neural	 crest-derived	 mandible	 are	 specialized	 for	 very	 different	 functions,	 and	previous	 work	 demonstrated	 that	 PLR	 can	 be	 regulated	 in	 a	 site-specific	 manner	 (5).	Therefore,	we	examined	both	femoral	and	mandibular	bone	to	learn	about	the	role	of	PLR	in	skeletal	disease.		
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Methods	
Mice		 Male	FVB	mice	were	purchased	from	Jackson	labs	and	acclimatized	in	the	UCSF	LARC	for	at	least	one	week.	At	8	weeks	old,	mice	were	anesthetized	with	inhaled	isofluorane,	and	slow-release	pellets	of	placebo	or	the	gluococorticoid	prednisolone	(Innovative	Research	of	America,	 2.8	mg/kg/day)	 were	 subcutaneously	 implanted.	 After	 7,	 21,	 35	 or	 55	 days	 of	treatment,	mice	were	euthanized	and	humeri,	femurs,	and	mandibles	were	collected.		
Flexural	testing		 For	 mechanical	 testing,	 bones	 were	 collected	 from	 mice	 treated	 with	 placebo	 or	prednisolone	for	35	days.	Femurs	were	gently	dissected	and	muscle	carefully	removed	to	avoid	 scratching	 the	bone	 surface,	 then	 stored	 in	HBSS	at	4	 °C	 for	up	 to	one	month.	The	temporomandibular	 joints	 were	 gently	 dislocated	 and	 the	 hemimandibles	 separated	between	the	incisors.	Muscle	was	carefully	removed	to	avoid	scratching	the	bone	surface.	Hemimandibles	were	stored	in	HBSS	at	4	°C	for	up	to	one	month.	All	 bones	 were	 brought	 to	 room	 temperature	 prior	 to	 testing.	 Femurs	 were	positioned	 on	 a	 6-mm	 span	with	 the	 central	 loading	 point	 at	 the	mid-diaphysis	 and	 the	posterior	side	in	tension.	Hemimandibles	were	positioned	on	a	4-mm	span	with	the	buccal	side	 facing	up	 (buccal	 compression)	 and	 the	 central	 loading	point	 at	 the	midpoint	of	 the	molars.	 Stiffness	 was	 calculated	 from	 the	 slope	 of	 the	 load-displacement	 curve	 using	 a	custom	 Python	 script,	 and	 ultimate	 load	 was	 defined	 as	 the	 maximum	 bending	 load	sustained.	
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I	 conducted	 extensive	 protocol	 development	 and	 optimization	 for	 mandible	mechanical	testing	prior	to	testing	of	experimental	samples.	Based	on	this,	I	chose	a	4-mm	span	and	buccal	 compression	 for	both	physiological	 relevance	 and	 to	minimize	 technical	variability.	 However,	 I	 still	 observed	 technical	 variation	 in	 mandible	 failure	 that	 was	unrelated	to	bone	material	or	mechanical	behavior.	To	control	for	this,	experimental	samples	were	 included	 for	 analysis	 if	 the	 fracture	 occurred	 immediately	 posterior	 to	 the	molars	without	preceding	fracture	of	the	condylar	process	or	angular	process	(Figure	4.1	A).	Hemi-mandibles	from	the	same	animal	were	treated	as	technical	replicates	and	averaged	together	for	final	comparisons.			
Quantitative	RT-PCR	analysis		Humeri	 from	mice	 treated	with	placebo	and	prednisolone	 for	7	days	were	quickly	cleaned	 of	 muscle,	 periosteum,	 and	 marrow	 and	 stored	 in	 liquid	 nitrogen.	 Bones	 were	homogenized	in	TRIzol,	and	purified	as	described	in	Chapter	2.	qPCR	was	performed	with	SYBR	primers	(Table	2.3).	Expression	was	quantified	by	the	DDCt	method	with	L19	as	the	housekeeping	gene.			
Cells	 MLO-Y4	 osteocytic	 cells	 were	 cultured	 as	 described	 in	 Chapter	 2.	 To	 set	 up	 each	experiment,	cells	were	trypsinized,	counted,	and	replated	into	collagen	type	I-coated	6-well	plates	at	50,000	cells/well.	The	next	day,	media	was	replaced	and	cells	were	pre-treated	with	1	μM	of	the	caspase-3	inhibitor	DEVD	or	vehicle	(PBS)	for	30	minutes.	The	glucocorticoid	dexamethasone	 (Dex)	 was	 dissolved	 in	 sterile	 water	 and	 applied	 to	 wells	 at	 a	 final	
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concentration	of	0.1	μM	or	1	μM.	An	equal	volume	of	vehicle	(water)	was	used	in	control	wells.	 All	 wells	 were	 harvested	 after	 24	 hours	 of	 Dex	 treatment	 for	 mRNA	 analysis	 or	measurement	of	cell	death.		To	 quantify	 cell	 death,	 nonadherent	 cells	 were	 collected	 from	 each	 well	 prior	 to	trypsinization	of	cells	adhered	to	the	culture	dish.	The	trypsinized	cells	were	collected	with	media	 containing	 serum	and	 combined	with	 the	nonadherent	 cells	 before	 centrifugation.	Each	cell	pellet	was	resuspended	in	an	equal	volume	of	media	and	diluted	in	0.4%	trypan	blue	 stain.	 Cells	 containing	 and	 excluding	 trypan	 blue	 stain	 were	 counted	 using	 a	hemacytometer,	with	eight	measurements	made	for	each	replicate	of	each	condition.			
Histological	analyses	For	 histology,	 femurs	 and	 hemimandibles	 from	 mice	 treated	 with	 placebo	 or	prednisolone	 for	21	or	55	days	were	 fixed	 in	10%	neutral	buffered	 formalin,	decalcified,	paraffin-embedded,	 and	 sectioned,	 as	 described	 in	 Chapter	 2.	 Cortical	 bone	 analysis	was	performed	on	axial	 femoral	 sections	at	 the	mid-diaphysis	 and	on	 sagittal	 sections	on	 the	inferior	border	of	the	mandible.	Immunohistochemistry	was	performed	with	antibodies	for	MMP13	 and	 Cathepsin	 K	 (Table	 2.2).	 Ploton	 silver	 stain	 and	 picrosirius	 red	 stain	 were	performed	as	described	in	Chapter	2.	To	 quantify	 changes	 in	 the	 lacunocanalicular	 network,	 greyscale	 images	 of	 silver-stained	sections	were	thresholded	in	ImageJ.	In	femurs,	the	orientation	of	dark	silver-stained	canaliculi	was	compared	and	their	area	relative	to	total	bone	area	per	image	was	compared.	In	mandibles,	the	area	of	stained	lacunae	and	canaliculi	was	normalized	to	total	bone	area	for	each	image.	
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Results	In	the	sclerotic	bone	of	human	femoral	heads	with	stage	IV	osteonecrosis,	histologic	hallmarks	of	PLR	were	severely	repressed	compared	to	regions	of	healthy	bone.	Osteocyte	expression	of	MMP13	was	 reduced,	 collagen	organization	was	disrupted,	 lacunar	volume	was	smaller,	and	canaliculi	were	shorter	and	less	numerous	than	in	adjacent	normal	bone.	However,	contrary	to	prior	reports,	osteocytes	appeared	viable	(6).	The	disruption	of	PLR	hallmarks	 in	 end-stage	 human	 disease	 establishes	 that	 osteocytes	 are	 affected	 by	glucocorticoid	treatment,	possibly	independent	of	apoptosis.		To	 learn	 whether	 osteocytes	 and	 PLR	 play	 a	 causal	 role	 in	 GC-induced	 skeletal	disease,	 we	 treated	 mice	 with	 the	 glucocorticoid	 prednisolone	 or	 with	 placebo	 pellets	implanted	subcutaneously	for	7-55	days.	At	35	days	of	treatment,	we	found	that	mandibles	and	femurs	from	prednisolone-treated	mice	were	significantly	more	fragile	than	those	from	placebo-treated	 mice	 (Figure	 4.1),	 suggesting	 efficacy	 of	 our	 osteonecrosis	 model.	 For	unknown	 reasons,	 neither	 ultimate	 load	 of	 mandibles	 (p=0.23)	 nor	 stiffness	 of	 femurs	(p=0.18)	different	significantly	between	treatments.						
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Figure	4.1:	Flexural	properties	of	placebo	and	prednisolone-treated	bones.	(A)	Examples	of	mandible	fracture	locations	included	for	analysis.	Scale	bar	=	4	mm.	(B)	Stiffness	of	mouse	mandibles	after	35	days	of	glucocorticoid	 treatment.	Points	represent	 the	average	of	 two	hemimandibles	 from	one	animal.	n=3	animals	 for	placebo,	n=4	animals	 for	prednisolone.	Graph	 shows	 mean	 +/-	 SEM.	 (C)	 Ultimate	 load	 of	 mouse	 femurs	 after	 35	 days	 of	glucocorticoid	treatment.	Points	each	represent	one	femur.	n=4.	Graph	shows	mean	+/-	SD.	*p<0.05.		 Since	prior	animal	studies	often	focused	on	osteocyte	apoptosis	in	response	to	GCs	(7,	8),	we	used	TUNEL	staining	to	measure	cell	death.	We	found	a	significant	 increase	 in	 the	percentage	 of	 TUNEL-positive	 osteocytes	 in	 trabecular	 bone,	 which	 agrees	 with	 prior	studies.	However	in	femoral	cortical	bone,	no	increase	in	osteocyte	death	was	observed	with	7	or	21	days	of	treatment	(6).	This	suggests	that	any	early	effects	of	glucocorticoid	treatment	in	cortical	bone	occur	independent	of	apoptosis.	After	just	7	days	of	treatment,	we	observed	severe	changes	in	osteocyte	behavior.	As	expected,	 the	 GC-induced	 gene	 Gilz	 was	 significantly	 upregulated.	 Expression	 of	 matrix	metalloproteinases	 (Mmp)-2,	 -13	 and	 -14,	 Cathepsin	K	 (Ctsk),	 and	 tartrate-resistant	 acid	phosphatase	(Acp5)	mRNA	was	repressed	25-80%	in	bone	from	GC-treated	mice	compared	to	 placebo-treated	mice,	 consistent	 with	 repression	 of	 PLR	 (Figure	 4.2	 A).	 Interestingly,	carbonic	anhydrase	II	(Car2),	which	was	co-regulated	with	these	other	genes	in	a	lactation	model	 of	 PLR	 induction	 (9),	 was	 upregulated	 in	 the	 GC-treated	 bone,	 perhaps	 as	 a	
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compensatory	mechanism.	 These	 changes	 in	 transcriptional	 activity	 preceded	 detectable	loss	of	bone	mass	in	the	femur	and	mandible	with	microCT	(6,	10).		To	 further	 determine	whether	 the	 observed	 changes	 in	 gene	 expression	 after	 GC	treatment	 were	 osteocyte-intrinsic	 and	 independent	 of	 apoptosis,	 we	 cultured	 MLO-Y4	osteocytes	with	the	GC	dexamethasone	with	or	without	 the	caspase-3	 inhibitor	DEVD.	24	hours	of	dexamethasone	treatment	repressed	Mmp13	expression	in	MLO-Y4	cells	in	a	dose-dependent	manner	(Figure	4.2	B).	Pre-treatment	with	DEVD	effectively	blocked	apoptosis	of	MLO-Y4	cells	(Figure	4.2	C)	without	affecting	the	repression	of	Mmp13.	These	in	vitro	results	further	support	that	GC-induced	changes	 in	osteocyte	activity	can	occur	 independently	of	apoptosis.							
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Figure	4.2:	Gene	expression	in	bones	and	MLO-Y4	osteocytes	treated	with	glucocorticoids.	(A)	Mean	fold	change	gene	expression	in	bone	from	prednisolone	and	placebo-treated	mice.	n=6.	(B)	Mean	fold	change	Mmp13	expression	in	MLO-Y4	cells	treated	with	dexamethasone	+/-	DEVD	for	24	hours.	n=3	experiments.	(C)	Apoptosis	in	MLO-Y4	cells	after	24	hours	of	Dex	treatment	was	blocked	by	DEVD.	n=3	experiments.	Graphs	show	mean	+/-	SD.	*p<0.05.				 Hypermineralization	 of	 glucocorticoid-treated	 bone	 also	 develops	 rapidly.	 After	 7	days	of	treatment	in	trabecular	bone,	and	after	21	days	of	treatment	in	cortical	bone,	peak	mineral	 density	 is	 increased	 in	 mice	 administered	 prednisolone	 (6).	 This	 finding	 is	particularly	 significant	because	sclerosis	 is	detectable	 in	end-stage	human	disease,	and	 it	may	persist	from	shortly	after	initiation	of	treatment.		
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Beginning	 at	 21	 days	 of	 treatment,	 we	 began	 to	 observe	 histological	 changes	consistent	with	repressed	PLR.	Expression	of	MMP13	protein	in	osteocytes	was	reduced	by	30-60%	in	the	cortical	bone	of	femurs	and	mandibles	and	remained	repressed	in	mandibular	bone	after	55	days	of	prednisolone	treatment	(Figure	4.3).	Cathepsin	K	protein	expression	was	also	lower	in	the	mandibles	of	GC-treated	mice	at	55	days	(10).	The	organization	of	the	extracellular	matrix	was	also	severely	altered.	Collagen	fibers,	which	are	aligned	with	axial	cross-sections	of	the	femur	in	control	mice,	were	broken	and	disorganized	in	femoral	cortical	and	trabecular	bone	from	GC-treated	mice	(6).	The	lacunocanalicular	network	in	trabecular	and	 cortical	 bone	 of	 femurs	 and	 mandibles	 was	 visibly	 degenerated,	 with	 significantly	reduced	area	and	canalicular	alignment	(Figure	4.4)(6).	The	disruption	of	osteocyte	behavior	and	maintenance	of	the	extracellular	matrix	induced	by	GCs	is	consistent	with	repression	of	PLR	seen	in	MMP13-deficient	mice	and	may	eventually	contribute	to	collapse	of	the	tissue.		
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Figure	4.3:	MMP13	expression	in	murine	femoral	and	mandibular	cortical	bone	treated	with	placebo	or	prednisolone.	(A,	C)	Representative	images	of	immunohistochemistry	for	MMP13	in	bones	from	mice	treated	for	21	days.	Scale	bars	=	20	µm.	(B)	Quantification	of	MMP13-expressing	osteocytes	in	femoral	cortical	bone,	n=4.	(D)	Quantification	of	MMP13-expressing	osteocytes	in	mandibular	cortical	bone	after	21	and	55	days	of	treatment,	n	³	5.	Graphs	show	mean	+/-	SEM.	*p<0.05.				
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Figure	 4.4:	 Lacunocanalicular	 network	 morphology	 in	 murine	 femoral	 and	 mandibular	cortical	 bone	 treated	 with	 placebo	 or	 prednisolone.	 (A,	 B)	 Representative	 images	 and	quantification	 of	 canalicular	 area	 in	 femoral	 cortical	 bone	 from	 mice	 treated	 with	prednisolone	or	placebo	for	21	days,	n³3.	(C,	D)	Representative	images	and	quantification	of	lacunocanalicular	area	in	mandibular	cortical	bone	from	mice	treated	with	prednisolone	or	placebo	for	55	days,	n³5.	Scale	bars	=	20	µm.	Graphs	show	mean	+/-	SEM.	*p<0.05.			 Therefore,	 glucocorticoid	 treatment	 affects	 hallmarks	 of	 PLR	 including	 gene	expression,	 protein	 expression,	 mineralization,	 and	 tissue	 organization	 in	 both	 the	mesodermally-derived	 femur	 and	 neural	 crest-derived	 craniofacial	 bone.	 Reduction	 of	flexural	strength	of	mandibles	and	femurs	occurred	after	repression	of	genes	and	proteins	associated	 with	 PLR,	 and	 so	 GC-related	 fragility	 may	 also	 derive	 from	 defects	 in	 PLR.	Particularly	in	cortical	bone,	where	increases	in	osteocyte	apoptosis	were	not	observed	over	
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the	 same	 timeline,	 these	 results	 suggest	 that	 osteocytes	 are	 active	 participants	 in	 the	progression	 of	 disease	 and	 bone	 fragility,	 rather	 than	 victims	 of	 glucocorticoid-induced	osteonecrosis.			
Discussion	The	 existing	 paradigm	 for	 glucocorticoid-induced	 osteonecrosis	 argues	 that	 high-dose	GC	treatment	causes	vascular	defects	and	osteocyte	apoptosis,	which	subsequently	lead	to	bone	degeneration	and	joint	collapse.	Here	we	showed	that	even	before	bone	fragility	and	before	 significant	 osteocyte	 apoptosis,	 glucocorticoids	 affect	 osteocyte	 PLR,	 suggesting	 a	causal	role	for	suppression	of	PLR	in	the	development	of	skeletal	diseases	like	ON.	While	PLR	is	in	some	cases	regulated	in	a	site-specific	manner	(5),	we	showed	that	osteocytes	in	tissues	with	 different	 mechanical	 demands	 and	 derived	 from	 different	 germ	 layers	 are	 both	susceptible	 to	 GCs.	 GC-induced	 ON	may	 eventually	 be	 understood	 as	 a	 disease	 in	which	osteocytes	fail	to	maintain	their	extracellular	matrix,	resulting	in	mechanical	failure	of	the	tissue.	With	osteocyte	dysfunction	identified	as	a	possible	causal	driver	of	osteonecrosis,	this	suggests	that	multiple	skeletal	diseases	may	be	 impacted	by	osteocyte	PLR.	However,	 the	systemic	 nature	 of	 GC	 treatment	 prevents	 definitive	 attribution	 of	 these	 bone	 defects	 to	osteocytes	alone,	so	future	studies	of	osteocytes	in	disease	will	need	to	utilize	cell-targeted	approaches.					
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		Chapter	5	Osteocyte	dysfunction	promotes	osteoarthritis	through	MMP13-dependent	suppression	of	subchondral	bone	homeostasis	
This	chapter	is	taken	from	the	peer-reviewed	article	of	the	same	name,	by	Courtney	M.	Mazur,	Jonathon	J.	Woo,	Cristal	S.	Yee,	Aaron	J.	Fields,	Claire	Acevedo,	Karsyn	N.	Bailey,	Serra	Kaya,	Tristan	W.	Fowler,	Jeffrey	C.	Lotz,	Alexis	Dang,	Alfred	C.	Kuo,	Thomas	P.	Vail,	and	Tamara	Alliston,	published	in	Bone	Research.			
Introduction	Osteoarthritis	(OA),	the	most	common	chronic	joint	disease,	is	a	leading	cause	of	pain	and	 disability	 worldwide	 (1).	 OA	 irreversibly	 damages	 articular	 cartilage	 and	 the	surrounding	tissues,	compromising	joint	function	and	mobility	of	over	30	million	Americans	(2).	 Abundant	 research	 efforts	 have	 investigated	 cartilage	 and	 its	 interactions	with	 other	joint	 tissues	 in	 order	 to	 understand	 the	 underlying	 mechanisms	 of	 OA	 initiation	 and	
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progression	 (3–5).	 Still,	 no	 permanent	 disease-modifying	 therapies	 exist	 short	 of	 joint	replacement.		A	major	question	in	the	field	is	the	extent	to	which	subchondral	bone	plays	a	causal	role	in	the	pathogenesis	of	OA.	Though	much	correlative	evidence	indicates	the	coordinated	degradation	 of	 subchondral	 bone	 and	 cartilage	 (3,	 6),	 causality	 is	 difficult	 to	 ascertain	because	 analyses	 are	 often	 conducted	 on	 tissues	with	 end-stage	 disease	 or	 in	models	 in	which	 both	 the	 bone	 and	 cartilage	 are	 affected.	 Recent	 studies	 have	 illuminated	 that	biological	(7)	and	mechanical	(8)	changes	to	the	subchondral	bone	can	precede	degradative	changes	to	overlying	cartilage.	However,	the	cellular	mechanisms	responsible	for	OA-related	changes	in	subchondral	bone,	and	particularly	the	role	of	osteocytes,	remain	unclear.			Recent	 reports	 have	 reinvigorated	 interest	 in	 the	 active	 role	 of	 osteocytes	 in	remodeling	 their	 surrounding	 bone	 matrix	 –	 a	 process	 called	 perilacunar/canalicular	remodeling	 (PLR)	 (9–12).	 PLR	 is	 a	 dynamic	 process	 by	which	 osteocytes	 secrete	matrix	metalloproteinases	(MMPs)	(13–15),	cathepsin	K	(CatK)	(10),	and	other	enzymes	(16,	17)	to	dynamically	 resorb	and	 then	 replace	 the	 local	bone	matrix.	PLR	maintains	bone	material	properties	(13,	18,	19),	systemic	mineral	homeostasis	(10,	12),	and	the	canalicular	channels	that	 facilitate	 osteocyte	 communication,	mechanosensation,	 and	nourishment	 (9,	 20,	 21).	Several	known	regulators	of	bone	homeostasis,	including	TGF-β	(19),	SOST	(17),	parathyroid	hormone	 (10,	 22),	 and	 Vitamin	 D	 (23,	 24),	 regulate	 PLR	 to	 support	 the	 metabolic	 and	mechanical	 function	of	 the	skeleton.	Although	PLR	is	a	 fundamental	mechanism	by	which	osteocytes	maintain	bone	homeostasis,	its	role	in	the	maintenance	of	subchondral	bone	and	the	progression	of	joint	disease	remain	unclear.		
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To	elucidate	the	role	of	PLR	in	disease,	we	previously	 investigated	osteonecrosis,	a	progressive	 and	 severe	 joint	 disease	 in	 which	 subchondral	 bone	mechanically	 fails	 with	painful	collapse	of	the	articular	surface	(25,	26).	We	found	that	glucocorticoids,	a	major	risk	factor	 associated	 with	 osteonecrosis	 (25),	 suppress	 PLR	 and	 cause	 the	 same	 changes	 in	subchondral	 bone	 of	 mice	 as	 seen	 in	 glucocorticoid-induced	 human	 osteonecrosis	 (27).	Although	suppression	of	PLR	is	clearly	associated	with	the	degradation	of	subchondral	bone	in	osteonecrosis,	 it	was	not	possible	 to	 isolate	 the	effects	of	osteocytes	 from	the	systemic	influence	 of	 glucocorticoids.	 Given	 that	 the	 health	 of	 articular	 cartilage	 depends	 upon	subchondral	bone	for	mechanical	and	vascular	support	(28,	29),	we	hypothesized	that	signs	of	 PLR	 dysregulation	 may	 also	 accompany	 the	 much	 more	 common	 joint	 disease,	osteoarthritis.	We	tested	this	hypothesis	by	examining	specific	hallmarks	of	PLR	suppression	and	their	relationship	to	cartilage	degeneration	in	OA	of	the	human	knee.	As	a	step	towards	evaluating	the	causality	of	PLR	suppression	in	joint	disease,	we	evaluated	the	bone	and	joint	phenotypes	of	a	novel	mouse	model	with	ablation	of	the	critical	PLR	enzyme	MMP13	from	osteocytes	 but	 not	 chondrocytes.	 Together,	 our	 results	 demonstrate	 the	 causal	 role	 of	osteocyte-derived	MMP13	in	the	pathogenesis	of	OA,	suggesting	the	importance	of	osteocyte	perilacunar/canalicular	remodeling	for	joint	homeostasis.		
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Results	
Degeneration	of	the	osteocyte	lacunocanalicular	network	in	human	osteoarthritis	To	 determine	 if	 osteocytic	 PLR	 is	 affected	 by	 osteoarthritis	 (OA)	 in	 humans,	 we	compared	subchondral	bone	 in	 tibial	plateaus	 from	patients	with	end-stage	OA	 to	 that	of	cadaveric	donors	with	no	clinical	evidence	of	joint	disease.	As	expected,	tibial	plateaus	from	patients	with	OA	had	gross	degeneration	of	the	articular	cartilage	(Supp.	Figure	5.1a-f)	and	radiographic	evidence	of	subchondral	bone	sclerosis,	particularly	on	the	medial	side	of	the	joint	(Supp.	Figure	5.1g-i).	 	Histological	analysis	confirmed	the	cartilage	degeneration	and	subchondral	bone	sclerosis	in	OA	specimens	(Figure	5.1a).	Consistent	with	prior	reports	(6),	both	the	subchondral	bone	plate	and	trabeculae	were	thicker	in	OA	than	in	controls	(Figure	5.1a).	 Relative	 to	 the	 cadaveric	 controls,	 OA	 tibial	 plateaus	 showed	 decreased	 cartilage	thickness,	 reduced	 Safranin-O	 positive	 proteoglycan	 staining	 in	 the	 superficial	 zone,	 and	cartilage	 fibrillation	 (Figure	 5.1a),	 resulting	 in	 significantly	 higher	 OARSI	 scores	 (Supp.	Figure	5.1b).	Although	the	control	cartilage	was	more	intact	than	the	OA	cartilage	overall,	the	medial	 compartment	 showed	 more	 evidence	 of	 degeneration	 in	 both	 OA	 and	 control	specimens.	 Therefore,	 the	 subsequent	 analyses	 of	 subchondral	 bone	 compared	 defined	regions	of	interest	between	the	control	and	OA	specimens,	as	well	as	between	the	medial	and	lateral	side	of	the	same	specimen.			While	 OA-dependent	 differences	 in	 osteoblast	 and	 osteoclast	 function	 have	 been	described	(3,	6),	the	effect	of	OA	on	osteocytes	is	not	well-defined.	Therefore,	we	evaluated	osteocyte	 PLR	 in	 subchondral	 bone	 by	 studying	 one	 of	 its	 key	 hallmarks,	 the	lacunocanalicular	 network	 (LCN).	 Silver	 staining	 revealed	 that	 cadaveric	 control	subchondral	bone	had	both	more	abundant	and	apparently	 longer	canalicular	projections	
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than	the	subchondral	bone	from	OA	patients	(Figure	5.1b).	The	dramatic	degeneration	of	the	canalicular	 network	 in	 OA	 bone	was	 particularly	 evident	 in	 the	medial	 side	 of	 the	 tibial	plateau,	 where	 cartilage	 degeneration	 was	 most	 severe.	 Quantitative	 analysis	 revealed	significant	OA-dependent	reductions	in	the	total	osteocyte	lacunocanalicular	area	(38-46%)	(Figure	5.1c)	and	canalicular	length	(51-54%)	(Figure	5.1d)	relative	to	cadaveric	controls,	consistent	with	this	hallmark	feature	of	PLR	suppression	(10,	13–15,	19,	27,	30).		Therefore,	the	reduced	canalicular	length	and	lacunocanalicular	area	in	OA	subchondral	bone	strongly	suggests	that	PLR	is	suppressed	in	OA.					
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Figure	5.1:	Lacunocanalicular	networks	are	disrupted	in	human	OA	subchondral	bone.	(a)	Control	 cadaveric	 and	 OA	 specimens	 stained	 with	 Safranin-O/Fast	 Green	 and	 imaged	 at	0.5x (top)	or	2x (bottom,	scale	bars:	400 μm)	magnification	displayed	differences	in	articular	cartilage	 and	 subchondral	 bone	morphology	 on	 the	 lateral	 and	medial	 sides	 of	 the	 tibial	plateau.	Subsequent	analyses	compared	the	indicated	regions	of	interest	(black	boxes	on	top	row)	between	control	and	OA	specimens,	and	between	the	less	affected	lateral	side	with	the	
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more	severely	degraded	medial	side.	(b)	These	identified	regions	of	interest	in	Ploton	silver-stained	sections	were	evaluated	at	low	(4x,	top,	scale	bars:	200 μm)	and	high	(100x,	bottom,	scale	bars:	20 μm)	magnification	to	visualize	the	lacunocanalicular	network	of	subchondral	bone.	(c,	d)	Quantification	of	the	lacunocanalicular	area	normalized	to	the	bone	area	(c)	and	canalicular	 length	 (d)	 revealed	 significant	 OA-dependent	 reductions	 in	 both	 parameters	(n = 5).	 Graphs	 show	mean ± SEM.	 *P < 0.05	 compared	 with	 respective	 regions	 of	 control	specimens,	⋄P	< 0.05	between	regions	by	Holm–Sidak	post	hoc	tests.		
Collagen	disorganization	and	hypermineralization	in	human	OA	subchondral	bone	In	mouse	models	of	PLR	suppression	and	in	human	osteonecrotic	subchondral	bone,	loss	 of	 lacunocanalicular	 area	 is	 often	 accompanied	 by	 collagen	 disorganization	 and	hypermineralization	 of	 the	 bone	 extracellular	 matrix	 (ECM)	 (13,	 27,	 30).	 Therefore,	 we	evaluated	 the	 organic	 and	 mineral	 constituents	 of	 OA	 subchondral	 bone.	 Birefringent	collagen	fibers	in	OA	subchondral	bone	showed	qualitatively	less	alignment	relative	to	the	control	tissue	(Figure	5.2a).	Upon	quantification,	collagen	linearity	was	significantly	lower	in	OA	 specimens	 compared	 to	 control	 specimens	 on	 both	 the	 lateral	 and	 medial	 sides.	Furthermore,	collagen	fibers	were	significantly	less	aligned	on	the	medial	side	of	the	joint	than	on	the	lateral	side	in	both	groups	(Figure	5.2b).		Consistent	with	these	site-	and	disease-dependent	patterns,	hypermineralization	of	subchondral	bone	was	most	pronounced	in	specimens	from	the	medial	side	of	the	OA	tibial	plateau	(Figure	5.2d).	Medial	OA	specimens	also	portrayed	a	rougher	subchondral	surface	than	control	specimens.	Statistical	analysis	confirms	that	the	distribution	of	mineral	density	is	significantly	shifted	in	medial	OA	samples	relative	to	lateral	OA	samples,	but	low	sample	size	 precludes	 quantitative	 comparison	 to	 control	 groups	 (Figure	 5.2c).	 Therefore,	 OA	 is	accompanied	by	subchondral	bone	collagen	disorganization	and	is	regionally	associated	with	bone	matrix	hypermineralization	within	samples,	concordant	with	suppressed	PLR	(13,	27,	30).	
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Figure	 5.2:	 Human	 OA	 subchondral	 bone	 shows	 collagen	 disorganization	 and	hypermineralization.	 (a)	Control	 cadaveric	 (n = 5)	 and	 OA	 (lateral	n = 5,	 medial	n = 4)	specimens	stained	with	Picrosirius	Red	and	imaged	at	low	(4x,	top,	scale	bars:	200 μm)	or	high	 (40x,	 bottom,	 scale	 bars:	 100 μm)	 magnification	 using	 polarized	 light	 microscopy	revealed	 differences	 in	 subchondral	 bone	 collagen	 organization.	 Collagen	 fibers	 are	 less	
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organized	 in	 OA	 samples	 than	 control	 samples	 and	 in	 medial	 regions	 than	 lateral	regions.	(b)	The	 distribution	 of	 collagen	 fiber	 orientation	 shows	 significant	 differences	between	 all	 four	 groups.	(c,	d)	Synchrotron	Radiation	 X-ray	micro-computed	 tomography	(SRμT)	of	subchondral	bone	from	the	lateral	and	medial	sides	of	cadaveric	control	and	OA	tibial	plateaus	showed	a	qualitative	increase	in	mineralization,	according	to	the	colorimetric	scale	(800–3	200 mg	HAcm−3),	in	3D-reconstructed	(d,	top)	and	2D	high-magnification	(d,	bottom)	images.	The	distribution	of	mineralization	through	the	subchondral	bone	from	each	region	(c)	confirms	the	shift	in	the	peak	mineralization	level	in	OA	medial	specimens	(n = 5)	compared	with	OA	lateral	(n = 4)	specimens.	OA	curves	were	not	statistically	compared	with	medial	or	lateral	control	samples	due	to	low	sample	size	(n = 2).	Lines	represent	the	mean	of	all	specimens	in	the	group.	*P < 0.05	by	mixed	model	with	random	intercepts.			
Reduced	osteocyte	expression	of	PLR	enzymes	in	human	OA	subchondral	bone	Given	that	OA	subchondral	bone	shows	multiple	signs	of	suppressed	PLR,	we	sought	to	 evaluate	 the	 expression	 of	 key	 enzymes	 implicated	 in	 PLR	 by	 osteocytes.	Immunohistochemistry	(IHC)	revealed	qualitatively	lower	levels	of	MMP13	(Figure	5.3a)	and	Cathepsin	K	(CatK,	Figure	5.3c)	protein	expression	 in	subchondral	bone	of	 the	medial	OA	tibial	plateau	relative	to	healthy	controls	and	relative	to	the	less	severely	affected	lateral	OA	tibial	plateau.	Accordingly,	 the	percentage	of	MMP13-positive	osteocytes	was	 lower	 in	OA	subchondral	bone	by	20%	on	the	medial	side	and	10%	on	the	lateral	side	relative	to	their	respective	control	sites	(Figure	5.3b).	The	percentage	of	CatK-positive	osteocytes	was	24%	lower	 on	 the	 medial	 side	 and	 13%	 lower	 on	 the	 lateral	 side	 in	 OA	 subchondral	 bone	compared	to	respective	cadaveric	controls	(Figure	5.3d).	No	differences	in	negative	control	immunostaining	 were	 observed	 between	 cadaveric	 and	 OA	 samples	 (Figure	 5.3e).	Interestingly,	 the	 percentage	 of	 MMP13-positive	 osteocytes	 is	 strongly	 correlated	 with	lacunocanalicular	area	and	with	canalicular	length	for	each	sample	and	region	(Figure	5.3f-g).		
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Together	these	results	suggest	that	human	OA	is	correlated	with	PLR	suppression	in	subchondral	bone,	as	demonstrated	by	repression	of	key	PLR	enzymes	in	subchondral	bone,	loss	of	lacunocanalicular	area,	collagen	disorganization,	and	hypermineralization.	As	a	next	step	in	evaluating	the	causality	of	PLR	suppression	in	joint	disease,	we	generated	mice	with	a	targeted	deletion	of	MMP13	from	osteocytes.	We	previously	reported	that	systemic	ablation	of	MMP13	suppresses	PLR	(13),	however,	chondrocyte	expression	of	MMP13	contributes	to	cartilage	degradation	(31),	and	ablation	of	MMP13	in	chondrocytes	is	chondroprotective	(32,	33).	 Therefore,	 we	 characterized	 the	 bone	 and	 joint	 phenotypes	 of	 mice	 with	 a	 novel,	osteocyte-intrinsic	ablation	of	MMP13.		
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Figure	5.3:	PLR	enzyme	expression	 is	suppressed	 in	human	OA	subchondral	bone.	 (a–d)	Immunohistochemical	 analysis	 of	 MMP13	 (a)	 and	 Cathepsin	 K	 (CatK,	 c)	 levels	 and	localization	 in	 subchondral	 bone	 from	 control	 and	 OA	 tibial	 plateau	 specimens	 was	performed	at	low	(4x,	top,	scale	bars:	200 μm)	and	high	(40x,	bottom,	scale	bars:	100 μm)	magnification.	 Qualitative	 and	 quantitative	 analyses	 show	 diminished	 MMP13	 and	 CatK	expression	 in	 the	 OA	 tibial	 plateau,	 with	 a	 significant	 reduction	 in	 the	 percentage	 of	osteocytes	stained	positively	for	MMP13	(b,	control	n = 4,	OA	n = 5)	and	CatK	(d,	control	n = 4,	OA	n = 5)	in	both	regions.	(e)	No	differences	in	negative	control	staining	were	observed.	(f–
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g)	Furthermore,	Pearson’s	product–moment	correlation	indicates	that	percent	of	MMP13-positive	osteocytes	is	strongly	correlated	with	lacunocanalicular	area	(f,	r = 0.79,	P < 0.0001)	and	canalicular	length	(g,	r = 0.82,	P < 0.0001).	Graphs	show	mean ± SEM.	*P < 0.05	compared	with	respective	regions	of	control	specimens,	⋄P < 0.05	between	regions	by	Holm–Sidak	post	hoc	tests.		
Targeted	ablation	of	MMP13	expression	in	osteocytes	An	established	floxed	MMP13	allele	(34)	was	deleted	under	control	of	DMP1-Cre	(9.6-kb	promoter)	(35),	resulting	in	mice	with	a	targeted	deletion	of	MMP13	in	osteocytes.	DMP1-Cre+/-;MMP13fl/fl	(MMP13ocy-/-)	animals	are	born	at	the	same	rate	and	are	grossly	similar	to	their	DMP1-Cre-/-;MMP13fl/fl	(wildtype)	littermates,	with	no	significant	differences	in	weight	or	lifespan.		We	 validated	 the	 tissue-specific	 reduction	 in	 MMP13	 expression	 at	 the	transcriptional	 and	 translational	 level.	 In	 femoral	 cortical	 bone	 of	 MMP13ocy-/-	 animals,	immunofluorescence	revealed	37%	fewer	MMP13-positive	osteocytes	(Figure	5.4a,	c),	and	in	subchondral	trabecular	bone,	the	number	of	MMP13-positive	osteocytes	was	reduced	by	63%	 (Figure	 5.4b,	 c,	 regions	 of	 interest	 shown	 in	 Supp.	 Figure	 5.2a,	 b,	 channels	 shown	separately	 in	 Supp.	 Figure	 5.2c).	 This	 result	 was	 consistent	 with	 the	 63%	 reduction	 in	MMP13	mRNA	expression	in	humeri	cleaned	of	marrow	and	periosteum	(Figure	5.4e).		Given	the	goal	of	identifying	the	role	of	osteocyte-derived	MMP13,	and	since	the	9.6-kb	DMP1-Cre	promoter	can	induce	off-target	recombination	in	late	osteoblasts	and	some	soft	tissues	(36),	we	also	evaluated	possible	changes	in	MMP13	expression	in	other	cell	types	in	the	MMP13ocy-/-	mouse	model.	Immunofluorescence	revealed	neither	significant	changes	in	the	 number	 of	 MMP13-positive	 chondrocytes	 in	 articular	 cartilage	 (Figure	 5.4g)	 nor	qualitative	differences	 in	MMP13	expression	in	growth	plate	chondrocytes	 in	MMP13ocy-/-	
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mice	(Supp.	Figure	5.2d).	MMP13	expression	in	periosteal	cells	(Figure	5.4a),	bone	marrow	(Figure	 5.4b,	 Supp.	 Figure	 5.2c),	 and	 skeletal	 muscle	 (not	 shown)	 was	 also	 unchanged	between	genotypes.	Further,	the	number	of	DAPI-stained	osteocytes	in	cortical	bone	is	not	affected	by	MMP13	ablation	(Figure	5.4f),	suggesting	that	recombination	in	this	model	is	not	affecting	the	differentiation	and	embedding	of	osteocytes.	Therefore,	the	MMP13ocy-/-	mouse	model	is	appropriate	to	observe	differences	in	bone	and	joint	phenotypes	arising	primarily	from	changes	in	osteocyte-derived	MMP13.	Trabecular	bone	volume	is	increased	in	mice	with	systemic	ablation	of	MMP13	and	in	other	models	of	PLR	suppression	(13,	19,	34).	To	determine	if	deletion	of	osteocyte-intrinsic	MMP13	is	sufficient	to	alter	bone	mass,	we	used	μCT	to	analyze	trabecular	and	cortical	bone	mass	 and	 microarchitecture.	 Relative	 to	 wildtype	 mice,	 MMP13ocy-/-	 femurs	 had	 a	 25%	increase	in	trabecular	bone	volume	fraction	due	to	a	16%	increase	in	trabecular	number	and	a	 corresponding	 decrease	 in	 trabecular	 spacing	 with	 no	 change	 in	 trabecular	 thickness	(Figure	5.4h).	MMP13ocy-/-	femurs	also	show	an	increase	in	volumetric	bone	mineral	density	and	 a	 decrease	 in	 SMI	 reflecting	 a	 shift	 to	more	 plate-like	microarchitecture.	 The	mRNA	levels	or	 ratio	of	RANKL	and	OPG	mRNA	expression	do	not	account	 for	 these	differences	(data	 not	 shown).	 Cortical	 bone	 thickness	 and	 total	 mineral	 density	 were	 normal	 in	MMP13ocy-/-	femurs	(Figure	5.4i).	Therefore	osteocyte-intrinsic	MMP13	is	sufficient	to	alter	trabecular	bone	volume	and	mineralization.		
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Figure	 5.4:	 Osteocyte-specific	 reduction	 in	 MMP13	 expression	 in	 the	 cortical	 and	subchondral	bone	causes	increased	trabecular	bone	mass.	(a–d)	In	cortical	bone	(a)	imaged	at	low	(left	and	center,	arrows	indicate	periosteal	surface,	scale	bars:	50 μm)	and	high	(right,	scale	bars:	10 μm)	magnification	and	in	subchondral	trabecular	bone	(b,	scale	bars:	50 μm),	
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the	 number	 of	 osteocytes	 stained	 positive	 for	 MMP13	 is	 reduced	 in	 MMP13ocy−/−	 bone	compared	with	wild-type	(c,	d,	n = 6-9).	No	differences	were	observed	in	osteoblasts	in	the	periosteum,	 in	 bone	marrow,	 or	 in	 negative	 control	 images.	 (e)	MMP13	mRNA	was	 also	significantly	reduced	in	MMP13ocy−/−	bone	compared	with	wild-type	(n = 7–9).	(f)	Osteocyte	number	was	not	changed	between	groups.	(g)	MMP13	expression	in	chondrocytes	was	not	significantly	different	between	groups	(scale	bars:	50 μm,	n = 6–8).	(h)	μCT	of	distal	femoral	trabecular	 bone	 (n = 11)	 shows	 that	 bone	 volume	 fraction	 and	 volumetric	 bone	mineral	density	are	increased	in	MMP13ocy−/−	bone	due	to	an	increase	in	the	trabecular	number	and	corresponding	decrease	in	trabecular	spacing	rather	than	a	change	in	trabecular	thickness.	Decreased	SMI	indicates	a	shift	 to	more	plate-like	trabecular	structures.	(i)	Cortical	bone,	however,	 did	 not	 present	 differences	 in	 thickness	 or	 mineral	 density.	 Graphs	 show	mean ± SD.	*P < 0.05	between	genotypes	by	unpaired	t	test.	
	
Suppressed	PLR	in	MMP13ocy-/-	bone	To	 determine	 the	 role	 of	 osteocyte-intrinsic	 MMP13	 in	 PLR,	 we	 evaluated	 the	osteocyte	 LCN	 and	 collagen	 alignment,	 both	 of	 which	 are	 sensitive	 to	 PLR	 suppression,	including	in	mice	with	systemic	ablation	of	MMP13	(13).	The	LCN	of	femoral	cortical	bone	is	visibly	disrupted	by	osteocyte-intrinsic	MMP13	deficiency	(Figure	5.5a).	Canalicular	length	in	MMP13ocy-/-	mice	is	reduced	by	20%	(Figure	5.5b)	with	no	significant	change	in	lacunar	area	(Figure	5.5c)	or	lacunar	density	(data	not	shown).	This	decrease	in	canalicular	length	occurs	in	a	coordinated	manner	across	the	medial,	lateral,	anterior	and	posterior	regions	of	MMP13ocy-/-	 cortical	 bone	 (Figure	5.5b).	We	 consistently	 observed	a	 small	 but	 significant	decrease	 in	peak	alignment	of	collagen	fibers	 in	MMP13ocy-/-	bones	compared	to	wildtype	bone	in	the	anterior	region	(Figure	5.5d,	e).	In	the	other	regions	studied,	no	differences	in	collagen	 linearity	 were	 detected	 despite	 the	 change	 in	 PLR	 activity	 suggested	 by	 LCN	analysis.			 	 Since	changes	to	collagen,	mineral,	or	LCN	organization	can	affect	bone	biomechanical	behavior	(13,	19,	37),	we	tested	mechanical	properties	of	femurs	from	2-	and	4-month-old	wildtype	 and	MMP13ocy-/-	mice	 using	 3-point	 bending.	 Small	 but	 significant	 decreases	 in	
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whole-bone	structural	stiffness	and	ultimate	load	were	detected	in	4-month-old	MMP13ocy-
/-	bones	(Table	5.1),	consistent	with	minor	deficiencies	in	both	collagen	and	mineral	(38,	39).	However,	no	significant	changes	were	detected	in	yield	properties,	postyield	displacement,	or	work-to-fracture,	so	cortical	bone	biomechanical	outcomes	were	relatively	insensitive	to	osteocyte-intrinsic	MMP13	deficiency	in	this	model.	Overall,	osteocyte-intrinsic	MMP13	is	required	 for	PLR	since	 its	ablation	disrupts	 the	maintenance	of	canalicular	networks	and	collagen	organization	and	reduces	bone	mechanical	properties.			
	
Figure	 5.5:	 MMP13ocy−/−	 cortical	 bone	 displays	 hallmarks	 of	 suppressed	perilacunar/canalicular	 remodeling.	 (a–c	 )Canalicular	 length	 in	 wild-type	 bone	 is	 longer	than	 that	 in	MMP13ocy−/−	bone	 in	all	 regions	 sampled	 (b,	n = 7),	while	 lacunar	area	 is	not	statistically	different	(c,	n = 7).	Graphs	show	mean ± SEM.	(d,	e)	Collagen	fiber	organization	is	reduced	in	MMP13ocy−/−	bone	(n = 9)	compared	with	wild-type	bone	(n = 8)	in	the	anterior	quadrant	but	not	in	other	regions.	Lines	represent	the	mean	of	all	specimens	in	the	group.	Scale	bars	are	20 μm	in	(a)	and	50 μm	in	(d).	*P < 0.05	between	genotypes	by	unpaired	t	test.	
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Table	5.1:	Flexural	properties	of	wild-type	and	MMP13ocy−/−	femurs.	Femurs	from	wild-type	and	MMP13ocy−/−	mice	were	broken	with	either	anterior	or	posterior	side	in	compression.	In	general,	structural	and	tissue	material	properties	were	stronger	in	posterior	(physiological)	compression	than	anterior	compression	and	get	stronger	with	age.	Ultimate	load	tended	to	be	lower	in	MMP13ocy−/−	bones	than	wild-type	bones,	particularly	in	4-month-old	samples	broken	 in	 anterior	 compression.	 MMP13ocy−/−	bones	 also	 had	 lower	 stiffness	 in	 this	 test	configuration.	Values	are	presented	as	mean ± SD.	*P < 0.05	between	genotypes,	#P < 0.065	between	genotypes	by	unpaired	t	test.		 	 Posterior	compression,	2	months	(n=9)	 Posterior	compression,	4	months		(n=8-9)		 WT	 MMP13ocy-/-	 WT	 MMP13ocy-/-	Bending	Stiffness	(N/mm)	 79.06	+/-	8.65	 77.37	+/-	5.03	 105.22	+/-	13.22	 104.83	+/-	9.33	Yield	Load	(N)	 11.57	+/-	1.55	 10.94	+/-	1.63	 13.05	+/-	2.43	 13.86	+/-	1.55	Ultimate	Load	(N)	 16.79	+/-	2.21	 15.11	+/-	1.24		#	 19.02	+/-	2.08	 18.24	+/-	1.63	Postyield	Displacement	(mm)	 0.50	+/-	0.22	 0.55	+/-	0.26	 0.50	+/-	0.37	 0.34	+/-	0.14	Work	to	Fracture	(N-mm)	 7.98	+/-	1.87	 7.86	+/-	3.09	 8.24	+/-	3.30	 6.55	+/-	1.85	Bending	Modulus	(GPa)	 10.37	+/-	1.52	 11.75	+/-	2.70	 14.35	+/-	1.08	 14.72	+/-	3.07	Yield	Stress	(MPa)	 158.04	+/-	11.51	 167.55	+/-	37.78	 186.41	+/-	35.28	 200.00	+/-	38.15		 	 	 	 		 Anterior	compression,	2	months	(n=3-9)	 Anterior	compression,	4	months	(n=8-9)		 WT	 MMP13ocy-/-	 WT	 MMP13ocy-/-	Bending	Stiffness	(N/mm)	 70.24	+/-	11.08	 58.11	+/-	1.55	 92.66	+/-	6.90	 83.03	+/-	9.27		*	Yield	Load	(N)	 10.18	+/-	1.94	 11.11	+/-	3.61	 12.28	+/-	0.91	 11.76	+/-	1.31	Ultimate	Load	(N)	 13.25	+/-	1.65	 13.61	+/-	1.67	 17.12	+/-	1.34	 15.64	+/-	1.35		*	Postyield	Displacement	(mm)	 0.91	+/-	0.53	 0.95	+/-	0.40	 0.28	+/-	0.10	 0.34	+/-	0.19	Work	to	Fracture	(N-mm)	 8.91	+/-	2.32	 9.16	+/-	2.40	 5.09	+/-	1.50	 5.27	+/-	2.01	
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Increased	cartilage	degradation	in	MMP13ocy-/-	mice		Though	subchondral	bone	clearly	contributes	to	osteoarthritis,	the	role	of	osteocytes	in	joint	disease	remains	unclear	(3,	5–8).	Given	the	strong	association	of	PLR	suppression	with	cartilage	degeneration	in	human	OA	(Figure	5.1-5.3),	we	tested	the	hypothesis	that	PLR	suppression	via	ablation	of	osteocyte	MMP13	is	sufficient	to	cause	cartilage	degeneration.	Articular	 cartilage	 of	 4-month-old	 wildtype	 and	MMP13ocy-/-	 mouse	 knees	 demonstrated	clear	histopathological	differences	(Figure	5.6a).	Relative	to	the	smooth,	proteoglycan-rich	articular	 cartilage	 in	wildtype	 knees,	MMP13ocy-/-	 cartilage	 had	 surface	 irregularities	 and	depletion	of	proteoglycans.	These	characteristic	features	of	degenerating	articular	cartilage	were	 apparent	 in	 basal	 conditions	 on	 the	medial	 and	 lateral	 tibial	 and	 femoral	 surfaces.	Accordingly,	 using	 two	 established	 OA	 grading	 scales	 (40,	 41),	 MMP13ocy-/-	 knees	 had	statistically	more	cartilage	degeneration	than	wildtype	knees	(Figure	5.6b,	c).	Therefore,	loss	of	 MMP13	 function	 in	 the	 subchondral	 bone	 osteocytes	 is	 sufficient	 to	 disrupt	 cartilage	homeostasis,	 causing	 the	 appearance	 of	 osteoarthritic	 features	 in	 otherwise	 healthy	cartilage.	 This	 result	 further	 suggests	 that	 the	 severe	 PLR	 suppression	 observed	 in	 OA	human	subchondral	bone	plays	a	causal	role	in	the	progression	of	joint	disease.	To	assess	the	role	of	PLR	suppression	in	post-traumatic	cartilage	degeneration,	we	used	an	established	medial	 ligamentous	injury	(MLI)	model	to	induce	OA	in	wildtype	and	MMP13ocy-/-	knees	(42).	As	in	non-injured	controls,	sham-injured	MMP13ocy-/-	joints	showed	more	 cartilage	degeneration	 than	 their	wildtype	 counterparts	 (Figure	5.6d).	 Increases	 in	chondrocyte	 hypertrophy	 and	 articular	 cartilage	 lesions,	 as	 well	 as	 proteoglycan	 loss,	contributed	to	the	more	severe	OA	grade	in	sham-injured	MMP13ocy-/-	knees	(Figure	5.6e,	f).	After	 injury,	both	genotypes	experienced	severe	loss	of	articular	cartilage	and	osteophyte	
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formation,	 but	 no	differences	were	 found	between	 genotypes	 (Figure	5.6d-f).	 These	data	suggest	 that	 although	 MMP13	 expression	 by	 osteocytes	 is	 important	 for	 cartilage	homeostasis,	the	severity	of	joint	injury	overshadows	the	osteocytic	contribution	to	healthy	joint	crosstalk	in	this	model.		
	
Figure	5.6:	Knees	of	non-injured	MMP13ocy−/−	mice	show	more	cartilage	damage	than	wild-type	 mice.	 (a–c)	 Safranin-O	 stained	 joints	 of	 16-week-old	 wild-type	 mice	 show	 intact	
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cartilage,	 while	 MMP13ocy−/−	 mice	 have	 areas	 of	 cartilage	 surface	 irregularity	 and	proteoglycan	depletion	(a),	leading	to	significantly	higher	OARSI	(b)	and	modified	Mankin	(c)	scores	(n = 6).	(d–f)	In	sham-injured	joints,	MMP13-dependent	proteoglycan	loss	is	still	apparent,	and	meniscal-ligamentous	injury	(MLI)	induces	severe	cartilage	damage	in	both	groups	(d).	On	OARSI	(e)	and	modified	Mankin	(f)	grading	scales,	sham-injured	MMP13ocy−/−	mice	score	significantly	higher	than	wild-type	mice	(n = 10),	but	scores	are	equivalent	after	MLI	(n = 10	for	wild-type,	n = 11	for	MMP13ocy−/−).	Arrows	denote	cartilage	damage	in	non-injured	joints.	Scale	bars	are	100 μm.	Graphs	show	mean ± SEM.	*P < 0.05	between	genotypes	by	unpaired	t	test.	
	
Mechanisms	of	subchondral	osteocyte	influence	on	cartilage	Although	a	causal	role	for	osteocytes	in	cartilage	degeneration,	to	our	knowledge,	has	not	previously	been	demonstrated,	 there	are	multiple	hypothetical	mechanisms	by	which	subchondral	bone	deterioration	could	exacerbate	cartilage	degeneration	and	drive	OA	(3,	5,	6).	 These	 include	 biological	 hypotheses	 such	 as	 cell	 death	 or	 vascular	 changes	 and	mechanical	hypotheses	such	as	rod	and	plate	distribution	in	subchondral	bone	(8,	43–45).		To	further	understand	why	MMP13ocy-/-	mice	are	predisposed	to	cartilage	degeneration,	we	evaluated	 biological	 and	 structural	 features	 of	 tibial	 cartilage	 and	 subchondral	 bone	 in	healthy	and	injured	joints.	First,	we	tested	the	hypothesis	that	MMP13ocy-/-	bone	causes	increased	chondrocyte	catabolism	 and	 apoptosis	 by	 evaluating	 the	 expression	 of	 cartilage	 matrix	 constituents	collagen	 II	 and	 aggrecan,	 of	 degeneration	 markers	 collagen	 X	 and	 MMP13,	 and	 of	 the	products	of	cartilage	matrix	degradation,	the	neoepitopes	VDIPEN	and	NITEGE.	Relative	to	the	 wildtype,	 MMP13ocy-/-	 chondrocytes	 had	 increased	 levels	 of	 collagen	 II	 and	 a	 slight	decrease	in	aggrecan	(Figure	5.7a).		The	resulting	increase	in	the	collagen	II	to	aggrecan	ratio	in	MMP13ocy-/-	cartilage	(Figure	5.7b)	is	a	hallmark	of	early	OA	(46).	MMP13	expression	by	MMP13ocy-/-	chondrocytes	was	also	significantly	elevated	(Figure	5.7a,	c),	consistent	with	the	observed	cartilage	degeneration	(Figure	5.6).	Significant	differences	were	not	observed	in	
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collagen	X,	VDIPEN,	or	NITEGE	expression	(not	shown),	nor	were	osteocyte	or	chondrocyte	viability	 altered	 by	 osteocyte	 MMP13	 deficiency	 or	 injury	 (Supp.	 Figure	 5.3),	 though	additional	timepoints	may	be	required	to	observe	these	cellular	responses	(47,	48).		
	
Figure	5.7:	Chondrocytes	in	MMP13ocy−/−	mice	have	altered	cartilage	matrix	synthesis	and	MMP13	 expression.	 (a)	 IHC	 of	 collagen	 II,	 aggrecan,	 and	 MMP13	 in	 wild-type	 and	MMP13ocy−/−	mice	(sham	group)	show	qualitative	genotype-dependent	changes	in	cartilage	matrix	synthesis	and	degradation,	with	apparent	increases	in	collagen	II	and	MMP13	and	a	decrease	in	aggrecan.	(b)	The	collagen	II	to	aggrecan	ratio	in	MMP13ocy−/−	chondrocytes	is	significantly	 increased	 (n = 6).	 (c)	 The	 percentage	 of	 MMP13-positive	 chondrocytes	 in	MMP13ocy−/−	 knees	 is	 significantly	 increased	 (n = 10).	 Scale	 bars	 are	 50 μm.	Graphs	 show	mean ± SD.	*P < 0.05	between	genotypes	by	unpaired	t	test.			 Second,	since	human	osteoarthritic	subchondral	bone	is	characterized	by	sclerosis,	collagen	disorganization,	and	disrupted	LCN	(Figure	5.1-5.3),	we	hypothesized	 that	 these	structural	features	would	be	observed	in	MMP13ocy-/-	subchondral	bone.	As	in	cortical	bone	(Figure	 5.5a),	 the	 canalicular	 length	 of	 osteocytes	 in	MMP13ocy-/-	 subchondral	 bone	 was	visibly	 shorter	 than	 in	 wildtype	 bone	 (Figure	 5.8a).	 Canaliculi	 were	 17-20%	 shorter	 in	MMP13ocy-/-	subchondral	bone	compared	to	wildtype	bone,	and	injured	samples	had	17-20%	shorter	canaliculi	than	in	the	corresponding	sham-injured	groups	for	each	genotype	(Figure	
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5.8b).	These	findings	suggest	that	the	cartilage	degradation	in	mice	lacking	osteocyte	MMP13	could	be	due	to	reduced	PLR	and	highlight	the	sensitivity	of	the	LCN	to	joint	injury.	Collagen	fiber	organization	in	sham-injured	tibial	subchondral	bone	was	also	disrupted	by	osteocytic	MMP13	 deficiency	 (Figure	 5.8c).	 Joint	 injury	 caused	 a	 loss	 of	 collagen	 fiber	 organization	compared	 to	wildtype	 shams	 (Figure	 5.8d),	 but	 no	 differences	 between	 genotypes	were	detected	after	injury.	Similarly,	μCT	of	tibial	subchondral	bone	revealed	a	MMP13-dependent	difference	in	bone	volume	fraction	between	the	sham	groups,	but	not	between	the	injured	groups	 (Figure	 5.8e,	 f).	 Thus,	 loss	 of	 osteocyte	 MMP13	 causes	 structural	 changes	 to	subchondral	bone	that	mimic	joint	injury,	possibly	via	its	effects	on	PLR.	
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Figure	5.8:	Subchondral	bone	shows	MMP13-dependent	changes	before	injury.	(a–b)	Like	in	cortical	bone,	canalicular	length	in	MMP13ocy−/−	subchondral	tibias	is	shorter	than	in	wild-type	 subchondral	 tibias	 (a).	 The	 difference	 is	 statistically	 significant	 in	 injured	 and	 non-injured	joints	(b,	n = 6,	mean ± SEM).	(c,	d)	Collagen	fiber	organization	is	significantly	affected	
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by	MMP13	 in	 sham-injured	 subchondral	 tibias,	 but	no	difference	 is	 apparent	 after	 injury	(n = 6,	lines	represent	the	mean	of	all	specimens	in	the	group).	(e,	f)	Similarly,	subchondral	bone	 volume	 fraction	 is	 increased	 in	 sham-injured	MMP13ocy−/−	 tibias	 (n = 10)	 compared	with	 sham-injured	 wild-type	 tibias	 (n = 10),	 but	 after	 injury	 wild-type	 (n = 10)	 and	MMP13ocy−/−	 (n = 11)	 joints	 are	 indistinguishable.	 Graph	 shows	mean ± SD.	 Scale	 bars	 are	20 μm	in	(a)	and	50 μm	in	(c).	*P < 0.05	between	genotypes,	⋄P < 0.05	between	treatments	by	Holm–Sidak	post	hoc	tests.		
Finally,	 we	 performed	 RNA-seq	 on	 wildtype	 and	MMP13ocy-/-	 bones	 to	 determine	which	biological	pathways	in	osteocytes	were	disrupted	by	MMP13	ablation.	We	detected	90	upregulated	and	454	downregulated	differentially	expressed	genes	in	MMP13ocy-/-	bone,	of	which	MMP13	was	one	of	the	most	significantly	downregulated	(Figure	5.9a).	With	induction	or	 suppression	 of	 PLR,	 we	 and	 others	 have	 previously	 observed	 coordinated	 and	compensatory	 changes	 in	 expression	 of	 genes	 required	 for	 matrix	 resorption,	 including	proteases	and	genes	involved	in	acid	secretion	(19,	27).	Thus,	it	was	striking	to	find	that	the	most	differentially	 induced	genes	 in	MMP13ocy-/-	bone	 included	Ctsk	and	Acp5,	as	well	 as	many	 subunits	 of	 vacuolar	 type	 ATPases	 associated	 with	 intracellular	 and	 extracellular	acidification	(Figure	5.9a,	b).		A	gene	signature	score	of	acidification-related	genes	showed	that	they	are	significantly	upregulated	in	MMP13ocy-/-	bone	(p<0.05).	On	the	other	hand,	a	gene	 signature	 score	 of	 transcription	 factors	 and	 markers	 of	 osteoblast	 differentiation	showed	no	significant	change	in	MMP13ocy-/-	compared	to	wildtype	bone	(p=0.19),	further	indicating	 that	 the	 phenotype	 of	 the	 MMP13ocy-/-	 joint	 is	 a	 result	 of	 defective	 osteocyte	function	rather	than	of	osteogenic	differentiation.	Using	qPCR	we	validated	that	MMP13ocy-/-	bone	has	reduced	expression	of	Mmp2	and	increased	expression	of	Ctsk,	Atp6v0d2,	and	Acp5	(Figure	 5.9c).	 No	 changes	 were	 observed	 in	 Timp1,	 Timp2,	 or	 Mmp14.	 The	 increase	 in	Cathepsin	K	is	due	to	a	change	in	osteocyte	expression	rather	than	osteoclast	expression,	
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which	 was	 verified	 by	 immunohistochemistry	 (Figure	 5.9d).	 Thus,	 MMP13	 ablation	 in	osteocytes	not	only	disrupts	PLR,	but	also	disrupts	structural	and	biological	homeostasis	of	the	joint.	
	
Figure	5.9:	Osteocyte	deficiency	of	MMP13	causes	dysregulation	of	genes	related	to	matrix	degradation	 and	 acidification.	 (a)	 RNA-seq	 of	 wild-type	 and	 MMP13ocy−/−	 mice	 (n = 4)	identified	differentially	expressed	genes	 (DEGs)	 that	are	 significantly	repressed	 (blue)	or	induced	 (red)	 in	MMP13ocy−/−	 bone,	with	 downregulation	 of	MMP13	 and	 upregulation	 of	several	proteases	and	acidification-related	genes	(highlighted	in	turquoise).	Transcription	factors	and	other	genes	implicated	in	osteoblast	differentiation	(yellow)	are	among	the	genes	that	did	not	show	significant	expression	differences	in	MMP13ocy−/−	bone	(gray).	(b)	Genes	related	to	acidification	were	hierarchically	clustered	in	a	heatmap	by	z-score.	(c)	qPCR	of	wild-type	 (n = 8)	 and	 MMP13ocy−/−	 (n = 6)	 bone	 validates	 both	 co-regulated	 and	compensatory	 expression	 of	 PLR	 genes	 (mean ± SD).	 (d)	 Immunohistochemistry	 reveals	increased	 levels	 of	 Cathepsin	 K	 in	 osteocytes	 in	MMP13ocy−/−	 cortical	 bone	 (scale	 bars	50 μm).	*P < 0.05	between	genotypes	by	unpaired	t	test.	
 73	
Discussion	This	 study	 advances	 our	 understanding	 of	 crosstalk	 between	 cartilage	 and	subchondral	 bone	 by	 implicating	 osteocytes	 as	 causal	 drivers	 of	 joint	 disease	 in	osteoarthritis.	 In	both	human	and	mouse	 joints,	 osteoarthritic	 subchondral	bone	exhibits	several	 outcomes	 of	 PLR	 suppression,	 including	 canalicular	 and	 collagen	 fiber	disorganization,	hypermineralization,	and	changes	in	PLR	enzyme	expression.	Furthermore,	osteocyte-intrinsic	deficiency	in	the	key	PLR	enzyme	MMP13	is	sufficient	to	suppress	PLR	and	 induce	premature	osteoarthritis,	with	 subchondral	 sclerosis	 and	 cartilage	damage	 in	otherwise	healthy	young	mice.	This	study	highlights	a	new,	causal	role	for	osteocytic	MMP13	in	 the	 regulation	 of	 cartilage	 homeostasis	 and	 suggests	 PLR	 suppression	 as	 a	 novel	mechanism	 in	 OA.	 Therefore,	 osteocytes	 emerge	 as	 a	 potential	 cellular	 target	 of	 new	therapeutics	to	block	or	reverse	OA	progression.			Several	features	of	the	bone	phenotype	in	MMP13ocy-/-	mice	resemble	those	in	other	models	 of	 MMP13	 ablation	 and	 PLR	 suppression.	 Col1-Cre+/-;MMP13fl/fl	 and	 systemic	MMP13-/-	mouse	models	together	implicate	bone-derived	MMP13	expression	in	trabecular	bone	 remodeling,	 PLR,	 and	 bone	 quality	 (13,	 30,	 34).	 As	 in	 systemic	 MMP13-/-	 bone,	osteocyte-specific	 MMP13	 ablation	 increased	 trabecular	 bone	 mass	 and	 disrupted	canalicular	 and	 collagen	 organization.	 However,	 whereas	 systemic	 ablation	 caused	decreased	postyield	deflection	and	decreased	fracture	toughness,	we	observed	changes	to	cortical	bone	stiffness	and	ultimate	strength	only.	This	was	surprising	because	we	previously	observed	severe	defects	in	bending	modulus,	yield	stress,	and	toughness	in	TbRIIocy-/-	bone	that	 also	 has	 severe	 PLR	 suppression	 (19).	 The	 less	 severe	 mechanical	 phenotype	 is,	however,	consistent	with	the	more	subtle	changes	to	canalicular	and	collagen	organization	
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in	 MMP13ocy-/-	 bone.	 Possible	 explanations	 for	 these	 differences	 include	 the	 incomplete	ablation	of	MMP13	in	MMP13ocy-/-	bone,	the	contribution	of	non-osteocytic	MMP13	to	the	systemic	MMP13-/-	phenotype,	partial	rescue	of	the	MMP13ocy-/-	phenotype	by	diffusion	of	MMP13	from	cells	in	which	it	is	not	ablated,	or	the	coordinated	repression	of	multiple	PLR	enzymes	in	TbRIIocy-/-,	but	not	in	MMP13ocy-/-	bone.	Whereas	Mmp2,	Mmp13,	Mmp14,	Ctsk,	and	Acp5	were	repressed	in	TbRIIocy-/-	bone,	MMP13ocy-/-	bone	showed	both	co-repression	(Mmp2)	 and	 an	 apparent	 compensatory	 upregulation	 (Ctsk,	 Acp5)	 of	 PLR	 enzymes.	Therefore,	the	partial	reduction	of	PLR	enzyme	expression	in	the	MMP13ocy-/-	model	may	be	insufficient	to	substantially	impact	material	properties	and	postyield	behavior	measured	at	the	 whole-bone	 scale.	 Overall	 the	 MMP13ocy-/-	 model	 was	 sufficient	 to	 suppress	 PLR	 in	cortical	and	subchondral	bone,	consistent	with	the	subchondral	bone	changes	seen	in	end-stage	human	OA.		This	MMP13ocy-/-	mouse	model	presented	a	unique	opportunity	to	investigate	the	role	of	osteocytes	in	joint	homeostasis.	Since	chondrocyte-derived	MMP13	drives	OA	by	cleaving	collagen	 II	 (31),	 systemic	 MMP13	 ablation	 is	 chondroprotective	 (32,	 33).	 By	 preserving	chondrocyte	expression	of	MMP13	while	reducing	its	expression	in	osteocytes,	we	observed	evidence	of	osteocyte-dependent	joint	crosstalk,	illustrating	a	novel	cellular	mechanism	by	which	bone	affects	the	overlying	cartilage.	Because	off-target	expression	of	the	9.6-kb	DMP1-Cre	 promoter	 has	 been	 reported	 in	 non-skeletal	 tissues	 and	 in	 osteoblasts	 (36),	 it	 is	impossible	 to	 rule	 out	 contributions	 from	 other	 cell	 types	 to	 the	 observed	 cartilage	phenotype.	 We	 anticipate	 that	 the	 effect	 on	 cartilage	 of	 possible	 non-skeletal	 MMP13	ablation,	 which	 participates	 in	 wound	 healing	 and	 cell	 migration	 (49),	 would	 be	 most	pronounced	 in	 sham	 or	 MLI	 animals.	 However,	 the	 cartilage	 phenotype	 in	 non-injured	
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controls	and	sham-operated	animals	was	consistent,	and	MLI	surgery	was	not	affected	by	genotype.	 Our	 immunostaining	 and	 RNA-seq	 results	 suggest	 that	 loss	 of	 MMP13	 in	osteocytes,	rather	than	in	chondrocytes	or	osteoblasts,	is	predominantly	responsible	for	the	MMP13ocy-/-	cartilage	phenotype.	 Indeed,	MMP13	was	not	ablated	 in	MMP13ocy-/-	articular	cartilage,	but	rather	was	elevated,	along	with	other	outcomes	of	cartilage	degeneration.		Together	the	results	of	the	current	study	address	an	important	gap	in	understanding	OA,	namely	 the	 identification	of	mechanisms	responsible	 for	 the	coupled	degeneration	of	cartilage	 and	 subchondral	 bone.	 We	 show	 here	 that	 suppression	 of	 osteocytic	 MMP13	causally	contributes	to	the	pathogenesis	of	OA,	and	several	lines	of	evidence	suggest	that	this	is	 a	 PLR-dependent	 mechanism.	 First,	 MMP13	 plays	 a	 key	 role	 in	 the	 induction	 and	suppression	of	PLR.	In	a	systemic	model	of	MMP13	ablation	and	in	glucocorticoid	treatment,	MMP13	expression	in	osteocytes	is	reduced	and	canaliculi	are	short	and	disorganized	(13,	27).	In	lactation,	MMP13	is	strongly	upregulated	as	lacunar	area	and	canalicular	size	increase	(10,	18).	In	human	subchondral	bone	we	show	that	MMP13	expression	is	tightly	correlated	with	LCN	area	and	canalicular	length	(Fig	3),	and	while	the	LCN	phenotype	is	more	subtle	in	MMP13ocy-/-	 subchondral	 bone	 than	 in	 humans,	 the	 relationship	 remains.	 Second,	 several	groups	have	observed	changes	to	osteocyte	morphology	in	OA	subchondral	bone	consistent	with	 suppressed	 PLR	 (50–53).	 Our	 findings	 complement	 and	 extend	 beyond	 these	 prior	reports	 of	 altered	 osteocyte	 morphology,	 viability,	 and	 gene	 expression	 in	 human	 OA	subchondral	 bone	 (50–53)	by	describing	 the	profound	effect	 of	OA	on	bone	 extracellular	matrix	organization,	canalicular	length,	and	lacunocanalicular	network	area.	Furthermore,	the	most	 severe	PLR	 suppression	was	 evident	 in	 the	medial	 compartment	with	 the	most	cartilage	damage.	Finally,	in	mouse	cortical	bone,	glucocorticoids	repress	MMP13	and	other	
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PLR	 enzymes,	 resulting	 in	 canalicular	 degeneration,	 collagen	 disorganization,	 and	hypermineralization	 of	 subchondral	 bone	 (27),	 all	 of	 which	 mimic	 the	 signs	 of	 PLR	suppression	in	subchondral	bone	from	another	human	joint	disease,	glucocorticoid-induced	osteonecrosis	(25,	26,	54).	Nevertheless,	it	is	possible	that	osteocytic	MMP13	supports	joint	homeostasis	 through	 PLR-independent	 mechanisms,	 such	 as	 activation	 of	 latent	 growth	factors	 (55–57),	 or	 control	 of	 osteocyte	 differentiation	 or	 embedding.	 Although	 RNA-seq	analysis	 indicates	 that	 MMP13ocy-/-	 bone	 expresses	 normal	 levels	 of	 osteogenic	differentiation	 markers,	 including	 Runx2,	 Sp7,	 and	 Atf4,	 an	 inducible	 model	 of	 MMP13	ablation	would	be	needed	to	definitively	rule	out	 this	possibility.	The	current	 findings,	 in	which	 cartilage	 degeneration	 results	 from	 osteocyte-intrinsic	 ablation	 of	 PLR	 enzyme	MMP13,	strengthen	the	idea	that	osteocytes	play	a	causal	role	in	joint	disease	through	PLR.			Much	 remains	 to	 be	 elucidated	 about	 the	 relative	 role	 of	 PLR	 in	 age-related	 joint	degeneration	and	 in	post-traumatic	OA	(PTOA).	Most	animal	models	of	OA	 involve	a	 joint	injury	 in	which	both	bone	 and	 cartilage	 are	 affected,	 and	which	may	additionally	 initiate	inflammatory	cascades	(40,	42,	58–62),	making	it	difficult	to	isolate	the	cell	type	responsible	for	cartilage	degeneration.	In	our	hands,	MLI	joint	injury	reduced	canalicular	length	in	both	genotypes	but	did	not	affect	MMP13ocy-/-	cartilage	more	severely.	This	suggests	that	reduced	subchondral	bone	MMP13	expression	is	sufficient	to	disrupt	PLR	and	cartilage	homeostasis,	but	that	joint	injury	can	override	preexisting	defects	(63).	In	human	bone,	the	more	dramatic	differences	 in	the	 lacunocanalicular	network	may	be	due	to	a	combination	of	biochemical	and	mechanical	effects	over	many	years	that	were	not	replicated	in	our	injury	model.	Review	of	additional	timepoints	post-injury,	or	use	of	a	milder	injury	model,	may	provide	a	clearer	illustration	 of	 how	 osteocytic	 MMP13	 and	 PLR	 contribute	 to	 PTOA	 pathogenesis.	 Basal	
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phenotypes	may	be	more	representative	of	age-related	joint	degeneration,	in	which	cartilage	degeneration	 occurs	without	 a	 known	 traumatic	 injury.	 The	 predisposition	 of	mice	with	suppressed	PLR	to	develop	cartilage	wear	is	consistent	with	the	idea	that	subchondral	bone	sclerosis	leads	to	cartilage	breakdown.	For	example,	in	a	guinea	pig	model	of	spontaneous	OA,	 trabecular	rod	 loss	and	plate	thickening	precede	significant	cartilage	degradation	(8).	Likewise,	 in	 non-human	 primates	 that	 spontaneously	 develop	 OA,	 subchondral	 bone	thickening	appears	to	precede	cartilage	fibrillation	(64).	In	humans,	longitudinal	tracking	of	bone	marrow	lesions	by	MRI	reveals	the	clinical	relationship	of	subchondral	changes	to	OA	progression	and	knee	pain	(44).	Although	similar	end-stage	OA	phenotypes	can	arise	from	age,	injury,	or	other	causes	(65),	PLR	may	play	a	causal	role	in	some	of	these	pathological	mechanisms,	but	not	others.	The	role	of	PLR	in	OA	in	female	patients	and	mice	must	also	be	considered	separately	since	PLR,	like	OA,	may	have	sexually	dimorphic	effects	(66).	Unraveling	the	circumstances	and	mechanisms	through	which	a	bone-intrinsic	defect	in	MMP13	suppresses	PLR	and	induces	OA	will	require	further	studies.	PLR	has	the	potential	to	 affect	 subchondral	 bone	 vascularity,	microarchitecture,	 and	mechanics,	 cartilage	 strain	distribution,	and	cell-cell	signaling,	any	of	which	could	impact	bone-cartilage	crosstalk.	The	LCN,	 maintained	 by	 PLR,	 is	 important	 for	 solute	 transport,	 and	 transport	 between	subchondral	bone	and	cartilage	is	altered	in	mouse	and	human	OA	(21,	67,	68).	Changes	in	subchondral	 bone	 volume	 fraction	 (43,	 69)	 and	 geometry	 (8),	 similar	 to	 those	 seen	 in	MMP13ocy-/-	bone,	can	precede	cartilage	pathology,	possibly	by	changing	strain	distribution	in	 the	 overlying	 cartilage.	 Based	 on	 our	 RNA-seq	 analyses,	 biological	 mechanisms	might	include	autocrine	or	paracrine	effects	resulting	from	excessive	acidification	by	osteocytes.	If	the	critical	points	at	which	osteocytes	cause	and	respond	 to	cartilage	degradation	can	be	
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identified,	these	cells	may	emerge	as	a	potential	target	of	new	therapies	to	prevent	or	treat	OA.	Although	many	questions	remain	about	the	role	and	regulation	of	PLR	in	OA,	our	data	collectively	 suggests	 that	 osteocyte	 MMP13	 dynamically	 maintains	 subchondral	 bone	homeostasis	and	joint	crosstalk,	and	that	its	disruption	can	exacerbate	joint	disease,	likely	through	suppression	of	PLR.			
	
Materials	&	Methods	
Human	donor	population	and	specimen	preparation	Five	 male	 subjects	 with	 clinically	 diagnosed	 stage	 IV	 osteoarthritis	 of	 the	 tibial	plateau,	who	were	scheduled	for	total	knee	arthroplasty,	were	recruited	for	this	study	(Supp.	Figure	 5.1a).	 	 Recruitment	 occurred	 through	 referral	 from	 orthopedic	 surgeons	 at	 a	Department	of	Veterans	Affairs	Medical	Center.	All	 samples	were	 collected	 from	patients	with	OA	of	the	femorotibial	joint	as	described	in	protocols	that	were	reviewed	and	approved	by	our	Human	Subjects	Protection	Program	Institutional	Review	Board.		Informed	consent	was	 obtained	 from	 each	 study	 participant	 prior	 to	 enrollment.	 Five	 freshly	 harvested	cadaveric	human	tibial	plateaus	from	age-	and	gender-matched	donors	without	history	of	OA,	 osteonecrosis,	 osteoporosis,	 or	 fractures	 were	 collected	 through	 the	 Willed	 Body	Program	at	University	of	California,	San	Francisco	for	use	as	controls.	Patients	with	OA	and	healthy	cadaveric	controls	had	similar	BMI.	All	samples	used	for	immunohistochemistry	and	mineralization	analysis	were	harvested	within	four	days	post-mortem	to	minimize	effects	of	degradation.	Integrity	of	the	tissue	and	epitopes	in	histological	analyses	(Figures	5.1,	5.3,	and	Supp.	Figure	5.1j-k)	suggests	that	refrigerated	storage	of	cadaveric	samples	for	up	to	4	days	did	not	significantly	affect	the	conclusions.	
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Each	 tibial	 plateau	 was	 removed	 en	 bloc	 (Supp.	 Figure	 5.1c,	 d),	 and	 X-rays	 were	collected	to	evaluate	the	severity	of	subchondral	bone	deterioration	(Supp.	Figure	5.1g-i).		To	facilitate	comparison	of	the	subchondral	bone	between	the	lateral	and	medial	side	of	the	joint,	which	was	more	severely	affected	by	OA	in	these	samples,	each	specimen	was	cut	into	8-10	mm	thick	coronal	slabs	with	a	band	saw	(Supp.	Figure	5.1e,	f).		Subchondral	bone	was	compared	between	the	medial	and	lateral	regions	of	interest	on	the	same	osteoarthritic	tibial	plateau,	as	well	as	with	comparable	regions	of	cadaveric	tibial	plateaus.	Data	was	collected	from	five	samples	per	group	for	all	outcomes	unless	otherwise	specified	in	figure	legends.			
Mice		 To	test	the	role	of	osteocytic	MMP13	in	bone	and	joint	health,	we	generated	mice	with	osteocyte-specific	ablation	of	MMP13.	Homozygous	MMP13fl/fl	mice	on	an	FVB	background	have	loxP	sites	flanking	exons	3,	4,	and	5,	which	encode	the	enzyme’s	active	site	(34)	(Table	2.1).	Hemizygous	DMP1-Cre+\-	mice	(9.6-kb	promoter)	on	a	C57BL/6	background	express	Cre	predominantly	in	osteocytes	and	odontoblasts	(35).	Mice	were	bred	at	UCSF	to	generate	wildtype	(DMP1-Cre-/-;	MMP13fl/fl)	and	MMP13ocy-/-	(DMP1-Cre+/-;	MMP13fl/fl)	mice	with	a	mixed	background.	Littermate	controls	were	used	throughout.	To	match	the	VA	population	of	human	patient	samples	and	to	exclude	the	sexually	dimorphic	effects	of	both	OA	and	PLR	(66,	70),	only	male	mice	were	utilized	for	this	study.	The	procedures	for	animal	experiments	were	 approved	 by	 the	 Institutional	 Animal	 Care	 and	Use	 Committee	 at	 the	University	 of	California,	San	Francisco.	Six	to	eleven	biological	replicates	were	used	for	each	outcome,	with	exact	n	given	in	figure	legends.			
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Histology	Human	 tibial	 plateaus	 were	 fixed	 in	 10%	 neutral	 buffered	 formalin	 (NBF)	 and	incubated	in	10%	di-	and	tetra-sodium	EDTA	for	56-60	days	until	fully	decalcified,	or	in	an	Ion	Exchange	Decalcification	Unit	(American	Master	Technologies)	for	5-6	days,	followed	by	serial	ethanol	dehydrations	and	paraffin	embedding.	Paraffin	sections	(7	μm	thick)	 in	the	coronal	plane	were	generated	 for	polarized	 light	microscopy,	Safranin-O	with	Fast	Green	stain,	Ploton	silver	stain,	and	immunohistochemistry.	To	standardize	evaluation,	a	consistent	region	of	subchondral	bone	was	selected	for	evaluation	in	the	medial	and	lateral	areas	of	each	specimen	(Figure	5.1a).	For	each	specimen,	values	were	collected	from	5	high-powered	field	images	per	region	of	interest.		Within	each	region,	these	values	were	averaged	to	obtain	a	mean	value	for	each	specimen.		Each	quantitative	average	represents	an	average	across	all	specimens.		 Intact	mouse	knee	joints	and	proximal	femurs	were	fixed	in	10%	NBF	and	decalcified	for	two	weeks	in	EDTA,	followed	by	serial	ethanol	dehydration	and	paraffin	embedding,	as	described	in	Chapter	2.			
Safranin-O/	Fast	Green	stain	and	OA	scoring	Safranin-O	with	Fast	Green	was	used	 to	visualize	 the	cartilage	quality	of	 the	 tibial	plateaus	using	a	protocol	adapted	from	University	of	Rochester	(71).	Briefly,	sections	were	deparaffinized,	 rehydrated,	 and	 incubated	 in	Weigert’s	 Iron	 Hematoxylin	 for	 3	 minutes.	Stained	 slides	 were	 then	washed	 in	 water	 and	 differentiated	 in	 1%	 Acid-Alcohol	 for	 15	seconds.	Slides	were	then	stained	with	a	0.02%	aqueous	Fast	Green	solution	for	5	minutes	and	differentiated	with	1%	acetic	acid	for	30	seconds.		Slides	were	then	washed	with	water	
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and	 stained	 in	 a	 1%	 Safranin-O	 solution	 for	 10	 minutes	 and	 subsequently	 dehydrated,	cleared,	and	mounted.			For	human	tibial	plateaus,	standardized	OARSI	grading	(72,	73)	was	used	to	assess	OA	 in	 Safranin-O	 stained	 histological	 sections	 by	 two	 orthopedic	 surgeons.	 For	 murine	samples,	Safranin-O	staining	was	conducted	on	sections	of	the	knee	in	a	plane	where	the	ACL	and	PCL	were	 visible	 to	maintain	 constant	 region	 of	 interest.	 Each	 quadrant	 of	 the	 knee	(medial	and	lateral	tibia	and	femur)	was	graded	by	three	blinded	graders	using	OARSI	(41)	and	modified	Mankin	(40)	scales.	For	each	sample,	the	numerical	scores	of	all	graders	were	averaged	to	obtain	a	mean	score.	Mean	scores	were	then	averaged	within	each	group.		
	
Analysis	of	collagen	fiber	orientation	by	picrosirius	red	stain	Polarized	 light	 microscopy	 was	 performed	 on	 picrosirius	 red-stained	 sections	 of	femurs	and	subchondral	bone,	as	described	in	Chapter	2.	Statistical	analysis	was	performed	as	described	below.	
	
Analysis	of	the	lacunocanalicular	network	by	Ploton	silver	stain		Ploton	silver	stain	was	performed	on	axial	sections	of	femurs	and	frontal	sections	of	subchondral	bone,	as	described	in	Chapter	2.	For	human	tibial	plateau	subchondral	bone,	quantification	 of	 the	 lacunocanalicular	 area	was	 performed	with	 ImageJ	 by	 thresholding	100x	gray-scale	images	for	dark,	silver	stained	lacunae	and	canaliculi.	The	resulting	area	was	normalized	to	total	bone	area	in	each	image	captured.	Canalicular	length	was	analyzed	with	ImageJ	by	individually	measuring	canaliculi	surrounding	osteocytes	(average	10	canaliculi	per	osteocyte).		
 82	
For	murine	 cortical	 bone,	 two	 images	were	 acquired	 in	 each	 quadrant	 of	 an	 axial	section	(medial,	lateral,	anterior	and	posterior).	In	murine	tibial	plateau	subchondral	bone,	four	images	were	captured	on	the	medial	and	lateral	side	of	the	joint.	In	each	of	the	8	images,	area	of	all	visible	lacunae	was	calculated	with	a	custom,	commercially	available	StrataQuest	application	 (TissueGnostics),	 yielding	 approximately	 90	 measurements	 per	 animal.	Additionally,	10	canaliculi	on	3	osteocytes	per	image	(24	osteocytes	per	animal)	were	traced	using	ImageJ	to	calculate	mean	canalicular	length.	To	determine	whether	we	had	sampled	canalicular	 length	 from	 enough	 osteocytes,	 we	 randomly	 sampled	 from	 within	 the	 24	osteocyte	averages	per	animal	and	found	that	group	averages	consistently	stabilize	once	15	osteocytes	per	animal	are	included	in	the	analysis.			
Analysis	of	PLR	enzyme	expression	Sections	of	medial	and	lateral	human	tibial	plateau	were	deparaffinized	and	hydrated	prior	to	incubation	in	Innovex	Uni-Trieve	low	temperature	retrieval	solution	(NB325)	in	a	40°C	 water	 bath	 for	 24	 hours.	 Endogenous	 peroxidase	 activity	 was	 quenched	 and	 the	Innovex	 Universal	 Animal	 Immunohistochemistry	 Kit	 (329ANK)	 utilized	 for	 subsequent	steps	as	detailed	in	Chapter	2.		Protein	 expression	 in	 murine	 cortical	 bone,	 subchondral	 bone,	 and	 cartilage	 was	detected	by	immunofluorescence	and	immunohistochemistry	as	described	in	Chapter	2.	For	immunofluorescent	detection	of	MMP13	in	bone,	sections	were	blocked	with	Background	Buster	(Innovex)	for	10	minutes,	then	incubated	with	primary	antibody	overnight	at	room	temperature.	For	cartilage,	sections	were	blocked	with	10%	normal	goat	serum	for	one	hour,	then	incubated	with	primary	antibody	overnight	at	4	°C.	Negative	controls	were	performed	
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by	substituting	rabbit	IgG	at	the	same	concentration	as	primary	antibody.	The	percentage	of	MMP13-expressing	osteocytes	and	chondrocytes	was	calculated	relative	to	the	total	number	of	cells	in	at	least	two	40x	fields	per	sample	for	6-9	mice	per	genotype.		
Analysis	of	cell	death	by	TUNEL	assay		 To	detect	osteocyte	and	chondrocyte	death,	mouse	knee	sections	were	deparaffinized	and	 permeabilized	 in	 0.1%	 sodium	 citrate	with	 0.1%	 Triton	 X-100	 for	 8	minutes.	 For	 a	positive	control,	two	sections	were	treated	with	DNase	for	10	minutes	at	room	temperature	to	induce	DNA	strand	breaks.	Then	all	samples	were	incubated	with	TUNEL	reaction	mix	for	60	minutes	at	37	°C	(Roche).	After	washing,	slides	were	mounted	with	Prolong	Gold	antifade	reagent	with	DAPI	and	imaged	on	a	Leica	DMi8	confocal	microscope.	Total	number	of	labeled	osteocytes	and	chondrocytes	per	bone	or	cartilage	area	was	calculated	 in	 the	medial	and	lateral	compartments	of	the	tibia	for	six	knees	per	group.			
Synchrotron	Radiation	X-ray	Computed	Micro-Tomography	(SRμT)	To	visualize	and	quantify	bone	mineralization,	4-mm-wide	specimens	of	cartilage	and	subchondral	 bone	were	 imaged	by	 SRμT	at	 beamline	8.3.2	 of	 the	Advanced	Light	 Source	(ALS)	 (Lawrence	 Berkeley	 National	 Laboratory,	 Berkeley)	 as	 described	 (27).	 Briefly,	transmission	radiographs	were	taken	over	a	180°	rotation	with	a	monochromatic	energy	of	20	keV	and	an	exposure	time	of	800	ms.		Computational	reconstruction	of	3D	images	reveals	bone	microstructure	at	1.3	μm/pixel	(5X	lens,	LuAG	scintillator).		Images	were	segmented	using	 ImageJ	 by	 binarization	 of	 the	 bone	 volume	 morphology.	 3D	 visualization	 and	quantification	of	bone	mineral	density	was	performed	using	Avizo	(Visualization	Sciences	
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Group).	Data	was	collected	from	n=2	control	medial,	n=2	control	lateral,	n=4	OA	medial,	and	n=5	 OA	 lateral	 human	 tibial	 plateaus.	 Statistical	 analysis	 was	 performed	 only	 between	medial	and	lateral	regions	of	OA	subchondral	bone,	as	described	below.			
Micro-computed	tomography	(μCT)	For	skeletal	phenotyping,	femurs	were	harvested	from	male	mice	at	13	weeks	old	and	stored	 in	 70%	 ethanol	 until	 scanning	 as	 described	 in	 Chapter	 2.	 For	 subchondral	 bone	analyses,	knee	joints	were	harvested	from	16-week-old	males	and	stored	in	saline	solution	at	 -20°	 C.	 A	 4-mm	 region	 centered	 on	 the	 joint	 was	 scanned.	 Medial	 and	 lateral	 tibial	subchondral	 bone	 were	 delineated	 200	 μm	 from	 the	 proximal	 surface	 of	 the	 tibia	 and	extending	for	250	μm	distally.	The	medial	and	lateral	femoral	condyles	were	designated	200	μm	from	the	distal	end	of	the	femur	and	extended	proximally	200	μm.		
RNA-seq	and	Quantitative	RT-PCR	analysis		Humeri	from	wildtype	and	MMP13ocy-/-	mice	were	cleaned,	homogenized	in	TRIzol,	and	 purified	 as	 described	 in	 Chapter	 2.	 qPCR	 was	 performed	 with	 TaqMan	 primers	 for	Mmp13	 and	 b-actin,	 and	 otherwise	 with	 SYBR	 primers	 (Table	 2.3).	 Expression	 was	quantified	by	the	DDCt	method	with	b-actin	as	the	housekeeping	gene	(79).		For	 RNA-seq,	 samples	 were	 sequenced	 on	 the	 Illumina	 HiSeq	 4000	 at	 the	 UCSF	Functional	 Genomics	 Core.	 Single-end	 50bp	RNA-seq	 reads	were	 aligned	 to	 the	 Ensembl	mouse	GRCm38.87	reference	genome	using	STAR	2.5.2b	aligner.	We	obtained	367.4	million	total	reads	and	average	of	82.6%	of	these	reads	aligned	uniquely	to	the	mouse	genome.	The	DESeq2	 package	 in	 R	 Statistical	 Computing	 Environment	 was	 used	 to	 find	 differentially	
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expressed	genes	with	false	discovery	rate	of	0.1	(77).	To	calculate	gene	signature	scores,	we	generated	 gene	 sets	 of	 acidification-related	 genes	 (Figure	 5.9b)	 and	 osteoblast	differentiation-related	 genes	 (Runx2,	 Sp7,	 Atf4,	 Alpl,	 Col1a1,	 Col1a2,	 Dmp1,	 Sost,	 Bglap,	Bglap2,	Spp1,	Phex,	Mepe,	Enpp1,	Enpp2)	(78),	subtracted	the	mean	from	each	element,	and	divided	by	the	standard	deviation.	RNA-seq	data	have	been	deposited	in	the	NCBI	BioProject:	PRJNA549974.		
Flexural	strength	tests	Whole-bone	 biomechanical	 properties	 were	measured	 in	 femurs	 isolated	 from	 2-month	 and	 4-month-old	wildtype	 and	MMP13ocy-/-	mice.	 Bones	were	 dissected,	 stored	 in	HBSS,	and	tested	on	 the	same	day	as	collection.	One	 femur	per	mouse	was	broken	 in	 the	direction	 of	 primary	 physiological	 bending	 (posterior	 compression)	 and	 the	 other	 was	broken	against	the	direction	of	physiological	bending	(anterior	compression).	An	8-mm	span	was	chosen	because	it	was	approximately	50%	of	the	bone	length.		Whole-bone	stiffness	was	calculated	from	the	linear	portion	of	the	load-displacement	curve	and	yield	was	designated	as	the	point	where	a	line	representing	a	10%	loss	in	stiffness	intersected	the	load-displacement	curve	(80).	Following	fracture,	bone	cross	sections	were	imaged	by	scanning	electron	microscopy	on	a	Sigma	500	VP	FE-SEM	(Zeiss)	at	an	excitation	voltage	of	15	kV	and	a	partial	pressure	of	35	Pa.	Measurements	of	cross-sectional	diameter	and	thickness	were	acquired	in	ImageJ	and	used	to	calculate	moment	of	inertia	assuming	an	elliptical	 cross	 section.	 These	 geometric	 parameters	 were	 used	 to	 convert	 the	 load-displacement	data	to	stress-strain	data	in	order	to	measure	tissue	modulus,	tissue	stress	and	tissue	strain	with	standard	beam	theory	equations	(81).		
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MLI	surgery		 8-week-old	male	mice	were	separated	into	three	groups:	control,	sham,	and	meniscal-ligamentous	injury	(MLI)	(42).	Under	general	isofluorane	anesthesia,	both	hind	limbs	of	MLI	animals	were	shaved	and	sterilized.	A	bilateral	approach	was	chosen	in	order	to	minimize	effects	of	altered	biomechanics	arising	from	a	single	knee	injury,	as	previously	described	(82,	83).	Briefly,	medial	incisions	through	the	skin	and	joint	capsule	were	made	adjacent	to	the	patella	to	expose	the	medial	collateral	ligament,	which	was	transected.	The	medial	meniscus	was	 then	 removed.	 Sham-injured	 animals	 received	 bilateral	 incisions	 without	 MCL	transection	 or	meniscus	 dissection.	 Skin	 incisions	were	 closed	with	 sutures	 and	 animals	received	an	injection	of	long-acting	buprenorphine	analgesic.	Control	animals	did	not	receive	anesthesia	or	analgesics.	All	animals	were	allowed	unrestricted	activity,	food,	and	water.	At	16	weeks	 of	 age,	 animals	were	 euthanized	 and	 hind	 limbs	 collected	 for	 histological	 and	radiographic	analyses.		
	
Statistics	Comparisons	between	two	groups	were	tested	with	unpaired	two-tailed	Student’s	t-test.	 Comparisons	 between	 disease	 state	 and	 region	 in	 human	 specimens	 or	 between	genotype	and	injury	in	mice	were	tested	with	two-way	ANOVA	followed	by	Holm-Sidak	post-hoc	 tests.	Analyses	were	performed	 in	GraphPad	Prism	8	 (GraphPad	Software,	 Inc.).	 The	Clinical	and	Translational	Science	Institute	Statistical	Consulting	Service	at	UCSF	evaluated	significant	 differences	 in	 the	 distributions	 of	 human	 collagen	 organization	 and	 mineral	density	 (SRμT)	among	each	group	using	a	mixed	model	with	random	 intercepts.	A	 linear	model	was	used	for	the	fixed	effects,	and	the	outcome	was	logarithmically	transformed.	In	
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all	figures,	p-values	less	than	0.05	were	considered	statistically	significant	and	are	reported	as	such.		As	appropriate	for	each	outcome,	the	mean	is	shown	+/-	SD	or	SEM,	as	specified	in	figure	legends.						
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Supplemental	Figure	5.1:	Osteoarthritic	human	tibial	plateaus	have	cartilage	degradation	and	subchondral	bone	sclerosis	compared	to	healthy	controls.	(a-i)	Human	tibial	plateau	specimens	from	patients	with	osteoarthritis	(OA)	undergoing	total	knee	replacement	surgery	were	compared	to	control	cadaveric	human	tibial	plateaus	from	donors	with	no	history	of	OA,	osteonecrosis,	osteoporosis,	or	fractures.	Donations	were	controlled	for	age,	sex,	and	body	mass	index	(BMI)	(a).	OARSI	scores	(b)	were	consistent	with	gross	(c,	d)	and	radiographic	(g,	h)	evidence	of	OA	in	surgical	specimens.	Gross	cartilage	degradation	and	sclerosis	predominated	in	the	medial	compartment	of	OA	specimens	(i).	For	further	histological	analysis,	specimens	were	cut	into	six	8-10	mm	thick	coronal	slabs	(e,	f).	(j-k)	
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While	control	specimens	(j)	could	not	be	fixed	as	quickly	as	OA	specimens	(k),	immunohistochemical	analysis	of	MMP13	suggests	that	this	delay	caused	neither	increased	protease	expression	nor	significant	epitope	degradation,	since	MMP13	expression	in	control	samples	is	qualitatively	lower	in	chondrocytes,	but	higher	in	subchondral	osteocytes	(Figure	3a-b)	compared	to	in	OA	specimens.	Scale	bars	are	2	cm	in	c-h,	1	cm	in	i,	and	200	µm	in	j-k.	Graph	shows	mean	±	SD.	*p<0.05	between	groups	by	unpaired	t-test.						
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Supplemental	Figure	5.2:	Data	supporting	phenotyping	of	MMP13ocy-/-	mice.	(a)	The	yellow	box	on	the	axial	section	of	murine	femur	demonstrates	a	representative	region	of	interest	for	cortical	bone	images	in	Figure	4a	(arrow	indicates	periosteal	surface).	(b)	The	medial	femur,	tibia,	and	meniscus	are	labelled	in	a	frontal	section	of	the	murine	knee.	The	yellow	box	demonstrates	a	representative	region	of	interest	for	subchondral	bone	images	in	Figure	5.4b.	Scale	bars	200	µm.	(c)	Both	immunofluorescence	and	immunohistochemistry	were	used	to	evaluate	the	efficiency	and	specificity	of	MMP13	ablation	in	osteocytes	of	MMP13ocy-/-	mice.	To	better	visualize	this	difference,	DAPI	staining	is	shown	separately	from	MMP13	and	negative	control	immunofluorescence	corresponding	with	Figure	4b.	Scale	bars	50	µm.	(d)	MMP13	expression	in	growth	plate	chondrocytes	is	not	significantly	different	between	genotypes.	Scale	bars	100	µm.	
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Supplemental	Figure	5.3:	No	difference	was	detected	in	TUNEL-positive	chondrocytes	due	to	genotype	or	treatment	(n=6).																
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		Chapter	6	Optimization	of	murine	in	vivo	tibial	loading	protocol	
	
Introduction	Bone	is	exquisitely	mechanosensitive,	adapting	to	loads	it	experiences	by	depositing	or	resorbing	bone.	Common	examples	include	a	tennis	player’s	dominant	arm	gaining	bone	mass,	whereas	astronauts	in	microgravity,	or	people	with	spinal	cord	injuries	lose	bone	mass	rapidly	(1–3).	In	many	bone	diseases,	this	balance	between	bone	anabolism	and	applied	load	is	 disrupted,	 such	 that	 bone	 mass	 is	 lost	 and	 no	 longer	 meets	 the	 demands	 of	 normal	physiological	loads.	The	range	of	molecular,	cellular,	and	tissue-level	responses	of	bone	to	a	wide	variety	of	 loading	 conditions	 is	under	 investigation	 to	better	understand	how	bone	mass	and	other	contributors	to	bone	fragility	can	be	improved.		While	 rodents	 do	 not	 perfectly	 replicate	 human	 bone	 anatomy,	 they	 are	 valuable	model	systems	for	bone	research	because	of	their	ease	of	use	and	numerous	genetic	models	available	 for	 manipulation.	 In	 vivo	 loading	 models	 such	 as	 forced	 treadmill	 running,	
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vertebral	compression,	tibial	four-point	bending,	ulnar	axial	loading,	and	tibial	axial	loading	are	used	to	apply	a	range	of	loads	intended	to	mimic	physiologic	and	anabolic	conditions.	Loaded	bones	are	 then	compared	 to	either	non-exercised	animals	or	non-loaded	 internal	control	bones	(4).		Murine	 axial	 tibial	 loading	 is	 one	 of	 the	most	 common	model	 systems	 for	 in	 vivo	loading	(5–9).	Generally,	the	heel	and	knee	are	held	between	fixtures	in	line	with	an	actuator	and	a	load	cell.	Load	is	applied	cyclically	to	one	tibia	while	the	mouse	is	under	anesthesia,	and	the	non-loaded	limb	is	used	as	a	control.	It	is	generally	accepted	that	any	systemic	effects	of	hind-limb	loading	are	minimal	compared	to	local	effects	(10).	Within	this	general	protocol,	many	variables	exist,	including	but	not	limited	to:	-Type	of	anesthesia	administered	-Geometry	of	leg	holders	and	resulting	knee	flexion		-Waveform	shape	(triangle,	trapezoid,	sine)	-Waveform	frequency	(11)	-Rest	insertion	between	cycles	(6)	-Maximum	load	(7)	-Strain	rate	of	applied	load	-Number	of	cycles	applied	per	session	(7,	8,	12)	-Number	of	loading	sessions	before	analysis	(7,	13)	Many	studies	have	compared	these	variables	to	maximize	the	anabolic	response	of	bone.	Dynamic	histomorphometry	to	measure	rate	of	bone	mineral	deposition,	microCT	to	measure	 bone	 size	 and	 shape,	 high	 resolution	 scans	 to	 measure	 mineral	 content	 and	composition,	and	flexural	testing	describe	the	structural	and	mechanical	outcomes	of	load.	
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Cellular	 and	 molecular	 mechanisms	 implicated	 in	 new	 bone	 formation	 are	 commonly	measured	with	RNAseq,	qPCR,	immunohistochemistry,	or	mice	with	reporter	constructs	for	osteogenic	 signaling	 pathways.	 As	 a	 result	 of	 these	 studies,	 loading	 protocols	 and	 their	associated	outcomes	that	are	reported	by	multiple	labs	provide	useful	positive	controls.	For	example,	three	to	five	consecutive	days	of	axial	tibial	load	followed	by	approximately	a	week	of	rest	reproducibly	induces	bone	formation.	At	the	molecular	level,	Ptgs2	gene	expression	and	Wnt	signaling	are	upregulated	and	sclerostin	expression	is	downregulated	3-24	hours	after	 a	 single	 loading	 session	 (9,	 14–16).	 Anabolic	 markers	 such	 as	 osteocalcin,	 Col1a1,	alkaline	phosphatase,	and	Timp1	are	also	upregulated	after	a	variety	of	loading	protocols	(9,	13,	15,	17).	The	response	of	bone	 to	 load	 is	 complex	and	varies	with	 time	post-load,	 site	analyzed,	 and	 with	 age,	 but	 these	 published	 outcomes	 provide	 helpful	 guidance	 for	troubleshooting	our	own	loading	protocol.		The	goal	of	 this	research,	described	further	 in	Chapter	8,	 is	 to	measure	changes	 in	bone	quality	induced	by	anabolic	loads.	I	began	with	the	murine	axial	tibial	loading	protocol	established	in	the	Alliston	lab	by	Nguyen	et	al,	which	increased	cortical	bone	mass,	repressed	sclerostin	 expression	 in	 osteocytes,	 and	 repressed	 the	 transforming	 growth	 factor	 beta	(TGFb)	 signaling	 effector	 pSmad3	 on	Western	 blots	 (18).	 Beginning	 with	 the	 published	methods,	 I	 sought	 to	 replicate	 the	 loading	 protocol	 and	 the	 positive	 control	 outcomes	established	by	Nguyen	et	al	and	others.	Anticipating	quick	success,	I	also	measured	Mmp13	expression	 in	 some	 experiments	 as	 an	 indicator	 of	 perilacunar	 remodeling	 activity.	 This	chapter	details	the	optimization	process	leading	to	the	loading	protocol	eventually	used	to	evaluate	mechanosensitive	changes	in	bone	quality.		
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Methods	
Mice		 SBE-Luciferase	mice	express	luciferase	in	response	to	pSmad2/3	activity.	Mice	were	bred	at	UCSF,	and	8-week-old	male	mice	were	used	for	experiments	(Table	2.1).		
	
In	vivo	loading	model	The	loading	model	previously	validated	in	our	lab	was	designed	to	simulate	the	forces	applied	 by	 vigorous	 jumping	 (approximately	 ten	 times	 body	 weight)	 (18).	 A	 BOSE	Electroforce	ELF3200	desktop	load	frame	was	fitted	with	custom	fixtures	to	cup	the	mouse	heel	 and	 knee	 and	 provide	 axial	 compressive	 load	 to	 the	 tibia.	 Before	 loading,	mice	 are	anesthetized	with	 injectable	 ketamine/xylazine	 anesthesia	 (100	mg/kg	 ketamine	 and	 16	mg/kg	xylazine)	and	lack	of	response	to	a	toe	pinch	is	confirmed	before	the	right	leg	is	placed	into	 the	 load	 frame.	 The	 actuator	 is	 programmed	 to	 displace	 until	 it	 applies	 -3.5	 N	(compressive	load)	to	the	limb,	then	to	back	off	to	-0.5	N.	This	cycle	is	repeated	in	a	sinusoidal	pattern	600	 times	 at	1	Hz	 in	 load-control	mode	 (Figure	6.1	A),	 after	which	 the	mouse	 is	returned	 to	 a	 warm	 cage	 to	 recover	 and	 then	 ambulate	 normally	 until	 the	 next	 loading	session	 or	 predetermined	 harvest	 time.	 After	 harvest,	 the	 non-loaded	 tibia	 serves	 as	 an	internal	control	 for	each	animal,	as	others	have	determined	that	the	anabolic	response	to	load	is	not	systemic	(10).		During	 optimization	 and	 troubleshooting	 of	 the	 in	 vivo	 loading	 protocol,	 several	variations	of	this	protocol	were	tested,	as	detailed	in	the	Results.	At	the	conclusion	of	this	process,	 the	 variables	 used	 to	 apply	 load	 in	 our	 in	 vivo	 loading	model	were	 changed	 as	follows.	The	final	dosage	of	injectable	ketamine/xylazine	anesthesia	is	100	mg/kg	ketamine	
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and	10	mg/kg	xylazine.	A	50	lb	load	cell	is	now	used	instead	of	a	10	lb	load	cell,	and	a	new	lower	fixture	maintains	the	mouse	ankle	at	approximately	30°	of	 flexion	(Figure	6.1	B-C).	Due	 to	 the	 decreased	 sensitivity	 of	 the	 50	 lb	 load	 cell,	 the	 waveform	 is	 now	 run	 on	displacement	 control.	 Once	 the	 mouse	 is	 anesthetized	 and	 positioned,	 the	 actuator	 is	manually	 displaced	 until	 the	 load	 feedback	 reads	 the	 desired	 maximum	 load	 (usually	between	 -3.5	 and	 -6	Newtons)	 and	 then	 the	 desired	minimum	 load	 (-0.5	Newtons).	 The	actuator	 is	 then	 set	 to	 cycle	 between	 these	 two	 positions	 for	 600	 cycles	 at	 1	 Hz	 in	displacement	control	mode.	The	load	and	displacement	data	are	recorded	at	10	Hz	in	order	to	 calculate	 the	actual	 applied	 loads	and	displacements	 for	each	 loading	 session	 for	each	mouse.	
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Figure	6.1:	Waveform	and	setup	for	murine	in	vivo	tibial	axial	loading.	(A)	Target	waveform	for	in	vivo	axial	tibial	loading.	(B)	Photo	of	adapters	and	fixtures	used	for	final	loading	setup.	(C)	Illustration	of	mouse	hindlimb	in	loading	configuration.			
MicroCT		 Right	legs	were	loaded	for	five	consecutive	days,	and	loaded	and	non-loaded	tibias	were	collected	3	days	later.	Bones	were	dissected,	fixed	in	10%	NBF	for	24	hours,	then	stored	in	70%	EtOH.	MicroCT	scans	were	performed	at	the	University	of	Oklahoma	Health	Sciences	Center.		
Quantitative	RT-PCR	analysis		Loaded	 and	 non-loaded	 tibias	 were	 dissected,	 epiphyses	 trimmed,	 marrow	centrifuged	out,	and	periosteum	cleaned.	For	Figure	6.3	and	6.4,	foil-wrapped	bones	were	
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stored	in	liquid	nitrogen	until	RNA	extraction	using	TRIzol.	qPCR	was	performed	with	SYBR	primers	(Table	2.3)	and	expression	quantified	by	the	DDCt	method	with	the	housekeeping	genes	designated	in	figure	legends.	For	Figures	6.13	–	6.15,	the	proximal	and	distal	portions	of	tibias	were	snap-frozen	in	liquid	nitrogen,	homogenized	in	1	mL	QIAzol,	and	stored	at	-80	°C.	qPCR	experiments	with	SYBR	primers	happened	in	multiple	batches,	so	samples	in	each	batch	were	combined	to	generate	a	standard	curve	 for	each	gene	being	assessed.	Results	were	 calculated	 in	 terms	 of	 nanograms	 transcript	 relative	 to	 nanograms	b-actin.	 Loaded	expression	was	then	compared	to	non-loaded	expression	of	each	gene	for	each	mouse.		
Protein	extraction	from	bone	Loaded	 and	 non-loaded	 tibias	 were	 dissected,	 epiphyses	 trimmed,	 marrow	centrifuged	out,	and	periosteum	scraped	away.	Foil-wrapped	bones	were	stored	 in	 liquid	nitrogen	until	protein	extraction.	RIPA	buffer	(Chapter	2)	was	prepared	fresh	on	the	day	of	protein	harvest.	In	the	initial	protocol,	porcelain	mortars	and	pestles	are	pre-chilled	in	a	bath	of	liquid	nitrogen	at	 least	50%	the	height	of	 the	mortars.	Bones	are	removed	 from	liquid	nitrogen	storage	and	pulverized	one	by	one	with	 clean	mortars	 and	pestles.	The	powder	 lysate	 is	scraped	into	an	Eppendorf	tube	and	resuspended	in	80	µL	ice	cold	RIPA.	In	the	final	protocol,	bones	are	homogenized	in	individual	tubes	with	a	bead	mill	homogenizer	(Chapter	2).		After	bone	lysate	is	in	RIPA,	samples	are	incubated	on	ice	for	30	minutes,	sonicated,	and	centrifuged	to	clarify	protein.	The	initial	protocol	suffers	from	loss	of	product	during	the	transfer	 out	 of	 the	mortar,	 which	 often	made	 it	 difficult	 to	 detect	 signal	 from	 the	 distal	portion	of	the	tibia.	The	final	protocol	suffers	from	loss	of	product	during	the	final	transfer	
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of	liquid	protein	lysate	from	a	flat-bottomed	tube,	but	it	provides	more	consistent	high-yield	protein	that	enables	comparison	of	distal	and	proximal	tibia	regions.			
Western	blotting	
	 Protein	from	loaded	and	non-loaded	bones	was	quantified	using	the	Bradford	Assay	as	described	in	Chapter	2.	Equal	quantities	of	protein	from	each	bone	were	resolved	on	8.5%	SDS-polyacrylamide	gels,	as	described	in	Chapter	2,	and	probed	with	antibodies	for	pSmad3	and	b-actin	(Table	2.2).			
Flexural	strength	tests	To	determine	whether	the	range	of	applied	loads	was	causing	bone	damage,	loaded	and	non-loaded	tibias	were	collected	within	one	hour	of	a	single	loading	session	with	a	low	(4	-	5.5	N)	or	high	(6.5	–	8	N)	peak	compressive	load.		Tibias	were	gently	cleaned	of	muscle	and	stored	in	HBSS-soaked	gauze	at	-20	°C.	Bones	were	brought	to	room	temperature	before	testing.	 Tibias	were	 broken	 in	 3-point	 bending	 on	 a	 6	mm	 span	with	 the	 postero-lateral	surface	in	compression.	The	distal	tibiofibular	junction	was	aligned	with	one	side	of	the	span	and	 the	central	 loading	point	was	 just	distal	 to	 the	 tibial	 crest.	Whole-bone	stiffness	was	calculated	 from	 the	 linear	 portion	 of	 the	 load-displacement	 curve	 and	ultimate	 load	was	defined	as	the	maximum	bending	load	sustained.			
Strain	gaging	
	 To	determine	the	surface	strain	engendered	by	compressive	loads	applied	to	the	tibia,	we	attached	strain	gages	to	the	antero-medial	surface	of	the	right	tibia	50%	of	the	distance	
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between	the	tibiofibular	junctions.	Five	animals	were	euthanized	and	the	right	tibia	exposed.	The	middle	of	the	antero-medial	surface	was	gently	scraped	to	remove	periosteum	and	then	cleaned	with	70%	ethanol.			 Pre-wired	strain	gages	(0.38	mm	x	0.50	mm)	were	purchased	from	VPG	Sensors	and	connected	to	a	Micro-Measurements	system	(8000-8-SM)	for	data	acquisition.	Strain	gages	were	prepared	by	brushing	with	a	thin	layer	of	catalyst	C	on	the	bonding	surface	(M-Bond	200	kit).	A	thin	layer	of	adhesive	was	applied,	and	the	gages	were	adhered	to	the	bone	surface	aligned	axially	with	 the	 tibia	and	held	with	 finger	pressure	 for	at	 least	one	minute.	After	curing,	 the	 mouse	 was	 positioned	 in	 the	 load	 frame	 and	 its	 right	 tibia	 was	 loaded	 in	displacement	 control	 at	 increasing	 amplitudes.	 Load-displacement	 data	 was	 recorded	through	WinTest	8	and	strain	data	was	collected	simultaneously	through	StrainSmart	8000.		
	
Statistics	Paired	t-tests	between	loaded	and	non-loaded	bones	from	the	same	animal	are	used	throughout.										
	
 110	
Results	&	Discussion	Experiments	were	initially	conducted	using	the	lab’s	existing	setup.	A	mouse’s	right	leg	 was	 held	 vertically	 between	 two	 hemispherical	 cups	 that	 each	 had	 a	 cutout	 to	accommodate	a	foot	or	thigh.	A	1	Hz	sinusoidal	waveform	was	run	on	load-control	with	a	10-lb	load	cell	providing	feedback.	600	cycles	were	applied,	and	the	entire	length	of	the	tibia	was	collected	for	analysis.	Five	consecutive	days	of	loading	to	a	maximum	load	of	3.5	N	with	this	method	had	previously	caused	a	significant	 increase	 in	cortical	 thickness	(18).	 In	my	hands,	the	load-induced	changes	in	bone	mass	were	more	modest	than	anticipated.	Five	days	of	 loading	 with	 a	 maximum	 load	 of	 3.5	 N	 caused	 small	 but	 non-significant	 increases	 in	cortical	bone	volume	fraction	at	the	tibial	midshaft.	No	further	changes	were	detected	when	the	maximum	load	was	increased	to	5	N	(Figure	6.2).	
	
Figure	6.2:	MicroCT	of	the	cortical	midshaft	of	 loaded	and	non-loaded	mouse	tibias.	n=6.	p=0.09.			Since	 structural	 changes	 may	 be	 slower	 to	 develop	 than	 transcriptional	 changes	following	 load,	 qPCR	was	 also	 performed	on	whole	 bones.	Mice	were	 again	 loaded	 for	 5	consecutive	days	to	a	maximum	of	3.5	N	and	harvested	three	days	later.	Our	lab	previously	found	 that	 TGFb	 signaling	 is	 repressed	 following	 load,	 and	 the	 TGFb-responsive	 gene	
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Serpine1	was	significantly	downregulated	here	(Figure	6.3).	However,	we	expected	other	known	mechanosensitive	genes	to	be	differentially	expressed.	Sost	was	not	downregulated	and	 anabolic	 markers	 Col1a1,	 OC	 and	 AP	 were	 not	 upregulated,	 suggesting	 insufficient	stimulus	 or	 improper	 timing	 of	 the	 analysis.	 Attention	 was	 instead	 turned	 to	 shorter	timepoints	for	faster	troubleshooting.		
	
Figure	6.3:	Gene	expression	 in	whole	 tibias	 loaded	 for	 five	consecutive	days.	Serpine1	 is	significantly	downregulated	by	paired	t-test.	n=4.	*p<0.05.				At	 30	 minutes	 to	 2	 hours	 after	 a	 single	 loading	 session,	 we	 expected	 to	 find	upregulation	 of	 the	 rapidly	 mechanoresponsive	 gene	 Ptgs2	 in	 addition	 to	 possible	downregulation	of	Sost	and	Serpine1.	At	30	minutes	post-load,	Sost	repression	was	nearly	significant	(p=0.11),	but	no	other	gene	expression	was	as	anticipated	(Figure	6.4).		
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Figure	6.4:	Gene	expression	 in	whole	 tibias	 shortly	after	one	10-minute	 loading	 session.	mRNA	expression	 is	normalized	to	18s	and	then	to	the	non-loaded	 internal	control	bone.	Bars	show	geometric	mean.	n=2-4	per	timepoint.				 Previous	in	vivo	tibial	loading	in	our	lab	characterized	post-translational	responses	to	 load	more	 than	 transcriptional	 outcomes,	 so	 I	 collected	protein	 from	 loaded	and	non-loaded	bones	to	determine	whether	I	could	replicate	 load-induced	repression	of	pSmad3.	Bones	 collected	 2	 hours	 after	 a	 single	 load	 showed	 inconsistent	 changes	 to	 Smad2/3	phosphorylation.	Instead	of	repression,	pSmad3	was	induced	or	unchanged	(Figure	6.5).			
	
Figure	6.5:	pSmad3	expression	two	hours	after	a	single	loading	session.	The	whole	length	of	the	 tibia	 was	 collected	 after	 10	minutes	 of	 loading	 to	 the	 indicated	magnitude	 on	 load-control.			
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I	later	learned	that	the	previous	experiments	showing	post-load	pSmad3	repression	were	conducted	on	only	a	middle	region	of	the	tibia,	distal	to	most	of	the	trabecular	bone.	This	region	mainly	contains	cortical	bone,	and	it	was	difficult	to	harvest	sufficient	protein	to	visualize	on	a	Western	blot	using	a	mortar	&	pestle.	When	it	was	possible,	and	after	applied	loads	as	high	as	8	N,	no	load-induced	changes	were	obvious	(Figure	6.6	B).	It	was	much	easier	to	collect	protein	from	the	more	proximal,	cancellous-rich	region	of	the	tibia.	After	maximum	loads	of	8	N,	induction	of	pSmad3	was	apparent	in	the	proximal	tibia	(Figure	6.6	A).	Given	the	 apparent	 induction	 of	 pSmad3	 in	 whole	 bone	 (Figure	 6.5)	 and	 in	 proximal	 tissue,	 I	hypothesized	 that	 the	 proximal	 region	 of	 the	 tibia	 may	 be	 so	 cellular	 that	 it	 masks	 the	possibly	unique	load	response	happening	more	distally	when	the	entire	tibia	is	homogenized	together.	Quantification	of	RNA	yield	from	whole	tibias,	proximal	regions,	and	distal	regions	supports	 the	 possibility	 that	 molecular	 outcomes	 from	 whole	 tibias	 are	 dominated	 by	proximal	tissue	(Figure	6.6	C).	Given	the	difficulties	of	harvesting	bone	lysate	from	the	distal	region,	bones	were	still	harvested	in	their	entirety	until	methods	could	be	improved.		
	
Figure	6.6:	Regional	differences	 in	pSmad3	expression	post-load	and	 in	RNA	yield.	 (A-B)	pSmad3	expression	in	proximal	and	distal	tibia	two	hours	after	a	single	loading	session	to	a	maximum	load	of	8	N	on	load	feedback.	(C)	RNA	yield	in	35	µL	volume	from	whole	tibias	compared	to	tibia	regions	harvested	individually.	n=4-6.	*p<0.0001.		
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Since	 the	 loading	 sessions	 described	 thus	 far	 were	 all	 performed	 in	 load-control	mode,	the	applied	load	depends	heavily	on	the	accuracy	of	the	load	cell.	The	displacement	amplitude	for	 loads	cycling	between	0.5	N	and	3.5	N	compression	were	consistently	0.2	-	0.25	 mm.	 Over	 the	 10	 minute	 loading	 protocol,	 the	 displacement	 amplitude	 tended	 to	decrease,	 and	 the	maximum	 applied	 displacement	 increased,	 perhaps	 compromising	 for	shifting	of	soft	tissues	(Figure	6.7).	A	major	weakness	of	this	load	setup	was	that	the	metal	foot	holder	does	not	provide	consistent	resistance	for	the	mouse	foot.	In	many	cases,	the	foot	slipped	 completely	 out	 of	 the	holder,	 indicating	 that	 load	had	not	 been	 applied	perfectly	axially.		
	
Figure	6.7:	Representative	load	track	from	the	10	lb	load	cell	run	on	load	control	between	0.5	N	and	3.5	N	compression.			 The	frequent	foot	slipping	was	likely	caused	by	a	bent	connector	on	the	10	lb	load	cell	that	shifted	the	foot	holder	out	of	axial	alignment,	so	future	loading	was	performed	on	the	intact	50	lb	load	cell.	Preliminary	experiments	were	conducted	to	determine	whether	load-controlled	 waveforms	 were	 still	 appropriate	 for	 a	 load	 cell	 with	 lower	 sensitivity	 or	 if	displacement	feedback	would	provide	better	accuracy.	Initial	tests	with	the	50	lb	load	cell	
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were	run	on	load-control,	and	results	suggested	suppression	of	pSmad3	in	lysate	from	the	entire	 tibia	 (Figure	 6.8).	 This	 suggested	 that	 with	 the	 tibia	 aligned	 more	 vertically,	 the	expected	mechanosensitive	response	could	actually	be	stimulated.	However,	 the	 load	cell	seemed	insensitive	to	the	differences	between	3.5,	5,	and	8	Newton	maximum	loads,	as	the	displacement	amplitude	selected	in	the	case	of	these	three	trials	was	identical.	
	
Figure	6.8:	pSmad3	expression	after	loading	with	the	50	lb	load	cell	on	load-control.	The	whole	length	of	the	tibia	was	collected	two	hours	after	10	minutes	of	loading	to	the	indicated	magnitude.			Across	 multiple	 experiments,	 mechanosensitive	 repression	 of	 pSmad3	 was	 not	consistent	after	loading	with	the	50	lb	load	cell	on	load-control.	After	learning	that	previous	loading	experiments	in	the	lab	had	in	fact	used	the	50	lb	load	cell	on	displacement-control,	I	switched	to	this	configuration.	Displacement	control	relies	less	on	the	real-time	computation	of	feedback	from	the	load	cell.	In	this	scenario,	the	mouse	leg	is	positioned	in	the	foot	and	knee	holders	and	the	actuator	is	manually	displaced	to	determine	positions	that	will	apply	the	 desired	 maximum	 and	 minimum	 forces.	 The	 actuator	 then	 cycles	 between	 those	positions	600	times	without	gathering	input	from	the	loadcell.		Over	 the	 course	 of	 a	 10	minute	 loading	 session	 run	 on	 displacement-control,	 the	displacement	 amplitude	 remains	 constant,	 but	 the	 applied	 load	 sensed	 by	 the	 load	 cell	decreases	over	time	(Figure	6.9).	This	again	may	be	due	to	shifting	of	soft	tissues	that	provide	
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less	resistance	to	load	over	time,	but	it	suggests	that	overshooting	the	applied	load	on	the	first	few	cycles	may	be	necessary	in	order	to	achieve	the	desired	load	through	the	end	of	the	10	minute	protocol.	Displacement-control	removes	the	necessity	of	fast	and	accurate	load-cell	readouts	for	tuning	of	the	waveform	in	real-time	but	may	introduce	additional	variation	in	 terms	of	 actual	 load	applied	 to	each	 subject.	The	 response	of	pSmad3	 to	 load	was	not	obviously	different	when	applied	via	load-control	or	displacement-control	(Figure	6.10).	
	
Figure	6.9:	Representative	load	track	from	50	lb	load	cell	run	on	displacement-control	for	goal	loads	between	3.5	N	and	0.5	N	compression.			
		
Figure	 6.10:	 Western	 blot	 comparing	 pSmad3	 mechanoregulation	 in	 load	 control	 and	displacement	control.	The	whole	length	of	the	tibia	was	collected	two	hours	after	one	10-minute	loading	session	to	a	maximum	of	3.5	N	compression	on	the	50	lb	load	cell.	
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In	 August	 of	 2016	 I	 learned	 that	 the	 existing	 loading	 protocol	 which	 caused	repression	of	pSmad3	did	not	use	an	anesthesia	recovery	agent,	atipamezole,	that	I	had	thus	far	been	using	at	 the	end	of	each	 loading	session.	My	 interpretation	of	 the	Western	blots	below	 was	 that	 without	 atipamezole,	 pSmad3	 was	 suppressed	 by	 load,	 but	 that	 with	atipamezole	 it	 was	 increased	 by	 load	 (Figure	 6.11).	 This	 finding	 instigated	 the	 results	detailed	 in	 Chapter	 7	 regarding	 adrenergic	 regulation	 of	 TGFb	 signaling	 and	mechanosensation.	While	the	effect	of	atipamezole	on	load-induced	Smad3	phosphorylation	was	not	significant	across	multiple	experiments,	the	mice	did	not	appear	to	suffer	from	its	omission,	and	so	atipamezole	was	not	used	in	the	remainder	of	the	loading	experiments.				
	
	
Figure	6.11:	Effect	of	atipamezole	on	the	mechanoregulation	of	pSmad3.	The	whole	length	of	 the	 tibia	 was	 collected	 four	 hours	 after	 one	 10-minute	 loading	 session	 run	 on	displacement-control	with	goal	loads	between	3.5	N	and	0.5	N	compression.	Mice	were	either	injected	with	atipamezole	recovery	agent	immediately	following	loading	or	simply	moved	to	a	warm	cage	for	recovery.	
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After	the	cessation	of	atipamezole	administration,	two	other	factors	were	changed	in	quick	 succession.	 First,	 to	 aid	 in	 mouse	 recovery	 from	 anesthesia,	 the	 concentration	 of	xylazine	in	the	injectable	anesthesia	mix	was	lowered	from	the	original	dose	of	16	mg/kg	to	10	mg/kg.	Second,	methods	for	protein	harvest	from	loaded	tibias	were	changed	when	the	lab	purchased	a	bead	mill	homogenizer	that	 lyses	bones	with	ceramic	beads	in	individual	tubes.	This	device	helped	me	increase	protein	yield	and	produce	Western	blots	with	more	even	protein	content	across	lanes.	This	blot	(Figure	6.12)	represents	results	from	the	nearly	finalized	loading	parameters,	with	a	displacement-controlled	loading	protocol	being	run	to	an	attempted	 load	of	3.5	N	using	 the	50	 lb	 load	cell.	Here,	 three	different	mice	 loaded	 to	approximately	3N	of	maximum	compression	regulated	pSmad3	in	three	different	ways	after	load	 (upregulation,	 downregulation,	 and	 no	 change).	 Because	 Westerns	 are	 inherently	semiquantitative,	we	turned	to	qPCR	for	further	troubleshooting.		
	
	
Figure	 6.12:	 pSmad3	 expression	 after	 loading	with	 reduced	 xylazine	 in	 anesthesia.	 The	whole	length	of	the	tibia	was	collected	three	hours	after	one	10-minute	loading	session	run	in	displacement-control	with	goal	loads	between	3.5	N	and	0.5	N	compression.	Xylazine	in	the	 anesthesia	 was	 reduced	 to	 10	 mg/kg	 and	 no	 atipamezole	 recovery	 agent	 was	administered.	
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To	evaluate	the	transcriptional	response	of	bones	to	load	in	our	system,	tibias	were	loaded	in	displacement	control	to	achieve	maximum	load	amplitudes	of	3-6	N.	Loaded	and	non-loaded	bones	were	harvested	24	hours	post-load	and	processed	for	RNA.	At	24	hours	post-load,	we	evaluated	sclerostin	(Sost)	and	osteocalcin	(OC)	as	positive	controls,	expecting	that	Sost	would	be	downregulated	and	OC	upregulated	after	load	(9).	Mmp13	was	used	as	a	metric	of	PLR	activity.	 In	whole	 tibias,	 in	which	we	expect	 the	signal	 to	be	dominated	by	proximal	 tissue,	we	 found	 that	 Sost	was	 significantly	 downregulated,	 but	 neither	OC	nor	Mmp13	showed	consistent	load-dependent	effects	(Figure	6.13	A-C).		Additional	mice	were	 loaded	 to	 harvest	 and	 analyze	 gene	 expression	 in	 the	distal	portion	 of	 the	 tibia.	 In	 the	 distal	 tibia,	 both	 Sost	 and	 Mmp13	 were	 significantly	downregulated	24	hours	post-load	(Figure	6.13	D-E),	and	their	mechanoregulation	tended	to	be	related	within	individual	mice	(Figure	6.13	F).	The	apparent	co-regulation	of	Sost	and	Mmp13	in	the	distal	tibia,	and	the	absence	of	this	relationship	in	the	proximal-rich	whole	tibia,	 supports	 the	 possibility	 that	 distinct	 transcriptional	 responses	 occur	 in	 a	 location-dependent	manner.	The	critical	location-dependent	factors	could	be	related	to	local	strains	and	 fluid	 flow	 velocities,	 distinct	 mechanosensory	 mechanisms,	 or	 crosstalk	 with	 other	nearby	cell	types.	
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Figure	 6.13:	 qPCR	 performed	 on	 tibias	 collected	 24	 hours	 after	 one	 10-minute	 loading	session.	(A-C)	Expression	of	Sost	in	the	entire	tibia	is	significantly	downregulated,	but	OC	and	Mmp13	are	not	significantly	changed.	n=17-19.	(D-E)	In	the	distal	region	of	the	tibia,	Sost	and	Mmp13	are	both	significantly	downregulated.	n=14.	Bars	show	geometric	mean.	*p=0.02	by	ratio	paired	t-test.	(F)	Mechanoregulation	of	Sost	and	Mmp13	is	related	within	each	distal	tibia	sample.	b-actin	was	used	as	the	housekeeping	gene	throughout.				 Because	 the	 transcriptional	 response	 to	 load	 is	 dynamic,	 we	 also	 analyzed	 gene	expression	in	proximal	and	distal	tibias	at	3	hours	post-load.	Based	on	prior	studies	on	the	effects	of	load	on	mouse	bone	gene	expression	in	a	hindlimb	loading	model,	we	expected	Sost	to	be	downregulated	and	Timp1	to	be	upregulated	(9).	We	found	no	significant	changes	in	Sost,	Timp1,	or	Mmp13	expression	post-load	in	proximal	or	distal	tibia	sections	(data	not	shown).	Although	Sost	was	not	 significantly	 regulated	by	 load,	 using	proximal	 and	distal	sections	 of	 tibias	 rather	 than	 comparing	 whole	 tibias	 to	 distal	 tibias	 allowed	 pair-wise	comparison	 of	 regional	 transcriptional	 control	 within	 each	 bone.	We	 found	 a	 significant	
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relationship	 between	 proximal	 and	 distal	 Sost	 expression,	which	was	 absent	 for	Mmp13	(Figure	6.14).	While	use	of	different	bones	for	regional	comparisons	at	24	hours	post-load	precludes	the	exact	same	analysis,	the	differences	between	Sost	and	Mmp13	expression	at	both	timepoints	might	suggest	that	while	Sost	transcription	is	governed	similarly	throughout	the	whole	bone,	genes	like	Mmp13	have	more	site-specific	mechanoregulation.			
	
Figure	6.14:	Regional	 relationships	of	gene	expression	 in	 the	 tibia	3	hours	after	one	10-minute	 loading	 session.	The	 ratio	 of	 gene	 expression	 in	 loaded	 to	non-loaded	 samples	 is	compared	between	the	distal	and	proximal	region,	where	each	point	represents	one	mouse.	(A)	Sost	mechanoregulation	 is	significantly	correlated	between	regions	of	 the	same	bone,	*p=0.024,	 but	 (B)	Mmp13	does	 not	 show	 the	 same	 relationship.	b-actin	was	 used	 as	 the	housekeeping	gene.			 With	the	inherent	variation	in	load	applied	when	samples	are	individually	calibrated	for	loading	in	displacement	control,	we	expected	that	sclerostin	expression	might	vary	as	a	function	of	 load	 applied	 to	 each	mouse	 (16).	 Instead	we	 found	 that	 no	 such	 relationship	existed,	and	despite	the	wide	range	of	loads	experienced	by	different	tibias,	suppression	of	sclerostin	seemed	to	occur	randomly	(Figure	6.15	A-B).		
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Investigation	into	the	lack	of	anticipated	relationship	between	Sost	expression	and	load	 magnitude	 revealed	 that	 no	 relationship	 existed	 between	 actuator	 displacement	amplitude	and	load	feedback	recorded	during	hindlimb	loading	sessions	(Figure	6.15	C).	This	was	concerning,	because	displacements	were	being	determined	based	on	load	feedback	in	the	first	30	seconds	of	setup	for	each	mouse	and	were	expected	to	correlate.			
		
Figure	 6.15:	 Relationship	 of	 Sost	 gene	 expression	 to	 applied	 load.	 (A-B)	 Sost	 gene	expression	 data	 shown	 in	 Figure	 6.13-6.14	 is	 plotted	 relative	 to	 the	 amplitude	 of	compressive	load	experienced	by	each	loaded	limb.	No	significant	relationship	is	found.	(C)	The	amplitude	of	compressive	loading	experienced	by	each	loaded	limb	is	plotted	relative	to	the	displacement	settings	used	to	run	the	loading	session	in	displacement	control.	Each	point	represents	one	mouse	used	for	RNA	analysis	at	3	or	24	hours.	No	significant	relationship	is	found	(n=49,	p=0.65).	
	
	 Further	 troubleshooting	 of	 the	 50	 lb	 load	 cell	 revealed	 that	 there	 was	 electrical	interference	 causing	 an	 artificially	 high	 load	 readout	 of	 at	 least	 one	 Newton.	 When	 the	actuator	was	set	to	cycle	at	a	small	displacement	amplitude,	the	metal	adapters	connecting	the	load	cell	to	the	load	frame	caused	a	load	readout	to	register	despite	the	fact	that	nothing	was	touching	the	load	cell.	This	false	load	readout	in	the	non-loaded	condition	was	corrected	by	the	addition	of	plastic	adapters	to	electrically	 isolate	the	 load	cell	 from	the	load	frame	(Figure	6.16,	left).	
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Applying	 a	 small	 displacement	 amplitude	 to	 a	 mouse	 tibia	 in	 the	 original	 setup	generated	a	much	higher	load	response	readout	than	that	recorded	in	the	same	tibia	when	the	load	cell	was	electrically	isolated	(Figure	6.16,	right).	While	the	load	amplitude	appears	similar	in	both	mouse	loading	cases,	the	magnitude	of	applied	load	is	artificially	high	when	electrical	interference	is	allowed.	This	finding	suggested	that	when	I	had	previously	set	up	displacement	control	waveforms	without	isolation,	the	load	readout	appeared	sufficiently	high	 when	 the	 displacement	 amplitude	 was	 relatively	 small,	 causing	 a	 displacement	amplitude	that	was	lower	than	truly	necessary	to	be	selected	for	each	mouse.			
	 		
Figure	 6.16:	 Effect	 of	 electrical	 interference	 on	 load	 readouts.	 Left	 panel:	 Load	 data	registered	 while	 no	 mouse	 limb	 is	 in	 place	 to	 provide	 resistance	 to	 cyclic	 actuator	displacement.	Electrical	 interference	causes	false	 loads	to	register.	Right	panel:	Load	data	registered	on	the	same	mouse	limb	under	the	same	cyclic	actuator	displacement,	with	and	without	electrical	isolation.				
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To	 further	 test	 the	 effects	 of	 electrical	 interference	 on	 displacement-controlled	loading,	 I	 set	up	a	waveform	 to	apply	a	5	N	 target	 load	 to	a	mouse	 tibia	 in	both	adapter	configurations.	As	expected,	a	significantly	higher	displacement	amplitude	was	required	to	achieve	the	desired	load	when	the	load	cell	was	electrically	isolated	(Figure	6.17).	The	final	load	cell	setup	now	includes	plastic	adapters	and	washers	 in	order	to	minimize	electrical	interference.		
	
Figure	 6.17:	 Effect	 of	 electrical	 interference	 on	 displacement	 amplitude	 selection.	 The	displacement	waveforms	required	to	engender	maximum	compressive	 load	of	5	N	on	the	same	mouse	tibia	with	and	without	electrical	interference	are	shown.			 Posthoc	 analysis	 of	waveforms	 from	mouse	 tibial	 loading	 sessions	between	2016-2019	 demonstrates	 a	 significant	 load-displacement	 relationship	 when	 the	 load	 cell	 is	isolated	(Figure	6.18).	Extrapolation	of	this	data	also	suggests,	but	cannot	confirm,	that	loads	applied	to	mice	on	the	50	lb	load	cell	while	electrical	interference	was	occurring	were	likely	in	the	range	of	2-4	N	peak	amplitude.	Therefore,	previous	experiments	performed	on	the	50	lb	 load	 cell	 (Figures	 6.8	 –	 6.15)	 are	 not	 strictly	 invalidated	 by	 the	 finding	 that	 electrical	interference	was	present.	Rather,	the	high	variability	of	mechanosensitive	responses	may	be	
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partially	explained	by	the	low	magnitude	of	mechanical	stimuli.	Similarly,	loading	sessions	conducted	 on	 the	 10	 lb	 load	 cell	 (Figures	 6.2	 –	 6.7),	 while	 not	 affected	 by	 electrical	interference,	also	likely	provided	quite	small	stimuli	due	to	the	non-axial	alignment.			 	
	
	
Figure	6.18:	 Relationship	between	 actuator	displacement	 and	 recorded	 load.	 Each	point	represents	 one	 loading	 session	 for	 one	 mouse.	 The	 amplitude	 of	 compressive	 loading	experienced	by	each	loaded	limb	is	plotted	relative	to	the	displacement	settings	used	to	run	the	loading	session	in	displacement	control.	The	“with	interference”	points	are	the	same	as	those	shown	in	Figure	6.15	C,	replotted	here	for	comparison.	A	significant	correlation	exists	when	the	load	cell	is	electrically	isolated	(n=116	,	p<0.0001).			 To	better	secure	the	mouse	foot	during	application	of	new	higher	loads,	I	generated	a	foot	 holder	 that	 constrains	 the	 foot	 laterally	 and	maintains	 the	 ankle	 at	 a	 slight	 angle	 to	prevent	slipping	of	the	heel	 into	a	non-axial	 loading	position	(Figure	6.1	C).	When	mouse	tibias	are	axially	loaded	in	this	configuration,	we	see	load-dependent	phosphorylation	of	Akt	and	load-dependent	increases	in	mineral	apposition	rate	and	bone	formation	rate	measured	from	double	fluorochrome	labelling	(Chapter	8).		To	check	whether	any	of	the	applied	loads	are	damaging,	we	dissected	loaded	and	non-loaded	 tibias	 immediately	 after	 a	 single	 loading	 session	 and	 tested	 their	 flexural	
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properties	 in	 three-point	 bending	 (Figure	 6.19).	No	 significant	 differences	 in	 stiffness	 or	ultimate	 load	were	observed	between	 loaded	and	non-loaded	bones	 in	 either	 load	 range	tested.	Importantly,	axial	applied	loads	up	to	8	N	have	not	been	observed	to	cause	ACL	tears	in	our	setup.				
	
Figure	6.19:	 Flexural	 properties	 of	 tibias	 collected	 immediately	 after	 a	 single	10-minute	loading	session.	Lines	connect	non-loaded	and	loaded	tibias	from	the	same	animal.	No	load-induced	 changes	 in	 mechanical	 properties	 were	 observed	 at	 either	 load	 range.	 n=5	 per	group.			 Finally,	to	calculate	the	load-induced	strains	on	the	tibia,	a	separate	set	of	euthanized	mice	were	used.	Muscle	was	dissected	from	the	right	tibia	and	strain	gages	were	adhered	to	the	antero-medial	surface	of	the	bone.	The	mouse	was	then	situated	in	the	load	frame	and	displacement-controlled	 sinusoidal	 waveforms	 of	 increasing	 amplitude	 were	 applied	 to	induce	 a	 range	 of	 loads	 and	 strains,	which	were	 recorded	 in	 real	 time.	 The	 relationship	between	applied	load	and	tensile	strain	on	the	anteromedial	surface	was	linear,	with	loads	of	 6	 N	 generating	 approximately	 1050	 microstrain	 (Figure	 6.20).	 These	 results	 were	comparable	 to	numerous	other	 tibial	 loading	studies	(5,	19–22).	However,	 in	our	 loading	
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setup,	likely	due	to	the	high	degree	of	knee	flexion,	loads	of	10-13	N	tended	to	tear	the	ACL,	which	precludes	us	from	consistently	engendering	strains	above	1500.				
	
Figure	6.20:	Tensile	strain	engendered	on	the	anteromedial	surface	of	the	mouse	tibia	by	compressive	loads	applied	through	the	flexed	knee.	n=5	legs.	R2	=	0.91.	p<0.0001.			 The	murine	axial	tibial	loading	protocol	is	now	optimized	within	the	constraints	of	currently	available	materials	at	UCSF.	For	future	optimization,	I	suggest	purchasing	a	new	load	cell	that	is	aligned,	not	prone	to	electrical	interference,	and	sensitive	enough	to	run	on	load	 control.	 New	 custom	 adapters	 could	 also	 be	 machined	 to	 decrease	 the	 number	 of	connections	in	the	setup	and	allow	the	mouse	knee	to	rest	at	90	degrees	of	flexion	during	loading.	Biological	conclusions	about	the	effect	of	load	on	TGFb	signaling	and	PLR-related	gene	 expression	 are	 reserved	 for	 Chapter	 8,	 in	 which	 the	 optimized	 loading	 protocol	 is	consistently	applied.									
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		Chapter	7		Interactions	between	adrenergic	signaling	and	TGFb	in	vitro	
	
Introduction	A	large	body	of	work	supports	the	role	of	the	central	and	peripheral	nervous	system	in	bone	development,	homeostasis,	and	anabolism	(1).	The	periosteum	is	densely	innervated	with	 sensory	 and	 sympathetic	 nerves,	 and	 nerves	 accompany	 blood	 vessels	 through	 the	mineralized	bone	and	into	the	marrow	(2,	3).	Nerve	fibers	have	even	been	observed	in	direct	contact	with	osteoblasts	and	hematopoietic	cells	(4).	In	humans,	spinal	cord	injury	causes	rapid	loss	of	bone	mass	that	is	greater	than	would	be	expected	from	disuse	alone,	supporting	a	critical	role	for	the	nervous	system	in	bone	homeostasis	(5).	Innervation	by	sensory	nerves	is	essential	for	proper	ossification	during	development	and	contributes	to	load-induced	bone	formation	(6–8).	The	sympathetic	nervous	system	regulates	bone	mass	through	local	and	systemic	mechanisms	(9).	Given	the	many	possibilities	for	crosstalk	between	bone	and	the	nervous	system,	it	is	important	to	better	understand	the	role	of	the	nervous	system	in	bone.	
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Furthermore,	it	is	essential	to	understand	the	effects	on	bone	of	experimental	agents	used	in	research	that	act	by	manipulating	the	molecular	pathways	involved	in	the	nervous	system,	such	as	anesthetics	and	sedatives.		 The	effect	of	the	sympathetic	nervous	system	(SNS)	on	bone	has	garnered	substantial	interest	due	to	the	numerous	pharmacologic	agents	targeting	adrenergic	receptors,	which	mediate	most	of	 the	effects	of	 the	SNS.	Adrenergic	signaling	 involves	 three	main	 types	of	transmembrane	 G-protein	 coupled	 receptors:	 a1,	 a2,	 and	 b.	 In	 response	 to	neurotransmitters	 like	 norepinephrine	 (NE)	 or	 circulating	 epinephrine,	 a1	 receptors	activate	 phospholipase	 C	 and	 increase	 protein	 kinase	 C	 activity,	 which	mediates	 further	downstream	 effects.	 Signaling	 through	 a2	 receptors	 inhibits	 adenylyl	 cyclase	 activity,	whereas	b-type	receptors	activate	adenylyl	cyclase	(Figure	7.1).	When	adenylyl	cyclase	 is	active,	 it	 generates	 cyclic	 AMP,	 which	 activates	 protein	 kinase	 A	 (PKA),	 which	 can	phosphorylate	 transcription	 factors	 like	 Creb.	 β-blockers,	 generally	 prescribed	 for	management	of	blood	pressure,	decrease	sympathetic	tone	and	have	a	modest	but	significant	beneficial	 effect	 on	 bone	 mass	 and	 fracture	 risk	 (10,	 11).	 Clonidine,	 which	 decreases	sympathetic	activity	via	a2-adrenergic	receptors,	increases	bone	resorption	in	humans	(12).	These	 seemingly	 contradictory	 effects	 demonstrate	 the	 receptor-specific	 control	 of	sympathetic	 activity	 and	 emphasize	 the	 large	 gap	 in	 knowledge	 regarding	 the	 specific	regulatory	mechanisms	linking	the	SNS	to	bone	homeostasis.		
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Figure	7.1:	a2	and	b-adrenergic	receptors	have	opposing	effects	on	downstream	adrenergic	signaling	 and	 may	 modulate	 the	 normal	 response	 of	 TGFb	 signaling	 to	 mechanical	stimulation.			 In	addition	to	expression	within	the	nervous	system,	a2-	and	b-adrenergic	receptors	are	also	expressed	in	osteoblasts,	osteoclasts,	and	osteocytes	(13).	The	ability	of	sympathetic	hyperactivity	to	induce	osteopenia	has	been	attributed	to	NE	signaling	through	osteoblastic	β2-adrenergic	receptors,	which	promotes	RANKL	expression	and	subsequent	bone	loss	(14).	This	 relationship	 between	 β-adrenergic	 signaling	 and	 RANKL	 expression	 has	 also	 been	demonstrated	 in	 osteocytes	 (15,	 16).	 However,	 systemic	 ablation	 of	 two	 inhibitory	 a2	isoforms	in	mice	caused	sympathetic	hyperactivity,	high	plasma	NE	and	a	high	bone	mass	phenotype	 even	 though	 β2-adrenergic	 receptors	 were	 intact	 (13).	 Recent	 work	 has	demonstrated	 that	 osteoblasts	 and	 osteocytes	 in	 cortical	 bone	 express	 norepinephrine	transporter,	which	acts	to	limit	the	extracellular	concentration	of	NE	(17).	Thus,	in	addition	to	 presynaptic	 reuptake	 of	 NE,	 osteocytes	 can	 participate	 in	 regulating	 NE	 in	 their	 local	
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environment	that	may	otherwise	interact	with	a-	or	β-receptors.	Despite	the	demonstrated	importance	 of	 adrenergic	 signaling	 at	 the	 cellular	 level	 in	 bone,	 the	 specific	 signaling	pathways	linking	a2-	and	b-adrenergic	receptors	to	changes	in	bone	mass	are	incompletely	understood.		In	the	course	of	troubleshooting	the	in	vivo	tibial	loading	protocol	that	had	previously	caused	 repression	 of	 transforming	 growth	 factor	 beta	 (TGFβ)	 signaling	 in	 osteocytes	(Chapter	6),	a	possible	role	for	adrenergic	signaling	in	the	mechanosensitive	regulation	of	TGFβ	signaling	was	identified.	To	sedate	and	anesthetize	mice	for	loading	sessions,	injectable	ketamine-xylazine	bypasses	the	spatial	constraints	and	human	exposure	concerns	of	inhaled	isofluorane.	 Ketamine,	 an	 uncompetitve	 NMDA	 receptor	 antagonist,	 and	 xylazine,	 an	adrenergic	 a2	 receptor	 agonist,	 together	 act	 on	 the	 central	 nervous	 system	 to	 provide	sedative	 and	 analgesic	 effects	 for	 10-30	minutes.	 Specifically,	 xylazine	mimics	 NE	 in	 the	synapse,	 binds	 to	 presynaptic	 autoreceptors,	 and	 inhibits	 further	 NE	 release.	 To	 hasten	recovery	 from	anesthesia,	 this	effect	 can	be	reversed	by	a2	antagonists	 like	atipamezole,	which	prevent	NE	feedback	to	autoreceptors	and	stimulate	further	neurotransmitter	release.	In	humans,	atipamezole	can	increase	norepinephrine	and	epinephrine	levels	detectable	in	the	circulation	(18).	Atipamezole	in	particular	became	an	interesting	variable	because	its	use	seemed	 to	 cause	 consistent	 upregulation	 of	 pSmad3	 post-load,	 whereas	 experiments	conducted	 without	 atipamezole	 more	 often	 found	 repression	 of	 pSmad3	 post-load	(19)(Chapter	6).	Several	studies	have	described	interactions	between	TGFb	signaling	and	adrenergic	signaling,	but	none	have	identified	this	relationship	in	bone.	Serpine1	expression	in	cardiac	fibroblasts	is	stimulated	by	neurotransmitter	norepinephrine	and	acts	additively	with	TGFb	
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(20).	In	cancer	cells,	norepinephrine	stimulated	production	of	TGF-b	ligand	(21).	TGFb	may	also	be	able	to	act	on	adrenergic	signaling	pathways,	as	low	concentrations	of	TGFb	were	found	to	induce	PKA	activity	in	Mv1Lu	cells	(22).	This	raised	the	possibility	that	adrenergic	signaling	was	interacting	with	TGFb	 in	the	context	of	mechanosensation,	either	through	a	cell-intrinsic	 mechanism,	 innervation	 of	 bones,	 or	 delivery	 of	 epinephrine	 and	norepinephrine	through	the	circulation	(Figure	7.2).	Given	the	important	role	of	TGFb	in	the	skeleton	and	the	known	 interactions	between	TGFb	 signaling	and	adrenergic	signaling	 in	other	 cell	 types,	 we	 tested	 the	 hypotheses	 that	 adrenergic	 signaling	 regulates	 TGFb	 in	osteocytes	 and	 that	 physical	 cues,	 such	 as	 fluid	 flow	 shear	 stress,	 interfere	 with	 this	regulation.					
	
Figure	 7.2:	 Possible	 mechanisms	 of	 crosstalk	 between	 adrenergic	 signaling	 and	 TGFb	signaling	 in	osteocytes.	 Left,	 atipamezole	 could	directly	 stimulate	a2-adrenoreceptors	on	osteocytes	and	integrate	with	TGFb	in	a	cell-intrinsic	manner.	Center,	atipamezole’s	effects	on	 the	sympathetic	nervous	system	could	propagate	 to	osteocytes	 through	nerves.	Right,	neurotransmitters	 released	 into	 circulation	 after	 atipamezole	 administration	 could	stimulate	multiple	adrenergic	receptors	on	osteocytes.									
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Methods	
Cells	 Osteocyte	MLO-Y4	and	OCY454	cell	 lines	were	cultured	as	described	 in	Chapter	2.	OCY454	cells	were	differentiated	at	37	°C	for	14	days	before	treatment.	While	MLO-Y4	cells	do	not	express	sclerostin,	OCY454	cells	differentiated	for	14	days	robustly	express	osteocytic	markers	 Dmp1,	 Sost,	 and	 Phex	 (Figure	 7.3).	 Additionally,	 human	 epithelial	 kidney	 cells	(HEK293)	were	selected	for	their	known	expression	of	adrenergic	receptors.	HEK293	cells	were	cultured	on	tissue	culture	plastic	in	DMEM	with	10%	FBS	and	1%	P/S	at	37	°C.	
	
Figure	7.3:	Osteocytic	gene	expression	in	OCY454	cells.	RNA	was	collected	from	confluent,	undifferentiated	 cells	 (D0)	 and	 cells	 differentiated	 for	 14	 days	 (D14)	 after	 one	 hour	 in	treatment	media	containing	1%	FBS.	Bars	represent	mean	+/-	SD	from	three	replicates	in	one	experiment.	*p<0.01.			
Cell	treatments	Treatment	media	contained	10%	of	the	serum	of	culture	media.	Aliquots	of	treatment	media	were	prepared	with	drugs	and	equal	concentrations	of	vehicle,	then	split	over	wells	of	 different	 timepoints.	 Forskolin	 (F3917)	 stocks	were	prepared	 in	DMSO	at	 40	mM	and	stored	at	-20	°C.	(-)-norepinephrine	(A7257)	is	initially	dissolved	at	80	mM	in	100	µm	HCl,	then	diluted	4x	in	sterile	water,	aliquoted,	and	stored	at	-20	°C.	Isoproterenol	(I5627)	stocks	were	prepared	in	sterile	water	at	100	mM.	H-89	(B1427)	stocks	were	prepared	in	DMSO	at	
 137	
50	mM	and	stored	at	-20	°C.	Atipamezole	(5	mg/mL	stock)	and	xylazine	(100	mg/mL	stock)	are	liquid	formulations	stored	at	room	temperature.	TGFb1	ligand	(Peprotech)	is	prepared	in	sterile	water	at	5	µg/mL,	and	all	treatments	were	given	at	5	ng/mL.			
Western	blotting	At	the	end	of	treatment,	media	was	aspirated	and	cell	culture	wells	were	washed	with	cold	D-PBS.	Plates	were	placed	on	ice,	and	cell	lysis	buffer	(50	mM	Tris	pH	7.5,	150	mM	NaCl,	2	mM	EDTA,	0.5%	NP-40,	 0.25%	sodium	deoxycholate,	 supplemented	with	protease	 and	phosphatase	inhibitor	tablets)	was	added	to	wells.	Cell	lysate	was	then	collected,	sonicated	in	an	ice	water	bath	for	5	15-second	bursts,	centrifuged	at	12,000	g	for	10	minutes,	and	liquid	supernatant	stored	at	-20	°C.	Equal	volumes	of	protein	from	each	condition	or	replicate	were	loaded	 in	 10%	 SDS-polyacrylamide	 gels	 for	 electrophoresis.	 Primary	 antibodies	 used	 for	Western	blots	are	described	in	Table	2.2.			
Quantitative	RT-PCR	and	PCR	At	the	end	of	treatment,	media	was	aspirated	and	cell	culture	wells	were	washed	with	cold	D-PBS.	Plates	were	placed	on	ice,	and	TRIzol	was	added	to	wells.	Cell	lysate	was	then	collected	 and	 stored	 at	 -80	 °C	 until	 RNA	 harvest,	 reverse	 transcription,	 and	 qPCR,	 as	described	 in	 Chapter	 2.	 Expression	 was	 quantified	 by	 the	 DDCt	 method	 with	 the	housekeeping	genes	designated	in	each	figure.	For	PCR,	RNA	was	additionally	collected	from	mouse	kidney	and	mouse	tibia	without	marrow	by	homogenization	in	TRIzol.	Equal	concentrations	of	cDNA	from	mouse	tissues	and	untreated	OCY454	cells	were	used	for	PCR	with	primers	for	adrenergic	receptors	(Table	2.3).		
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Results	
Adrenergic	signaling	is	functionally	intact	in	osteocytes	and	dominated	by	b-adrenergic	
receptors	Expression	 of	 adrenergic	 receptors	 and	 existence	 of	 the	 signaling	 cascade	 from	adenylyl	cyclase	to	PKA	have	been	identified	in	osteocytes	(13,	23,	24),	but	their	functional	coupling	and	ability	to	stimulate	pCreb	in	osteocytes	has	not	been	demonstrated	(Figure	7.1).	To	test	whether	adrenergic	signaling	can	occur	in	an	osteocyte-intrinsic	manner,	we	treated	cells	in	culture	with	forskolin	and	with	norepinephrine.		As	expected	in	HEK293	cells,	forskolin	stimulation	of	adenylyl	cyclase	induced	rapid,	dose-dependent	Creb	phosphorylation	(Figure	7.4).	In	MLO-Y4	and	OCY454	osteocyte	cell	lines,	 forskolin	 also	 stimulated	 pCreb	 within	 15	 minutes	 of	 exposure.	 In	 all	 cells,	 the	magnitude	of	the	effect	was	sustained	through	30	minutes.		
	
Figure	7.4:	Intracellular	signaling	from	adenylyl	cyclase	to	pCreb	is	intact	in	osteocytes.	Cells	were	cultured	with	forskolin	(Fsk)	at	the	indicated	concentrations	or	with	an	equal	volume	of	DMSO	vehicle	for	15	or	30	minutes.	
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Since	 norepinephrine	 can	 interact	 with	 a2-	 and	 b-adrenoreceptors	 to	 induce	opposing	effects	on	adenylyl	cyclase	(Figure	7.1),	we	were	not	sure	whether	we	would	see	induction	or	repression	of	pCreb	if	osteocytic	adrenergic	receptors	were	indeed	functional.	In	all	three	cell	types,	norepinephrine	induced	pCreb	at	most	concentrations	by	30	minutes	(Figure	7.5	A).	Results	collected	at	60	minutes	showed	a	similar	trend.	We	performed	PCR	on	OCY454	cells	and	on	cDNA	from	mouse	kidneys	and	tibias	to	confirm	the	expression	of	both	a2-	and	b-adrenergic	receptors	in	our	samples.	As	reported	by	Fonseca	et	al,	we	found	that	 a2a,	 a2c,	 and	 b2	 receptors	 are	 expressed	 in	 bone.	 OCY454	 cells	 expressed	predominantly	 a2a	 and	 b2	 receptors.	 We	 focused	 on	 the	 b2	 subtype	 because	 it	 has	previously	 been	 shown	 to	 play	 a	 key	 role	 in	 sympathetic	 regulation	 of	 bone	mass	 (14).	Therefore,	 adrenergic	 signaling	 from	 the	 receptor	 level	 to	 the	 effector	 pCreb	 is	 intact	 in	osteocytes,	and	while	osteocytes	express	a2-	and	b-adrenoreceptors,	the	adenylyl	cyclase-activating	b-receptors	appear	to	be	functionally	predominant.		
	
Figure	7.5:	Adrenergic	signaling	from	norepinephrine	to	pCreb	is	intact	in	osteocytes.	(A)	Western	blots	of	cells	treated	with	norepinephrine	(NE)	at	the	indicated	concentrations	or	
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with	 an	 equal	 volume	 of	 acid	 vehicle	 for	 15	 or	 30	 minutes.	 (B)	 PCR	 of	 adrenoreceptor	subtybes	expressed	in	OCY454,	mouse	kidney,	and	mouse	tibia.			 We	 hypothesized	 that	 if	 b-adrenergic	 receptors	 dominate	 the	 norepinephrine	response	 in	osteocytes,	 then	direct	 stimulation	of	b-adrenergic	 receptors	would	 induce	a	similar	pCreb	response.	Indeed,	a	1	µM	dose	of	isoproterenol,	a	non-selective	agonist	of	b-adrenergic	 receptors,	was	 sufficient	 to	 double	 Creb	 phosphorylation	 in	 OCY454	 cells,	 an	effect	that	strengthened	and	persisted	longer	with	higher	doses	(Figure	7.6).	Therefore,	 if	neurotransmitters	released	 into	circulation	after	atipamezole	 treatment	reach	osteocytes,	they	may	induce	an	osteocyte-intrinsic	signaling	cascade	through	b-adrenergic	receptors.		
	
Figure	7.6:	Isoproterenol	stimulates	pCreb	in	osteocytes.	(A)	Western	blots	of	OCY454	cells	treated	 with	 isoproterenol	 (Iso)	 at	 the	 indicated	 concentrations	 for	 15-90	 minutes.	 (B)	Quantification	of	pCreb	relative	to	b-actin	control	for	n=1	replicate	per	condition/timepoint.				
Direct	action	of	xylazine	and	atipamezole	on	osteocytes	is	unlikely	The	anesthesia	component	xylazine	and	the	reversal	agent	atipamezole	both	act	on	
a2	 receptors,	 but	 their	 ability	 to	 initiate	 downstream	 signaling	 in	 an	 osteocyte-intrinsic	manner	is	unknown.	Xylazine,	an	agonist	of	inhibitory	a2	receptors,	would	be	expected	to	repress	pCreb.	The	effect	was	actually	more	complex	than	expected,	with	a	possible	short-
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term	upregulation	of	pCreb	followed	by	slight	repression.	HEK293	cells	and	OCY454	cells,	in	particular,	showed	a	slight	reduction	in	pCreb	after	30-60	minutes	of	treatment	(Figure	7.7).				
	
Figure	7.7:	Xylazine	may	repress	pCreb	in	osteocytes.	Cells	were	treated	with	xylazine	(Xyl)	at	the	indicated	concentrations	for	15-60	minutes.	n=1	replicate	per	condition/timepoint.			 Atipamezole,	as	an	antagonist	of	the	inhibitory	a2	receptors,	would	be	expected	to	increase	 pCreb.	We	 saw	 a	modest	 increase	 in	 pCreb	 in	 two	 cell	 types	with	 low	 doses	 of	atipamezole	(Figure	7.8),	but	it	would	probably	cause	a	bigger	increase	in	conjunction	with	isoproterenol-induced	activation	of	b-adrenergic	receptors.			
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Figure	 7.8:	 Atipamezole	 may	 induce	 pCreb	 in	 osteocytes.	 Cells	 were	 treated	 with	atipamezole	 (Atip)	 at	 the	 indicated	 concentrations	 for	 30-60	minutes.	 n=1	 replicate	 per	condition/timepoint.					 Compared	 to	stimulation	of	b-adrenergic	receptors,	osteocyte-intrinsic	stimulation	and	inhibition	of	a2-adrenergic	receptors	cause	a	weaker	effect.	We	therefore	hypothesize	that	 xylazine	 and	 atipamezole	 do	 not	 act	 directly	 on	 osteocytes	 in	 vivo,	 and	 the	 more	meaningful	 stimulus	 is	 the	 change	 in	 norepinephrine	 in	 circulation	 and	 from	 local	sympathetic	 nerves	 which	 serves	 to	 activate	 b-adrenergic	 receptors	 on	 osteocytes	 to	interfere	with	TGFb	signaling.										
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Forskolin	regulates	canonical	and	non-canonical	TGFb	signaling	in	osteocytes	To	test	the	hypothesis	that	b-adrenergic	signaling	regulates	TGFb	signaling,	we	used	forskolin	 to	 stimulate	 the	 intracellular	 signaling	 cascade	 following	 b-AR	 activation.	 As	expected,	 forskolin	 significantly	 induced	 pCreb	 in	 OCY454	 cells	 with	 15-90	 minutes	 of	treatment	(Figure	7.9).	To	determine	the	effect	of	forskolin	on	TGFb	signaling,	we	evaluated	its	ability	to	regulate	canonical	effector	pSmad3	and	non-canonical	effectors	p-p38	and	pAkt.	p-p38	 and	 pAkt	 were	 significantly	 induced	 and	 repressed,	 respectively,	 by	 forskolin	treatment,	 indicating	 robust	 adrenergic	 regulation	 of	 non-canonical	 TGFb	 signaling.	 The	effect	of	forskolin	on	pSmad3	was	modest	but	significant	at	15	min,	but	not	at	other	time	points.	However,	in	multiple	independent	experiments	on	OCY454	and	MLO-Y4	cells	(Figure	7.10),	we	consistently	saw	forskolin-induced	upregulation	of	pSmad3	with	15-30	minutes	of	treatment	 and	 downregulation	 of	 pSmad3	 to	 50%-90%	 of	 untreated	 levels	 after	 60-90	minutes	 of	 treatment.	 Therefore,	 forskolin	 regulates	 canonical	 and	 non-canonical	 TGFb	effectors.	We	also	investigated	the	effect	of	1	µM	isoproterenol	on	TGFb	signaling.	We	found	that	 pCreb	 and	 pSmad3	were	 significantly	 induced	 by	 b-adrenergic	 stimulation	 after	 60	minutes	of	treatment,	but	the	difference	was	not	significant	by	90	minutes	(n=3,	data	not	shown).	This	may	 indicate	 that	 the	 signaling	 timeline	 is	 lengthened	by	stimulating	at	 the	receptor	level	rather	than	activating	adenylyl	cyclase.	Additional	experiments	with	longer	treatments	 or	 higher	 concentrations	 of	 isoproterenol	 will	 be	 necessary	 to	 discern	 any	receptor-specific	effects.		
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Figure	7.9:	Forskolin	regulates	TGFb	effectors	in	osteocytes.	OCY454	cells	were	treated	with	25	µM	forskolin	or	DMSO	vehicle	for	the	indicated	times.	Graphs	show	mean	+/-	SD	of	three	replicates	for	each	timepoint.	*p<0.05.					
	
Figure	7.10:	Forskolin	represses	pSmad3	in	MLO-Y4	cells.	(A)	Western	blot	of	MLOY4	cells	treated	with	25	µM	forskolin	or	DMSO	vehicle	for	90	minutes.	(B)	Quantification	of	pSmad3	relative	to	b-actin	control.	Graph	shows	mean	+/-	SD	of	three	replicates.	*p<0.05.				 Since	we	 previously	 observed	 a	 possible	 in	 vivo	 effect	 of	 adrenergic	 signaling	 on	pSmad3,	we	decided	to	further	probe	the	relationship	between	forskolin	and	canonical	TGFb	signaling.	To	determine	whether	the	effects	of	forskolin	on	pSmad3	are	dependent	on	PKA,	we	used	the	PKA	inhibitor	H-89.	We	tested	a	range	of	doses	of	H-89	on	OCY454	cells	and	two	
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different	 pretreatment	 durations	 before	 applying	 forskolin.	We	 found	 that	 regardless	 of	pretreatment	time,	the	highest	25	µM	dose	of	H-89	was	needed	to	lower	the	pCreb	response	to	forskolin,	but	this	dose	still	did	not	return	pCreb	to	non-forskolin-treated	levels.	In	these	experiments,	30	minutes	of	forskolin	slightly	raised	pSmad3	levels,	but	pretreatment	with	H-89	at	25	µM	blocked	this	response	(Figure	7.11).	Followup	experiments	suggested	that	pretreatment	is	not	strictly	necessary,	and	25	µM	H-89	is	effective	at	reducing	pCreb	if	added	to	 cells	 at	 the	 same	 time	 as	 forskolin.	 These	 results	 show	 that	 adrenergic	 regulation	 of	pSmad3	is	indeed	dependent	on	PKA.			
	
Figure	7.11:	 Induction	of	pCreb	and	pSmad3	by	 forskolin	depends	on	PKA.	OCY454	cells	were	 treated	with	25	µM	 forskolin	 or	DMSO	vehicle	with	 or	without	H-89.	Graphs	 show	quantification	of	one	replicate	per	condition/timepoint.			
	
	
Forskolin	reduces	the	response	of	osteocytes	to	TGFb	ligand	Another	group	has	reported	additive	effects	of	TGFb	and	norepinephrine	in	cardiac	fibroblasts	 (20),	 so	 we	 hypothesized	 that	 regulation	 of	 pSmad3	 by	 forskolin	 would	 be	stronger	 in	 the	presence	of	TGFb	 ligand.	A	maximal	pSmad3	 response	 to	TGFb	 generally	occurs	around	60	minutes	of	treatment,	so	we	treated	OCY454	cells	with	TGFb	and	forskolin	together	for	30-90	minutes.	As	expected,	TGFb	significantly	induced	Smad3	phosphorylation	
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at	all	 timepoints	(Figure	7.12).	No	forskolin-dependent	effects	on	pSmad3	were	observed	between	30-60	minutes	of	treatment,	consistent	with	Figure	7.9.	At	90	minutes,	however,	forskolin	 suppressed	 pSmad3	 relative	 to	 vehicle-treated	 cells	 in	 the	 control	 and	 TGFb-treated	groups	(Figure	7.12).			
	
Figure	7.12:	Forskolin	represses	TGFb-induced	pSmad3.	OCY454	cells	were	treated	with	25	
µM	forskolin	or	DMSO	vehicle	concurrently	with	0	or	5	ng/mL	TGFb	for	the	indicated	times.	Graphs	show	mean	+/-	SD	of	pSmad3	relative	to	b-actin	control	for	three	replicates	of	each	condition.	*p<0.05	effect	of	forskolin	by	two-way	ANOVA.					 To	determine	if	adrenergic	and	TGFb	signaling	pathways	interact	in	their	effects	on	downstream	gene	expression,	we	examined	the	expression	of	c-fos,	Serpine1,	Ptgs2	and	Sost.	C-fos	serves	as	a	positive	control	for	forskolin	treatment,	and	Serpine1	serves	as	a	positive	control	for	TGFb	treatment,	while	Ptgs2	and	Sost	are	involved	in	the	response	to	mechanical	stimuli.	All	genes	were	subject	 to	significant	regulation	by	 forskolin,	with	c-fos	and	Ptgs2	
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upregulated	 and	 Sost	 and	 Serpine1	 downregulated	 (Figure	 7.13).	 Mmp13	 was	 also	significantly	 induced	by	 forskolin	after	 three	hours	of	 treatment	 (data	not	shown).	While	Serpine1	 is	 responsive	 to	 TGFb	 in	 the	 presence	 of	 DMSO,	 the	 overall	 effect	 of	 TGFb	 is	diminished	 in	 the	 presence	 of	 forskolin.	 This	 result	 is	 consistent	 with	 the	 repression	 of	pSmad3	after	 long-duration	forskolin	treatment	but	 inconsistent	with	the	upregulation	of	pSmad3	 observed	 in	 loaded,	 atipamezole-treated	 bones.	 Nevertheless,	 these	 results	illustrate	 both	 post-translational	 and	 transcriptional	 modulation	 of	 TGFb	 signaling	 by	forskolin	treatment.			
		
Figure	7.13:	Forskolin	diminishes	the	transcriptional	response	of	Serpine1	to	TGFb.	RNA	was	collected	from	OCY454	after	(A)	one	hour	or	(B)	three	hours	of	treatment	with	25	µM	Fsk	or	DMSO	vehicle	concurrently	with	0,	1,	or	5	ng/mL	TGFb.	Graphs	show	mean	+/-	SD	of	three	replicates	of	each	condition.	*p<0.05	effect	of	forskolin	by	two-way	ANOVA.		
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Discussion	These	 results	 establish	 that	 TGFb	 signaling	 is	 subject	 to	 regulation	 by	 adrenergic	signaling	 in	 osteocyte	 cell	 lines.	 Activating	b2	 receptors	 and	 inhibitory	a2	 receptors	 are	expressed	and	functional	in	osteocytes.	When	signaling	through	adenylyl	cyclase,	cAMP,	PKA	and	pCreb	is	activated,	the	canonical	TGFb	effector	pSmad3	is	dynamically	regulated,	and	multiple	non-canonical	effectors	are	rapidly	induced	or	repressed.	Therefore,	the	systemic	changes	in	neurotransmitter	availability	expected	to	occur	after	atipamezole	treatment	can	have	 an	 osteocyte-intrinsic	 effect	 on	 TGFb	 signaling	 that	 may	 disrupt	 its	 normal	mechanosensitive	response.		 Osteocytes	in	vitro	are	particularly	sensitive	to	the	activating	stimuli	of	isoproterenol	and	norepinephrine	(NE)	through	b-adrenergic	receptors	(ARs).	This	is	consistent	with	prior	work	 demonstrating	 the	 expression	 of	 b-ARs	 in	 the	 osteoblast	 lineage	 (13)	 and	 the	sensitivity	of	bone	mass	to	b-adrenergic	stimulation	and	inhibition	(11,	14).	While	current	reports	are	extremely	dose-,	time-,	receptor	subtype-,	and	target	tissue-specific,	stimulation	of	b2-ARs	both	reduces	bone	formation	and	induces	resorption	in	rodents	(14,	25–27).	The	regulation	of	canonical	TGFb	signaling	in	bone	by	adrenergic	signaling	pathways	may	be	one	driver	of	these	changes	in	bone	mass	(28).			 Sympathetic	 control	 of	 mechanosensitive	 bone	 remodeling	 has	 also	 received	extensive	research	attention.	While	antagonizing	b2-ARs	with	propranolol	did	not	affect	the	magnitude	of	 load-induced	bone	 formation	 in	young	mice	 (29),	 it	was	 found	 to	 suppress	unloading-induced	bone	loss	(30).	Adenylyl	cyclase	has	an	established	role	in	osteocytes	as	a	mediator	 of	mechanosensitive	 gene	 expression	 (23),	 and	we	 found	 here	 that	 forskolin	upregulated	 mechanosensitive	 Ptgs2.	 The	 forskolin-induced	 upregulation	 of	 Ptgs2	 and	
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downregulation	of	Sost	would	be	expected	after	 load,	however	 their	global	 regulation	by	sympathetic	hyperactivity	may	mask	further	mechanosensitive	responses	in	a	single	loaded	limb.	Bone	 loading	during	treadmill	exercise	was	recently	 found	to	suppress	sympathetic	tone	through	action	of	bone-derived	PGE2	on	sensory	nerves	(31).	This	finding	suggests	that	mechanosensation	in	bones	involves	the	hypothalamus	to	change	systemic	SNS	activity	and	favor	bone	anabolism.	High	plasma	NE	availability	and	activation	of	osteocytic	b-ARs	after	atipamezole	administration	would	compete	with	this	existing	signaling	mechanism,	which	may	 partially	 explain	 the	 absence	 of	 normal	 mechanosensitive	 anabolism	 in	 our	 earlier	mouse	 experiments	 (Figure	 6.2).	 Future	 work	 should	 determine	 the	 magnitude	 and	dynamics	of	NE	release	after	atipamezole	administration	in	mice.	While	sympathetic	tone	is	regulated	on	a	somewhat	systemic	level,	control	of	bone	remodeling	also	depends	on	local	signaling,	at	least	in	part	through	the	TGFb	pathway.	Past	work	 found	 that	 loading	 at	 low,	 physiological	 magnitudes	 repressed	 canonical	 effector	pSmad3,	 and	 that	 mice	 with	 inhibition	 of	 TGFb	 signaling	 are	 insensitive	 to	 load	 (19).	Therefore	the	 long-term	suppression	of	pSmad3	by	forskolin	 in	vitro,	and	the	diminished	transcriptional	 response	 of	 osteocytes	 to	 TGFb	 ligand	 after	 forskolin	 treatment	 in	 vitro	(Figure	 7.13),	 may	 suggest	 that	 atipamezole	 treatment	 in	 mice	 leads	 to	 systemic	 TGFb	inhibition.	 Similarly,	 the	 short-term	 induction	 of	 pSmad3	 by	 adrenergic	 signaling	 was	consistent	with	the	post-load	upregulation	of	pSmad3	observed	after	atipamezole	treatment	in	vivo,	and	may	mask	further	mechanosensitive	changes	in	Smad3	phosphorylation.	Since	
b-agonists	 reduce	 bone	mass,	maybe	 in	 addition	 to	 a	 RANKL-dependent	mechanism,	 the	short-term	induction	of	pSmad3	initiates	an	anti-anabolic	signaling	cascade.	Together	this	
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work	illustrates	that	TGFb	signaling	through	multiple	effectors	is	a	new	possibility	for	the	local	effects	of	sympathetic	nerve	activity	on	mechanosensitive	bone	remodeling.																																										
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		Chapter	8	Mechanosensitive	regulation	of	PLR	
	
Introduction	Skeletal	 tissue	 has	 the	 remarkable	 ability	 to	 adapt	 to	 the	mechanical	 demands	 it	experiences.	In	cases	of	microgravity	or	disuse,	bone	mass	is	resorbed	(1).	After	high	loads,	bone	cells	change	their	transcriptional	profile	and	increase	bone	deposition	in	order	to	meet	similar	mechanical	demands	in	the	future	(2,	3).	Bone	strength	is	determined	not	only	by	bone	mass,	but	also	by	bone	quality.	Therefore,	a	major	question	in	the	field	is	whether	bone	quality	is	also	mechanosensitively	regulated.		In	addition	 to	evaluating	 the	mechanosensitivity	of	bone	mass,	many	studies	have	utilized	the	same	rodent	models	of	loading	or	exercise	in	order	to	characterize	load-induced	changes	in	bone	material	quality	at	multiple	length	scales.	Three	weeks	of	treadmill	running	affected	 strain	 to	 failure,	 yield	 stress,	 ultimate	 stress	 in	 the	 tibia	 (4,	 5),	 with	 further	significant	increases	in	ultimate	stress	and	modulus	after	two	weeks	of	recovery	time	(6).	At	a	smaller	scale,	treadmill	running	also	affects	carbonate-to-phosphate	ratio	(7)	and	collagen	crosslinking	 (8).	 Two	weeks	 of	 tibial	 loading	 at	 2000	 με	 affects	mineral	 crystal	 size	 and	
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mineralization	ratio	measured	with	Raman	spectroscopy	in	addition	to	tibia	ultimate	stress	and	toughness	(9,	10).	Therefore	in	addition	to	changes	in	bone	mass,	and	sometimes	even	in	its	absence,	metrics	of	bone	quality	are	mechanosensitive.	The	response	of	bone	mass	and	quality	to	load	varies	with	the	magnitude	of	the	loading	stimulus	and	with	location	within	the	bone	(10–13),	suggesting	the	existence	of	specific,	calibrated	cellular	mechanisms	that	regulate	bone	quantity	and	quality.	Studies	of	bone	quality	have	been	largely	descriptive,	so	the	 cellular	 and	 molecular	 mechanisms	 linking	 applied	 loads	 to	 changes	 in	 quality	parameters	are	unknown.	Osteocytes	are	major	regulators	of	both	bone	mass	and	bone	quality.	In	response	to	glucocorticoids,	 hormones,	 TGFb	 signaling,	 and	 expression	 of	 individual	 proteases,	 they	increase	or	decrease	their	perilacunar/canalicular	remodeling	activity	with	implications	for	the	organization	and	strength	of	the	surrounding	bone	matrix.	 In	addition	to	their	role	 in	maintaining	 their	 local	 environment,	 osteocytes	 also	 communicate	 extensively	 with	osteoblasts	and	osteoclasts	in	response	to	physical	and	biochemical	stimuli.	Osteocytes	are	the	major	mechanosensory	 cells	 in	 bone,	 and	 they	 relay	 these	 signals	 to	 osteoblasts	 and	osteoclasts	to	control	bone	mass.	Receptor	activator	of	nuclear	factor-κB	ligand	(RANKL),	for	example,	 is	 released	 by	 osteocytes	 during	 bone	 disuse,	 which	 recruits	 osteoclasts	 and	increases	 resorption	 at	 the	 bone	 surface	 (14).	 Expression	 of	 sclerostin	 by	 osteocytes	 is	repressed	following	load,	which	relieves	inhibition	on	the	Wnt/β-catenin	signaling	pathway	that	 ultimately	 increases	 osteoblast	 deposition	 (15).	 Despite	 their	 known	 ability	 of	osteocytes	to	respond	to	load	with	paracrine	signaling,	it	is	not	known	whether	osteocyte	perilacunar/canalicular	remodeling	itself	is	a	mechanosensitive	process.		
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Several	studies	provide	cellular	evidence	for	and	against	the	mechanosensitivity	of	PLR.	 Exercise	 and	 hind-limb	 loading	 induce	 a	 dynamic	 transcriptional	 response	 in	 bone	including	changes	in	PLR-related	genes	Acp5,	Mmp14,	Fgf23,	and	Timp1	(2,	7,	16,	17).	Botox	paralysis	of	a	hindlimb	for	four	weeks	caused	a	decrease	in	lacunar	density,	and	15	days	of	spaceflight	increased	both	lacunar	area	and	canalicular	diameter	measured	by	NanoCT	(18,	19).	Neither	3-4	weeks	of	hindlimb	suspension,	nor	three	weeks	of	treadmill	running	were	sufficient	to	induce	a	change	in	lacunar	area	(7,	20).	However,	osteocyte	dendrites	are	much	more	mechanosensitive	than	cell	bodies	(21,	22),	and	we	have	often	observed	changes	to	canalicular	 morphology	 without	 corresponding	 changes	 to	 lacunae	 (23,	 24).	 To	 our	knowledge,	 the	 mechanosensitive	 regulation	 of	 canalicular	 remodeling	 in	 response	 to	increased	load	has	not	been	investigated.	Canalicular	 length	and	bone	material	quality	are	highly	dependent	on	homeostatic	TGFβ	signaling.	Systemic	inhibition	or	induction	at	the	ligand,	receptor	or	effector	level	alters	bone	mass,	 toughness	and	elastic	modulus	 (25–27).	Osteocyte-specific	 inhibition	of	TGFβ	signaling	 reduces	 expression	 of	 PLR	 enzymes,	 PLR-mediated	 organization	 of	 the	lacunocanalicular	network,	flexural	properties,	and	toughness	(23).	If	the	expression	of	PLR	enzymes	and	markers	of	bone	quality	are	controlled	by	TGFβ	signaling	in	osteocytes,	then	mechanosensitive	perturbations	in	TGFβ	signaling	could	also	affect	PLR	and	bone	quality.		TGFβ	 signaling	 is	 mechanoregulated	 at	 the	 ligand,	 receptor	 and	 effector	 levels,	processes	which	are	especially	relevant	in	a	tissue	exposed	to	as	many	mechanical	cues	as	bone	(28).	Our	lab	showed	in	2012	that	mechanosensitive	anabolism	depends	on	intact	TGFβ	signaling	(29).	Additionally,	preliminary	data	has	shown	that	 in	vivo	 load	leads	to	a	rapid	repression	of	MMP13,	known	to	be	under	the	control	of	TGFβ	and	essential	for	control	of	
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bone	quality	(30).	While	TGFβ	signaling	and	osteocytes	themselves	are	each	known	to	be	mechanosensitive,	their	interactions	to	regulate	bone	quality	have	not	been	elucidated.	By	examining	enzymes	involved	in	PLR,	and	the	organization	and	strength	of	bone	at	the	tissue-level,	 this	 project	 tests	 the	 hypothesis	 that	 osteocyte	 PLR	 controls	 bone	 quality	 in	 a	
mechanosensitive	and	TGFβ-dependent	manner.			
Methods	
In	vivo	axial	tibial	loading	The	mice	 used	 for	 these	 experiments	 were	 8-week	 old	male	 SBE-luciferase	mice,	which	 express	 luciferase	when	 Smad2/3-dependent	 TGFb	 signaling	 is	 active	 (Table	 2.1).	After	troubleshooting	and	optimization	(Chapter	6),	the	final	protocol	for	murine	axial	tibial	loading	 is	 described	 in	 Chapter	 2.	 Briefly,	 mice	 are	 anesthetized	 with	 injectable	ketamine/xylazine	anesthesia	(100	mg/kg	ketamine	and	10	mg/kg	xylazine)	and	the	right	knee	and	heel	are	positioned	between	custom	jigs	on	a	BOSE	Electroforce	ELF3200	desktop	load	frame.	600	cycles	of	axial,	compressive	load	between	approximately	-0.5	N	and	-6	N	are	applied	at	1	Hz	in	displacement	control.	The	load	and	displacement	data	are	recorded	at	10	Hz	in	order	to	calculate	the	actual	applied	loads	and	displacements	for	each	loading	session	for	each	mouse.	At	the	end	of	loading,	mice	are	returned	to	a	warm	cage	to	recover	and	then	ambulate	normally	until	the	next	loading	session	or	predetermined	harvest	time.	Loading	was	applied	for	either	one	10-minute	session,	or	for	one	10-minute	session	per	day	on	three	consecutive	days.	After	harvest,	 the	non-loaded	 tibia	serves	as	an	 internal	control	 for	each	animal,	as	others	have	determined	that	the	anabolic	response	to	load	is	not	systemic	(3).		
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Protein	harvest	and	Western	blotting	3-4	hours	after	a	single	10-minute	load	session,	mice	were	euthanized	and	both	tibias	dissected.	Marrow	was	centrifuged	out,	proximal	and	distal	regions	cut	apart	(Figure	8.1	A),	and	bone	portions	stored	 in	 liquid	nitrogen.	Protein	was	extracted	 from	 loaded	and	non-loaded	 bones	 using	 a	 bead	 mill	 homogenizer,	 quantified	 with	 the	 Bradford	 assay,	 and	separated	on	8.5%	SDS-polyacrylamide	gels.	Primary	antibodies	are	shown	in	Table	2.2.		Protein	was	detected	on	an	Odyssey	Infrared	Imager	(Licor)	and	images	quantified	in	ImageStudio	Lite	software.	Signal	 from	test	protein	bands	was	normalized	 to	signal	 from	corresponding	β-actin	 control	 bands	 for	 each	 sample.	Normalized	protein	 expression	 for	loaded	 bone	 regions	was	 then	 compared	 to	 corresponding	 non-loaded	 samples	 for	 each	mouse.		
Quantitative	RT-PCR	analysis		3	hours	and	24	hours	after	a	single	10-minute	loading	session	and	4	hours	after	the	last	of	three	loading	sessions,	mice	were	euthanized	and	both	tibias	dissected.	Marrow	was	centrifuged	out,	proximal	and	distal	regions	cut	apart	(Figure	8.1	A),	and	bone	portions	snap-frozen	in	liquid	nitrogen.	Bone	portions	were	immediately	homogenized	in	QIAzol	and	the	lysate	stored	at	-80	°C	until	RNA	extraction	and	purification	with	the	miRNeasy	Kit.	1000	ng	or	15	uL	of	RNA	was	reverse	transcribed	and	cDNA	concentration	normalized	to	10	ng/uL.	qPCR	was	performed	with	TaqMan	primers	(Table	2.3)	and	normalized	by	the	DDCt	method	with	β-actin	as	the	housekeeping	gene.					
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Dynamic	histomorphometry	
	 Mice	 used	 for	 histomorphometry	 were	 loaded	 for	 10	 minutes	 per	 day	 on	 three	consecutive	days.	Calcein	(20	mg/kg)	was	injected	three	days	after	the	first	load,	and	alizarin	(30	mg/kg)	was	injected	8	days	after	the	first	load.	Mice	were	euthanized	10	days	after	the	first	load,	and	both	tibias	were	stored	in	70%	ethanol.	Tibias	were	embedded	in	PMMA	and	sectioned	axially	at	a	site	approximately	50%	of	the	distance	between	the	two	tibiofibular	junctions.	Imaging	was	performed	on	a	confocal	microscope	and	quantification	conducted	in	ImageJ.	Mineralizing	surface	per	bone	surface	(MS/BS),	mineral	apposition	rate	(MAR),	and	bone	formation	rate	(BFR)	were	calculated	for	periosteal	and	endosteal	surfaces	(31).	Due	to	a	 lack	of	double	 labeling	observed	on	 the	periosteal	surface,	only	endosteal	values	are	reported.	Samples	without	endosteal	double	labeling	are	not	included	in	the	MAR	and	BFR	graphs.		
Histology		24	hours	after	a	single	10-minute	loading	session,	and	10	days	after	the	first	of	three	consecutive	days	of	 loading,	mice	were	euthanized	and	both	 tibias	dissected.	Tibias	were	fixed	in	10%	NBF,	decalcified	in	EDTA,	embedded	in	paraffin,	and	sectioned	in	the	axial	plane.	Immunohistochemistry	and	silver	nitrate	staining	were	performed	as	detailed	in	Chapter	2.		For	immunofluorescence,	sections	were	deparaffinized	and	antigens	were	retrieved	with	0.25%	trypsin-EDTA	at	37	°C	for	25	minutes.	Sections	were	blocked	with	Background	Buster	(Innovex)	for	10	minutes,	then	incubated	overnight	with	anti-sclerostin	antibody	at	4	°C,	as	described	in	Chapter	2.	Sections	chosen	for	analysis	were	selected	at	comparable	axial	positions	approximately	50%	of	the	distance	between	tibiofibular	junctions.	
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For	3D	canalicular	analysis,	decalcified	bones	were	incubated	in	sucrose	solution	and	then	embedded	in	OCT.	50	µm	sections	were	generated	on	a	Cryostat,	mounted	on	slides,	and	then	infiltrated	with	phalloidin,	DiI,	and	DAPI	(32).			
	
	
Results		
	 To	 evaluate	 the	 possible	mechanoregulation	 of	 PLR,	 I	 first	 sought	 to	 validate	 the	loading	model	with	established	mechanosensitive	outcomes.	I	loaded	the	right	hindlimbs	of	8-week	old	mice	for	10	minutes	and	collected	the	loaded	and	non-loaded	control	bones	4	hours	later	to	measure	the	mechanosensitive	phosphorylation	of	Akt	(33)(Figure	8.1	A,	D).	I	found	that	loads	above	5	N	tended	to	induce	pAkt	in	the	loaded	bone	compared	to	the	non-loaded	 bone,	 indicating	 effective	 mechanosensation	 (Figure	 8.1	 B,	 E).	 The	 relationship	between	 load	 and	pAkt	was	particularly	 strong	 in	 the	distal	 region	of	 the	 tibia,	 from	 the	midpoint	between	tibiofibular	junctions	to	the	distal	tibiofibular	junction	(Figure	8.1	A-C).	The	magnitude	of	pAkt	induction	in	the	loaded	limb	is	even	more	strongly	related	to	the	load	applied	when	it	is	normalized	to	the	weight	of	the	mouse,	suggesting	that	individual	bones	are	calibrated	for	their	physiological	experience	(Figure	8.1	C).	In	the	more	proximal	portion	of	bone,	which	contained	cortical	and	cancellous	bone,	4	N	 loads	were	often	sufficient	 to	induce	Akt	phosphorylation,	and	the	magnitude	of	response	was	not	increased	further	with	higher	loads	(Figure	8.1	A,	E,	F).		Analyses	of	strain	at	the	midpoint	between	tibiofibular	junctions	indicate	that	loads	of	4-6	N,	which	induce	pAkt,	engender	650-1050	microstrain	on	the	bone	surface	(Chapter	
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6).	To	determine	whether	these	load	and	strain	magnitudes	were	sufficient	to	induce	bone	formation,	 I	 loaded	 the	 right	 hindlimbs	 of	 mice	 on	 three	 consecutive	 days.	 Dynamic	histomorphometric	measurements	at	the	midpoint	between	tibiofibular	junctions	indicated	that	 loads	 of	 4-6	 N	 were	 indeed	 sufficient	 to	 induce	 bone	 formation	 (Figure	 8.1	 G-K).	Endocortical	 mineralizing	 surface	 (MS/BS),	 mineral	 apposition	 rate	 (MAR),	 and	 bone	formation	rate	(BFR)	were	significantly	increased	in	the	loaded	limb	compared	to	the	non-loaded	 limb.	 We	 expect	 that	 a	 loading	 protocol	 that	 induces	 mechanosensitive	 changes	related	to	bone	mass	would	also	be	sufficient	to	induce	changes	in	bone	quality.	
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Figure	8.1:	Validation	of	murine	axial	tibial	loading	protocol.	(A)	Diagram	of	murine	tibial	loading	setup	showing	where	proximal	and	distal	regions	of	the	tibia	were	separated	for	bulk	analyses.	 (B-F)	 Western	 blot	 analysis	 of	 pAkt	 in	 loaded	 limbs	 compared	 to	 non-loaded	control	limbs	of	the	same	animals.	The	ratio	of	pAkt	expression	in	loaded	and	non-loaded	bone	 is	plotted	for	the	(B,	C)	distal	and	(E,	F)	proximal	regions	relative	to	(B,	E)	 the	 load	applied	 to	 the	whole	 tibia	or	 (C,	F)	 the	 load	normalized	 to	mouse	body	weight.	n=13-15.	*p<0.05	 excluding	 outliers.	 (G-K)	 Dynamic	 histomorphometric	 analysis	 at	 the	 midpoint	between	 tibiofibular	 junctions.	 (H)	 Mineralizing	 surface	 per	 bone	 surface	 (MS/BS),	 (I)	mineral	 apposition	 rate	 (MAR),	 and	 (J)	 bone	 formation	 rate	 (BFR)	 are	 plotted	with	 non-loaded	and	loaded	limbs	from	the	same	animal	connected	by	a	line.	(K)	The	ratio	of	BFR	in	loaded	and	non-loaded	tibias	 is	plotted	relative	 to	 load	applied	 to	 the	whole	 tibia.	n=5-6,	because	no	double	labeling	was	observed	in	one	animal.	*p<0.05.	
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The	transcriptional	activity	of	bone	cells	in	response	to	high	loads	(9-11	N,	³1200	με)	at	high	frequencies	(2-4	Hz)	has	been	described	(2,	16,	17),	but	the	effect	of	physiological	load	 on	 genes	 encoding	 enzymes	 associated	with	 PLR	 has	 not.	 To	 begin	 to	 address	 this	question,	 I	 applied	 load	 to	 the	 right	 hindlimbs	 of	 mice	 for	 three	 consecutive	 days	 (34),	separated	 the	 proximal	 and	 distal	 portions	 of	 the	 tibia,	 and	 measured	 expression	 of	mechanosensitive	 gene	 Gja1,	 which	 encodes	 connexin	 43	 (35).	 I	 found	 that	 after	 three	consecutive	 days	 of	 load,	 connexin	 43	mRNA	was	 significantly	 upregulated	 in	 the	 distal	portion	of	the	tibia	(Figure	8.2	A).	Interestingly,	connexin	43	tended	to	be	downregulated	in	the	proximal	tissue	of	the	same	loaded	bones	(Figure	8.2	B).	Given	that	TGFb	signaling	 is	mechanosensitive	 and	 is	 involved	 in	 PLR	 (23,	 28,	 29),	 I	 expected	 to	 observe	mechanoregulation	 of	 the	 TGFb-responsive	 gene	 Serpine1,	 but	 its	 regulation	 was	 not	significant	 (Figure	 8.2	 C-D).	 However,	 across	 distal	 and	 proximal	 regions,	 the	mechanoregulation	of	Gja1	and	Serpine1	were	strongly	co-regulated	in	individual	samples	(Figure	 8.2	 E).	 Combined	 with	 the	 Western	 blot	 data	 showing	 the	 mechanosensitive	phosphorylation	of	Akt,	this	illustrates	the	site-specificity	of	the	molecular	response	to	load	in	the	tibia.	Analysis	of	PLR	genes	including	Mmps,	Cathepsin	K,	and	Acp5	by	Nanostring	is	in	progress.		 						
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Figure	8.2:	Gene	expression	in	distal	and	proximal	tibias	loaded	on	three	consecutive	days.	(A-B)	Gja1	 (Connexin	43)	 is	upregulated	 in	 the	distal	 tibia	4	hours	after	 the	 last	of	 three	loading	sessions,	but	 it	 is	not	mechanoregulated	in	the	proximal	tibia,	n=6	*p<0.02.	(C-D)	Serpine1	 is	 not	 significantly	 mechanoregulated	 at	 this	 timepoint	 in	 either	 region.	 Gene	expression	in	loaded	and	non-loaded	bones	from	the	same	animal	are	connected	by	a	line.	(E)	 Serpine1	 expression	 is	 related	 to	 Gja1	 expression	 in	 the	 same	 samples.	 Grey	 shaded	regions	indicate	repression.			
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To	learn	whether	proteins	involved	in	mechanosensation	and	PLR	were	regulated	in	our	 loading	model,	 we	 used	 immunofluorescence	 and	 immunohistochemistry	 to	 analyze	osteocyte	expression	of	sclerostin	and	MMP13.	Loaded	and	non-loaded	bones	were	collected	24	hours	after	a	single	 loading	session,	and	sections	at	 the	midpoint	between	tibiofibular	junctions	were	analyzed.	At	the	highest	loads	tested	–	6	N	or	above	0.2	N/g	body	weight	–	the	mechanosensitive	protein	 sclerostin	was	 repressed	 compared	 to	non-loaded	 controls	(Figure	8.3	A-C).	While	regions	predominantly	experiencing	tension	and	compression	were	analyzed	separately	 in	anticipation	of	 site-specific	differences	 (15),	 the	mechanosensitive	changes	 in	 sclerostin	were	uniform	across	 the	 axial	 cross	 section.	 Expression	of	 the	PLR	enzyme	MMP13	was	quantified	 in	 the	posterior	quadrant	of	 the	axial	 tibial	cross	section,	where	a	similar	response	to	load	was	observed.	MMP13	appeared	to	be	mechanosensitive,	with	higher	loads	causing	more	repression	(Figure	8.3	D-F).	This	result	may	indicate	that	while	high,	anabolic	loads	repress	PLR	enzyme	expression,	lower	loads	allow	normal	PLR	or	even	induce	it.	More	bones	loaded	at	higher	magnitudes	are	being	processed	for	analysis.	
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Figure	 8.3:	 Mechanosensitive	 expression	 of	 sclerostin	 and	 MMP13	 in	 osteocytes.	 (A)	Representative	immunofluorescence	images	of	sclerostin	24	hours	after	load.	(B-C)	The	ratio	of	 sclerostin	 expression	 in	 loaded	 and	 non-loaded	 osteocytes	 is	 plotted	 relative	 to	 (B)	applied	 load	 and	 (C)	 load	 normalized	 to	 mouse	 body	 weight.	 (D)	 Representative	immunohistochemistry	 images	of	MMP13	24	hours	 after	 load.	 (E-F)	The	 ratio	of	MMP13	expression	in	loaded	and	non-loaded	osteocytes	is	plotted	relative	to	(E)	applied	load	and	(F)	load	normalized	to	mouse	body	weight.	n=7.	
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 To	determine	the	ability	of	osteocytes	to	remodel	their	lacunocanalicular	network	in	response	 to	mechanical	 load,	we	 conducted	2D	 and	3D	 canalicular	 analyses.	 Bones	were	loaded	 for	 three	 consecutive	days	 at	 low	 (4	N)	 and	high	 (6	N)	 loads	within	our	 range	of	interest.	Preliminary	analysis	reveals	qualitative	differences	in	canalicular	morphology	with	load,	such	as	increased	canalicular	length	and	density	(Figure	8.4).	Quantitative	analyses	are	underway.	
 
 
Figure	8.4:	3D	whole-mount	staining	of	the	lacunocanalicular	network	in	the	distal	tibia.	
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Discussion	To	determine	the	extent	to	which	PLR	is	mechanoregulated	in	vivo,	we	investigated	cellular	and	tissue-level	hallmarks	of	PLR	in	loaded	and	non-loaded	mouse	tibias.	We	found	that	bone	anabolism	was	sensitive	to	load	magnitude	at	lower	loads	and	incident	strains	than	are	commonly	reported	(12,	13).	Loads	of	4-6	N	were	sufficient	to	induce	a	dynamic	response	in	mRNA	and	protein	expression	of	enzymes	associated	with	PLR	and	may	also	affect	the	morphology	 of	 the	 lacunocanalicular	 network.	 Together	 this	 study	 provides	 evidence	 in	support	of	the	hypothesis	that	PLR	is	mechanosensitively	regulated	in	a	way	that	may	couple	load	to	control	of	bone	quality.				 In	contrast	to	studies	that	focus	on	mechanosensitive	changes	to	bone	mass,	we	used	physiological	loads	to	determine	their	effect	on	osteocyte	behavior.	Reports	on	in	vivo	strain	gaging	 of	 mouse	 tibias	 have	 found	 that	 normal	 walking	 and	 jumping	 engenders	approximately	200-600	microstrain	of	tension	on	the	middle	of	the	medial	bone	surface	(12,	36).	Our	applied	loads	between	4-6	N	engendered	between	650-1050	microstrain,	and	were	sufficient	to	induce	modest	but	significant	changes	in	Akt	phosphorylation	and	MAR.	There	was	minimal	double	labeling	observed	on	the	periosteal	surface	of	bone,	consistent	with	the	low	 strains	 engendered	 relative	 to	 other	 work	 (37,	 38).	 We	 also	 found	 load-depended	changes	 in	 MMP13	 expression	 and	 canalicular	 morphology	 consistent	 with	mechanoregulation	of	PLR.		The	observed	responses	to	load	were	highly	dependent	on	the	magnitude	of	applied	load	and	strain.	MMP13	protein	expression,	for	example,	may	be	slightly	upregulated	at	low	loads,	 but	 downregulated	 at	 higher	 loads	 within	 our	 tested	 range.	 This	 switch	 from	upregulation	 to	 downregulation	 does	 not	 appear	 to	 coincide	 with	 the	 loads	 at	 which	
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anabolism	is	induced,	which	challenges	the	existing	paradigm	in	which	low	loads	fall	within	a	 “lazy	zone”	 that	does	not	 induce	a	mechanosensitive	 response.	The	switch	may	 involve	sequential	activation	of	cellular	mechanosensors	with	different	sensitivities,	crosstalk	with	nerves	or	vasculature	in	bone,	or	other	as-yet	unidentified	mechanisms.	Our	previous	 findings	that	 inhibition	of	TGFb	 signaling	reduces	osteocyte	PLR	and	bone	 quality	 and	 that	 pSmad3	 is	 repressed	 with	 load	 would	 together	 suggest	 that	 load	suppresses	 processes	 that	 are	 required	 for	 the	 maintenance	 of	 healthy	 bone	 quality,	however,	exercise	is	overall	beneficial	for	reducing	risk	of	fracture	(39,	40).	Therefore	it	was	ultimately	not	surprising	 to	 find	 that	 the	response	of	PLR	hallmarks	 to	 load	 is	 intricately	regulated	 in	 a	manner	 that	 could	 allow	 for	 cyclic	 induction	 and	 repression	 of	 osteocyte	activity	in	response	to	different	types	of	mechanical	stimuli.	For	example,	relatively	low	loads	may	 induce	 PLR	 activity,	whereas	 higher	 loads	 could	 repress	 local	 osteocyte	 remodeling	through	 PLR	while	 upregulating	 paracrine	 signaling	 to	 induce	 anabolism.	 As	 detailed	 in	Chapter	 6,	 there	 are	 many	 variables	 in	 the	 application	 of	 load,	 and	 other	 magnitudes,	frequencies,	 durations	 or	 recovery	 periods	may	 induce	 different	 effects.	 The	 differences	between	load	applied	directly	to	the	hindlimb	and	loading	induced	through	exercise	are	also	likely	important.			 Together	 this	 study	 and	 related	 ongoing	 work	 provides	 evidence	 for	 the	mechanosensitivity	of	osteocyte	PLR.	The	dependence	of	this	phenotype	on	TGFb	signaling	will	be	reserved	for	separate	investigation	using	a	different	strain	of	mice.	Further	studies	will	 be	 needed	 in	 order	 to	 link	mechanosensitive	 changes	 in	 bone	 quality	 to	 PLR	 and	 to	inform	clinical	decision-making	on	best	practices	for	modifying	bone	quality	in	vivo.			
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		Chapter	9	Conclusions	
	 The	 belief	 that	 osteocytes	 were	 dormant	 placeholders	 in	 bone	 has	 evolved	 to	 an	understanding	 of	 their	 essential	 dynamic	 role	 in	 bone	 maintenance.	 Largely	 in	 the	 past	decade,	 essential	 roles	 for	osteocytes	 in	bone	material	 quality	 and	 fracture	 resistance,	 in	bone	 disease,	 and	 in	mechanosensation	 have	 been	 elucidated.	 My	 doctoral	 research	 has	explored	and	contributed	to	each	of	these	themes.		The	 major	 findings	 of	 my	 dissertation	 research	 relate	 to	 bone	 quality	 and	 bone-cartilage	crosstalk.	I	identified	osteocyte-driven	crosstalk	between	bone	and	cartilage	as	a	causal	 factor	 in	 joint	 disease,	 where	 suppression	 of	 perilacunar/canalicular	 remodeling	(PLR)	 contributes	 to	 osteonecrosis	 and	 osteoarthritis.	 I	 helped	 to	 elucidate	 cell-intrinsic	roles	for	MMP13	and	TGFb	signaling	in	PLR,	and	I	demonstrated	that	PLR	regulates	bone	quality	during	homeostasis.	I	also	identified	a	novel	regulatory	role	for	adrenergic	signaling	in	mechanosensitive	TGFb	signaling.	Together,	we	now	know	that	osteocyte-specific	changes	in	signaling	regulate	PLR,	which	maintains	bone	quality	at	multiple	sites	and	has	implications	for	joint	disease	(Figure	9.1).		
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Figure	9.1:	Schematic	describing	findings	of	dissertation	research.		
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This	work	 also	pushes	 the	 field	 forward	 to	new	questions.	 For	 example,	 it	 is	 now	becoming	clear	that	osteocyte	maintenance	of	canaliculi	and	lacunae	are	distinct	processes,	but	 the	molecules	 and	mechanisms	 underlying	 this	 differential	 regulation	 are	 unknown.	Similarly,	different	genetic	or	drug	interventions	that	disrupt	PLR	show	different	patterns	of	co-regulation	 or	 compensatory	 expression	 of	 PLR	 genes,	 and	 these	 patterns	 are	 not	 yet	understood.	The	specific	biological	and	mechanical	mechanisms	through	which	osteocyte-intrinsic	defects	in	bone	are	able	to	affect	cartilage	also	need	to	be	investigated	further.	The	site-	and	load-specific	mechanoregulation	of	osteocyte	activity	in	the	mouse	tibia	also	merits	further	study	to	determine	how	healthy	osteocytes	calibrate	bone	material	properties	 for	their	functions	and	how	these	processes	are	disrupted	in	diseases	of	bone	fragility.		Future	work	will	hopefully	identify	additional	hallmarks	of	PLR	that	can	be	studied	in	vitro	or	in	high-throughput	systems.	The	development	of	clinical	markers	of	PLR	will	also	be	needed	 to	 further	 understand	 the	 contribution	 of	 osteocytes	 to	 disease	 development	 in	humans	and	to	evaluate	the	efficacy	of	novel	drugs	that	target	osteocytes.			
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